1.1 	A bill for an act
1.2 	relating to state government; modifying cannabis provisions; appropriating money;
1.3 	amending Minnesota Statutes 2023 Supplement, sections 3.9224; 151.72, 
1.4 	subdivisions 1, 2, 4, 5a, 5b, 6, 7; 256B.0625, subdivision 13d; 290.0132, subdivision 
1.5 	29; 290.0134, subdivision 19; 295.81, subdivisions 1, 4; 297A.70, subdivision 2; 
1.6 	342.01, subdivisions 3, 4, 14, 16, 17, 19, 20, 48, 64, 65, 66, by adding a subdivision; 
1.7 	342.02, subdivisions 2, 3, 5, 6; 342.07, subdivision 3; 342.09, subdivisions 1, 3; 
1.8 	342.10; 342.11; 342.12; 342.13; 342.14; 342.15, subdivisions 1, 2, by adding a 
1.9 	subdivision; 342.17; 342.18, subdivision 3, by adding subdivisions; 342.19, 
1.10 	subdivisions 1, 3, 4, 5; 342.22; 342.24, subdivisions 1, 2; 342.28, subdivision 2, 
1.11 	by adding a subdivision; 342.29, subdivisions 1, 4; 342.30, subdivision 4; 342.31, 
1.12 	subdivision 4; 342.32, subdivision 4; 342.35, subdivision 1, by adding a 
1.13 	subdivision; 342.37, subdivision 1; 342.40, subdivision 7; 342.41, subdivisions 1, 
1.14 	3; 342.44, subdivision 1; 342.51; 342.515; 342.52, subdivisions 1, 2, 3, 4, 5, 9, 
1.15 	11; 342.53; 342.54; 342.55, subdivisions 1, 2; 342.56, subdivisions 1, 2; 342.57, 
1.16 	subdivisions 1, 2, 3, 4, 5, 6, 7; 342.58; 342.60; 342.61, subdivisions 4, 5; 342.63, 
1.17 	subdivisions 2, 3, 4, 6; Laws 2023, chapter 63, article 1, sections 2; 51; 52; 53; 
1.18 	54; 55; 56; 57; 58; 59; 61; article 6, section 73; proposing coding for new law in 
1.19 	Minnesota Statutes, chapter 342; repealing Minnesota Statutes 2023 Supplement, 
1.20 	sections 342.01, subdivisions 28, 52, 53, 54, 55; 342.18, subdivision 1; 342.27, 
1.21 	subdivision 13; 342.29, subdivision 9; 342.47; 342.48; 342.49; 342.50; 342.52, 
1.22 	subdivision 8; Laws 2023, chapter 63, article 7, sections 4; 6.
1.23 	BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

1.24 	Section 1. Minnesota Statutes 2023 Supplement, section 3.9224, is amended to read:
1.25 	3.9224 MEDICAL CANNABIS; COMPACTS TO BE NEGOTIATED.
1.26 		Subdivision 1.Definitions. (a) As used in this section, the following terms have the 
1.27 	meanings given.
1.28 	(b) "Medical cannabis law" or "medical cannabis program" means the regulatory 
1.29 	framework for cultivation, production, distribution, and sale of cannabis to qualifying 
1.30 	patients for therapeutic use in the treatment of a qualifying condition.
2.1 	(c) "Medical Cannabis flower" means cannabis flower approved for sale under the 
2.2 	medical cannabis law of a Minnesota Tribal government or under a compact entered into 
2.3 	under this section.
2.4 	(d) "Medical cannabis product" means a cannabis product approved for sale under the 
2.5 	medical cannabis law of a Minnesota Tribal government or under a compact entered into 
2.6 	under this section.
2.7 	(e) "Medical cannabis business" means a medical cannabis cultivator, processor, or 
2.8 	retailer business with a medical cannabis retail endorsement.
2.9 	(f) "Medical cannabis industry" means every item, product, person, process, action, 
2.10 	business, or other thing or activity related to medical cannabis flower or medical cannabis 
2.11 	products and subject to regulation under the law of a Minnesota Tribal government or under 
2.12 	a compact entered into under this section.
2.13 	(g) "Cannabis product" means any of the following:
2.14 	(1) cannabis concentrate;
2.15 	(2) a product infused with cannabinoids, whether artificially derived, or extracted or 
2.16 	derived from cannabis plants or cannabis flower, including but not limited to 
2.17 	tetrahydrocannabinol; or
2.18 	(3) any other product that contains cannabis concentrate.
2.19 	(h) "Minnesota Tribal governments" means the following federally recognized Indian 
2.20 	Tribes located in Minnesota:
2.21 	(1) Bois Forte Band;
2.22 	(2) Fond Du Lac Band;
2.23 	(3) Grand Portage Band;
2.24 	(4) Leech Lake Band;
2.25 	(5) Mille Lacs Band;
2.26 	(6) White Earth Band;
2.27 	(7) Red Lake Nation;
2.28 	(8) Lower Sioux Indian Community;
2.29 	(9) Prairie Island Indian Community;
2.30 	(10) Shakopee Mdewakanton Sioux Community; and
3.1 	(11) Upper Sioux Indian Community.
3.2 	(i) "Tribal medical cannabis business" means a medical cannabis business licensed by 
3.3 	a Minnesota Tribal government, including the business categories identified in paragraph 
3.4 	(e), as well as any others that may be provided under the law of a Minnesota Tribal 
3.5 	government.
3.6 	(j) "Tribally regulated land" means:
3.7 	(1) all land held in trust by the United States for the benefit of a Minnesota Tribal 
3.8 	government ("trust land");
3.9 	(2) all land held by a Minnesota Tribal government in restricted fee status; and
3.10 	(3) all land within the exterior boundaries of the reservation of a Minnesota Tribal 
3.11 	government that is subject to the civil regulatory jurisdiction of the Tribal government. For 
3.12 	the purposes of this section, land that is subject to the civil regulatory jurisdiction of the 
3.13 	Tribal government includes:
3.14 	(i) trust land, or fee land held, including leased land, by the Tribe, entities organized 
3.15 	under Tribal law, or individual Indians; and
3.16 	(ii) land held, including leased land, by non-Indian entities or individuals who consent 
3.17 	to the civil regulation of the Tribal government or are otherwise subject to such regulation 
3.18 	under federal law.
3.19 		Subd. 2.Acknowledgment and purpose; negotiations authorized. (a) The state of 
3.20 	Minnesota acknowledges the sovereign right of Minnesota Tribal governments to regulate 
3.21 	the medical cannabis industry and address other matters of cannabis regulation related to 
3.22 	the internal affairs of Minnesota Tribal governments or otherwise within their jurisdiction, 
3.23 	without regard to whether such Tribal government has entered a compact authorized by this 
3.24 	section. The purpose of this section is to provide for the negotiation of compacts to 
3.25 	proactively address jurisdictional issues related to the regulation of the medical cannabis 
3.26 	industry. The legislature finds that these agreements will facilitate and promote a cooperative 
3.27 	and mutually beneficial relationship between the state and the Tribes regarding the 
3.28 	legalization of cannabis. Such cooperative agreements will enhance public health and safety, 
3.29 	ensure a lawful and well-regulated medical cannabis market, encourage economic 
3.30 	development, and provide fiscal benefits to both Indian Tribes and the state.
3.31 	(b) The governor or the governor's designee shall negotiate in good faith, and has the 
3.32 	authority to execute and bind the state to, a compact with any Minnesota Tribal government 
4.1 	wishing to enter into such a compact regulating medical cannabis flower and medical 
4.2 	cannabis products.
4.3 		Subd. 3.Terms of compact; rights of parties. (a) A compact agreed to under this 
4.4 	section may address any issues related to the medical cannabis industry, including medical
4.5 	cannabis flower, medical cannabis products, extracts, concentrates, and artificially derived 
4.6 	cannabinoids that affect the interest of both the state and Minnesota Tribal government or 
4.7 	otherwise have an impact on Tribal-state relations. Indian Tribes are not required to enter 
4.8 	into compacts pursuant to this section in order to regulate the medical cannabis industry, 
4.9 	or engage in medical cannabis businesses or activities on Tribally regulated land or participate 
4.10 	as a licensee in the state's legal medical cannabis market.
4.11 	(b) The state shall not, as a condition for entering into a compact under this section:
4.12 	(1) require any Minnesota Tribal government to waive any right, privilege, or immunity 
4.13 	based on their status as independent sovereigns;
4.14 	(2) require that any revenue generated by a medical cannabis business licensed by a 
4.15 	Minnesota Tribal government be subject to any state cannabis gross receipt taxes or state 
4.16 	and local sales or use taxes on sales of cannabis;
4.17 	(3) require any taxes collected by Minnesota Tribal governments to be shared in any 
4.18 	manner with the state or any subdivisions thereof;
4.19 	(4) require a Minnesota Tribal government to consent to state licensing of a medical 
4.20 	cannabis business on the Tribally regulated land of the Minnesota Tribal government;
4.21 	(5) require any Minnesota Tribal government or any medical cannabis business licensed 
4.22 	by a Minnesota Tribal government pursuant to a compact agreed to under this section to 
4.23 	comply with specific state law or regulations on Tribally regulated land; or
4.24 	(6) impose, or attempt to impose, and shall not require or attempt to require any Indian 
4.25 	Tribe to impose, any taxes, fees, assessments, and other charges related to the production, 
4.26 	processing, sale, purchase, distribution, or possession of medical cannabis flower and medical 
4.27 	cannabis products on Minnesota Tribal governments, or their members, on a reservation or 
4.28 	Tribally regulated land.
4.29 	(c) Compacts agreed to under this section may allow an exemption from any otherwise 
4.30 	applicable tax for: (i) sales to a Minnesota Tribal government, a Tribal medical cannabis 
4.31 	business, or Tribal members, of medical cannabis flower and cannabis products grown, 
4.32 	produced, or processed as provided for in said compacts; or (ii) for activities of Tribal 
4.33 	medical cannabis businesses.
5.1 		Subd. 4.Civil and criminal immunities. (a) Without limiting any immunity or exemption 
5.2 	that may apply under federal law, the following acts, when performed by a Tribal medical 
5.3 	cannabis business or an employee in the course of their employment for a Tribal medical 
5.4 	cannabis business, pursuant to a compact entered into under this section, do not constitute 
5.5 	a criminal or civil offense under state law:
5.6 	(1) the cultivation of medical cannabis flower, and the extraction, processing, or 
5.7 	manufacture of medical cannabis and artificially derived cannabinoid products, extracts, or 
5.8 	concentrates;
5.9 	(2) the possession, purchase, and receipt of medical cannabis seed, cannabis flower, and 
5.10 	medical cannabis products that are properly packaged and labeled as authorized under a 
5.11 	compact entered into pursuant to this section, and the sale, delivery, transport, or distribution 
5.12 	of such products to a licensed cannabis business; and
5.13 	(3) the delivery, distribution, and sale of medical cannabis seed, cannabis flower, and 
5.14 	medical cannabis products as authorized under a compact entered into pursuant to this 
5.15 	section and that takes place on, or originates from, the premises of a Tribal medical cannabis 
5.16 	business on Tribally regulated land, to any person eligible to participate in a medical cannabis 
5.17 	program.
5.18 	(b) The following acts, when performed by a patron of a Tribal medical cannabis business 
5.19 	do not constitute a criminal or civil offense under state law: the purchase, possession, or 
5.20 	receipt of medical cannabis seed, cannabis flower, and medical cannabis products as 
5.21 	authorized under a compact entered into pursuant to this section.
5.22 	(c) Without limiting any immunity or exemption that may apply under federal law, 
5.23 	actions by a Tribal medical cannabis business, a Tribal member, employee, or agent of a 
5.24 	Minnesota Tribal government or Tribal medical cannabis business on Tribally regulated 
5.25 	land pursuant to Tribal laws governing cannabis, or a compact entered into under this section, 
5.26 	do not constitute a criminal or civil offense under state law.
5.27 	(d) The following acts, when performed by a state-licensed medical cannabis business, 
5.28 	or an employee of such business, and which would be permitted under the terms of the 
5.29 	applicable medical cannabis business license if undertaken with another state-licensed 
5.30 	medical cannabis business, are permitted under the state license conditions when undertaken 
5.31 	with a Tribal medical cannabis business and do not constitute a criminal or civil offense 
5.32 	under state law: the possession, purchase, wholesale and retail sale, delivery, transport, 
5.33 	distribution, and receipt of medical cannabis, seed, cannabis flower, and medical cannabis 
6.1 	products that are properly packaged and labeled as authorized under a compact entered into 
6.2 	pursuant to this section.
6.3 	(e) Without limiting any immunity or exemption that may apply under federal law, the 
6.4 	following acts, when performed by a Minnesota Tribal government, a Tribal medical cannabis 
6.5 	business licensed by such Tribal government, or an employee of such Tribal government 
6.6 	or Tribal medical cannabis business, regardless of whether the Minnesota Tribal government 
6.7 	issuing such license has compacted with the state under this section, do not constitute a 
6.8 	criminal or civil offense under state law: purchase, sale, receipt, or delivery (including 
6.9 	delivery that involves transit through the state, outside a reservation), of medical cannabis 
6.10 	flower, cannabis seed, and medical cannabis products from or to another Minnesota Tribal 
6.11 	government or cannabis business licensed by such government.
6.12 	(f) Notwithstanding any other provision of law, a state-licensed cannabis testing facility 
6.13 	may provide cannabis testing services to a Tribal medical cannabis business, and the 
6.14 	possession or transport of cannabis flower or cannabis products for such purpose by a Tribal 
6.15 	cannabis business shall not constitute a criminal or civil offense under state law.
6.16 		Subd. 5.Publication. The governor shall post any compact entered into under this section 
6.17 	on a publicly accessible website.

6.18 	EFFECTIVE DATE. This section is effective the day following final enactment.

6.19 	Sec. 2. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 1, is amended 
6.20 	to read:
6.21 		Subdivision 1.Definitions. For the purposes of this section, the following terms have 
6.22 	the meanings given.
6.23 	(a) "Artificially derived cannabinoid" means a cannabinoid extracted from a hemp plant 
6.24 	or hemp plant parts with a chemical makeup that is changed after extraction to create a 
6.25 	different cannabinoid or other chemical compound by applying a catalyst other than heat 
6.26 	or light. Artificially derived cannabinoid includes but is not limited to any 
6.27 	tetrahydrocannabinol created from cannabidiol.
6.28 	(b) "Batch" means a specific quantity of a specific product containing cannabinoids 
6.29 	derived from hemp, including an edible cannabinoid product, that is manufactured at the 
6.30 	same time and using the same methods, equipment, and ingredients that is uniform and 
6.31 	intended to meet specifications for identity, strength, purity, and composition, and that is 
6.32 	manufactured, packaged, and labeled according to a single batch production record executed 
6.33 	and documented.
7.1 	(c) "Certified hemp" means hemp plants that have been tested and found to meet the 
7.2 	requirements of chapter 18K and the rules adopted thereunder.
7.3 	(d) "Commissioner" means the commissioner of health.
7.4 	(e) (d) "Distributor" means a person who sells, arranges a sale, or delivers a product 
7.5 	containing cannabinoids derived from hemp, including an edible cannabinoid product, that 
7.6 	the person did not manufacture to a retail establishment for sale to consumers. Distributor 
7.7 	does not include a common carrier used only to complete delivery to a retailer.
7.8 	(f) (e) "Edible cannabinoid product" means any product that is intended to be eaten or 
7.9 	consumed as a beverage by humans, contains a cannabinoid in combination with food 
7.10 	ingredients, and is not a drug.
7.11 	(g) (f) "Hemp" has the meaning given to "industrial hemp" in section 18K.02, subdivision 
7.12 	3.
7.13 	(h) (g) "Label" has the meaning given in section 151.01, subdivision 18.
7.14 	(i) (h) "Labeling" means all labels and other written, printed, or graphic matter that are:
7.15 	(1) affixed to the immediate container in which a product regulated under this section 
7.16 	is sold;
7.17 	(2) provided, in any manner, with the immediate container, including but not limited to 
7.18 	outer containers, wrappers, package inserts, brochures, or pamphlets; or
7.19 	(3) provided on that portion of a manufacturer's website that is linked by a scannable 
7.20 	barcode or matrix barcode.
7.21 	(j) (i) "Matrix barcode" means a code that stores data in a two-dimensional array of 
7.22 	geometrically shaped dark and light cells capable of being read by the camera on a 
7.23 	smartphone or other mobile device.
7.24 	(k) (j) "Nonintoxicating cannabinoid" means substances extracted from certified hemp 
7.25 	plants that do not produce intoxicating effects when consumed by any route of administration.
7.26 	(k) "Office" means the Office of Cannabis Management.
7.27 	(l) "Synthetic cannabinoid" means a substance with a similar chemical structure and 
7.28 	pharmacological activity to a cannabinoid, but which is not extracted or derived from hemp 
7.29 	plants, or hemp plant parts and is instead created or produced by chemical or biochemical 
7.30 	synthesis.

8.1 	Sec. 3. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 2, is amended 
8.2 	to read:
8.3 		Subd. 2.Scope. (a) This section applies to the sale of any product that contains 
8.4 	cannabinoids extracted from hemp and that is an edible cannabinoid product or is intended 
8.5 	for human or animal consumption by any route of administration.
8.6 	(b) This section does not apply to any product dispensed by a registered medical cannabis 
8.7 	manufacturer pursuant to sections 152.22 to 152.37.
8.8 	(c) The commissioner office must have no authority over food products, as defined in 
8.9 	section 34A.01, subdivision 4, that do not contain cannabinoids extracted or derived from 
8.10 	hemp.

8.11 	Sec. 4. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 4, is amended 
8.12 	to read:
8.13 		Subd. 4.Testing requirements. (a) A manufacturer of a product regulated under this 
8.14 	section must submit representative samples of each batch of the product to an independent, 
8.15 	accredited laboratory in order to certify that the product complies with the standards adopted 
8.16 	by the board on or before July 1, 2023, or the standards adopted by the commissioner office. 
8.17 	Testing must be consistent with generally accepted industry standards for herbal and botanical 
8.18 	substances, and, at a minimum, the testing must confirm that the product:
8.19 	(1) contains the amount or percentage of cannabinoids that is stated on the label of the 
8.20 	product;
8.21 	(2) does not contain more than trace amounts of any mold, residual solvents or other 
8.22 	catalysts, pesticides, fertilizers, or heavy metals; and
8.23 	(3) does not contain more than 0.3 percent of any tetrahydrocannabinol.
8.24 	(b) A manufacturer of a product regulated under this section must disclose all known 
8.25 	information regarding pesticides, fertilizers, solvents, or other foreign materials applied to 
8.26 	industrial hemp or added to industrial hemp during any production or processing stages of 
8.27 	any batch from which a representative sample has been sent for testing, including any 
8.28 	catalysts used to create artificially derived cannabinoids. The disclosure must be made to 
8.29 	the laboratory performing testing or sampling and, upon request, to the commissioner office. 
8.30 	The disclosure must include all information known to the licensee manufacturer regardless 
8.31 	of whether the application or addition was made intentionally or accidentally, or by the 
8.32 	manufacturer or any other person.
9.1 	(c) Upon the request of the commissioner office, the manufacturer of the product must 
9.2 	provide the commissioner office with the results of the testing required in this section.
9.3 	(d) The commissioner office may determine that any testing laboratory that does not 
9.4 	operate formal management systems under the International Organization for Standardization 
9.5 	is not an accredited laboratory and require that a representative sample of a batch of the 
9.6 	product be retested by a testing laboratory that meets this requirement.
9.7 	(e) Testing of the hemp from which the nonintoxicating cannabinoid was derived, or 
9.8 	possession of a certificate of analysis for such hemp, does not meet the testing requirements 
9.9 	of this section.

9.10 	Sec. 5. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5a, is amended 
9.11 	to read:
9.12 		Subd. 5a.Additional requirements for edible cannabinoid products. (a) In addition 
9.13 	to the testing and labeling requirements under subdivisions 4 and 5, an edible cannabinoid 
9.14 	must meet the requirements of this subdivision.
9.15 	(b) An edible cannabinoid product must not:
9.16 	(1) bear the likeness or contain cartoon-like characteristics of a real or fictional person, 
9.17 	animal, or fruit that appeals to children;
9.18 	(2) be modeled after a brand of products primarily consumed by or marketed to children;
9.19 	(3) be made by applying an extracted or concentrated hemp-derived cannabinoid to a 
9.20 	commercially available candy or snack food item;
9.21 	(4) be substantively similar to a meat food product; poultry food product as defined in 
9.22 	section 31A.02, subdivision 10; or a dairy product as defined in section 32D.01, subdivision 
9.23 	7;
9.24 	(5) contain an ingredient, other than a hemp-derived cannabinoid, that is not approved 
9.25 	by the United States Food and Drug Administration for use in food;
9.26 	(6) be packaged in a way that resembles the trademarked, characteristic, or 
9.27 	product-specialized packaging of any commercially available food product; or
9.28 	(7) be packaged in a container that includes a statement, artwork, or design that could 
9.29 	reasonably mislead any person to believe that the package contains anything other than an 
9.30 	edible cannabinoid product.
10.1 	(c) An edible cannabinoid product must be prepackaged in packaging or a container that 
10.2 	is child-resistant, tamper-evident, and opaque or placed in packaging or a container that is 
10.3 	child-resistant, tamper-evident, and opaque at the final point of sale to a customer. The 
10.4 	requirement that packaging be child-resistant does not apply to an edible cannabinoid product 
10.5 	that is intended to be consumed as a beverage.
10.6 	(d) If an edible cannabinoid product, other than a product that is intended to be consumed 
10.7 	as a beverage, is intended for more than a single use or contains multiple servings, each 
10.8 	serving must be indicated by scoring, wrapping, or other indicators designating the individual 
10.9 	serving size that appear on the edible cannabinoid product.
10.10 	(e) A label containing at least the following information must be affixed to the packaging 
10.11 	or container of all edible cannabinoid products sold to consumers:
10.12 	(1) the serving size;
10.13 	(2) the cannabinoid profile per serving and in total;
10.14 	(3) a list of ingredients, including identification of any major food allergens declared 
10.15 	by name; and
10.16 	(4) the following statement: "Keep this product out of reach of children."
10.17 	(f) An edible cannabinoid product must not contain more than five milligrams of any 
10.18 	tetrahydrocannabinol in a single serving. An edible cannabinoid product, other than a product 
10.19 	that is intended to be consumed as a beverage, may not contain more than a total of 50 
10.20 	milligrams of any tetrahydrocannabinol per package. An edible cannabinoid product that 
10.21 	is intended to be consumed as a beverage may not contain more than two servings per 
10.22 	container.
10.23 	(g) An edible cannabinoid product may contain delta-8 tetrahydrocannabinol or delta-9 
10.24 	tetrahydrocannabinol that is extracted from hemp plants or hemp plant parts or is an 
10.25 	artificially derived cannabinoid. Edible cannabinoid products are prohibited from containing 
10.26 	any other artificially derived cannabinoid, including but not limited to THC-P, THC-O, and 
10.27 	HHC, unless the commissioner office authorizes use of the artificially derived cannabinoid 
10.28 	in edible cannabinoid products. Edible cannabinoid products are prohibited from containing 
10.29 	synthetic cannabinoids.
10.30 	(h) Every person selling edible cannabinoid products to consumers, other than products 
10.31 	that are intended to be consumed as a beverage, must ensure that all edible cannabinoid 
10.32 	products are displayed behind a checkout counter where the public is not permitted or in a 
10.33 	locked case.

11.1 	Sec. 6. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 5b, is amended 
11.2 	to read:
11.3 		Subd. 5b.Registration; prohibitions. (a) On or before October 1, 2023, every person 
11.4 	selling edible cannabinoid products to consumers must register with the commissioner in 
11.5 	a form and manner established by the commissioner. After October 1, 2023, the sale of 
11.6 	edible cannabinoid products by a person that is not registered is prohibited.
11.7 	(a) Every person selling an edible cannabinoid product to a consumer must be registered 
11.8 	with the office. Existing registrations through the Department of Health, Office of Medical 
11.9 	Cannabis, must be transferred to the office by July 1, 2024. All other persons required to 
11.10 	register must register in a form and manner established by the office. The sale of edible 
11.11 	cannabinoid products by a person who is not registered with the office is prohibited.
11.12 	(b) The registration form must contain an attestation of compliance and each registrant 
11.13 	must affirm that it is operating and will continue to operate in compliance with the 
11.14 	requirements of this section and all other applicable state and local laws and ordinances.
11.15 	(c) The commissioner shall office must not charge a fee for registration under this 
11.16 	subdivision.

11.17 	Sec. 7. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 6, is amended 
11.18 	to read:
11.19 		Subd. 6.Noncompliant products; enforcement. (a) A product regulated under this 
11.20 	section, including an edible cannabinoid product, shall be considered a noncompliant product 
11.21 	if the product is offered for sale in this state or if the product is manufactured, imported, 
11.22 	distributed, or stored with the intent to be offered for sale in this state in violation of any 
11.23 	provision of this section, including but not limited to if:
11.24 	(1) it consists, in whole or in part, of any filthy, putrid, or decomposed substance;
11.25 	(2) it has been produced, prepared, packed, or held under unsanitary conditions where 
11.26 	it may have been rendered injurious to health, or where it may have been contaminated with 
11.27 	filth;
11.28 	(3) its container is composed, in whole or in part, of any poisonous or deleterious 
11.29 	substance that may render the contents injurious to health;
11.30 	(4) it contains any food additives, color additives, or excipients that have been found by 
11.31 	the FDA to be unsafe for human or animal consumption;
12.1 	(5) it contains an amount or percentage of nonintoxicating cannabinoids that is different 
12.2 	than the amount or percentage stated on the label;
12.3 	(6) it contains more than 0.3 percent of any tetrahydrocannabinol or, if the product is 
12.4 	an edible cannabinoid product, an amount of tetrahydrocannabinol that exceeds the limits 
12.5 	established in subdivision 5a, paragraph (f); or
12.6 	(7) it contains more than trace amounts of mold, residual solvents, pesticides, fertilizers, 
12.7 	or heavy metals.
12.8 	(b) A product regulated under this section shall be considered a noncompliant product 
12.9 	if the product's labeling is false or misleading in any manner or in violation of the 
12.10 	requirements of this section.
12.11 	(c) The commissioner office may assume that any product regulated under this section 
12.12 	that is present in the state, other than a product lawfully possessed for personal use, has 
12.13 	been manufactured, imported, distributed, or stored with the intent to be offered for sale in 
12.14 	this state if a product of the same type and brand was sold in the state on or after July 1, 
12.15 	2023, or if the product is in the possession of a person who has sold any product in violation 
12.16 	of this section.
12.17 	(d) The commissioner office may enforce this section, including enforcement against a 
12.18 	manufacturer or distributor of a product regulated under this section, under sections 144.989 
12.19 	to 144.993 section 342.19.
12.20 	(e) The commissioner may enter into an interagency agreement with The office of 
12.21 	Cannabis Management and may enter into an interagency agreement with the commissioner 
12.22 	of agriculture to perform inspections and take other enforcement actions on behalf of the 
12.23 	commissioner office.

12.24 	Sec. 8. Minnesota Statutes 2023 Supplement, section 151.72, subdivision 7, is amended 
12.25 	to read:
12.26 		Subd. 7.Violations; criminal penalties. (a) Notwithstanding section 144.99, subdivision 
12.27 	11, A person who does any of the following regarding a product regulated under this section 
12.28 	is guilty of a gross misdemeanor and may be sentenced to imprisonment for not more than 
12.29 	364 days or to payment of a fine of not more than $3,000, or both:
12.30 	(1) knowingly alters or otherwise falsifies testing results;
12.31 	(2) intentionally alters or falsifies any information required to be included on the label 
12.32 	of an edible cannabinoid product; or
13.1 	(3) intentionally makes a false material statement to the commissioner office.
13.2 	(b) Notwithstanding section 144.99, subdivision 11, A person who does any of the 
13.3 	following on the premises of a registered retailer or another business that sells retail goods 
13.4 	to customers is guilty of a gross misdemeanor and may be sentenced to imprisonment for 
13.5 	not more than 364 days or to payment of a fine of not more than $3,000, or both:
13.6 	(1) sells an edible cannabinoid product knowing that the product does not comply with 
13.7 	the limits on the amount or types of cannabinoids that a product may contain;
13.8 	(2) sells an edible cannabinoid product knowing that the product does not comply with 
13.9 	the applicable testing, packaging, or labeling requirements; or
13.10 	(3) sells an edible cannabinoid product to a person under the age of 21, except that it is 
13.11 	an affirmative defense to a charge under this clause if the defendant proves by a 
13.12 	preponderance of the evidence that the defendant reasonably and in good faith relied on 
13.13 	proof of age as described in subdivision 5c.

13.14 	Sec. 9. Minnesota Statutes 2023 Supplement, section 256B.0625, subdivision 13d, is 
13.15 	amended to read:
13.16 		Subd. 13d.Drug formulary. (a) The commissioner shall establish a drug formulary. Its 
13.17 	establishment and publication shall not be subject to the requirements of the Administrative 
13.18 	Procedure Act, but the Formulary Committee shall review and comment on the formulary 
13.19 	contents.
13.20 	(b) The formulary shall not include:
13.21 	(1) drugs, active pharmaceutical ingredients, or products for which there is no federal 
13.22 	funding;
13.23 	(2) over-the-counter drugs, except as provided in subdivision 13;
13.24 	(3) drugs or active pharmaceutical ingredients when used for the treatment of impotence 
13.25 	or erectile dysfunction;
13.26 	(4) drugs or active pharmaceutical ingredients for which medical value has not been 
13.27 	established; and
13.28 	(5) drugs from manufacturers who have not signed a rebate agreement with the 
13.29 	Department of Health and Human Services pursuant to section 1927 of title XIX of the 
13.30 	Social Security Act; and.
14.1 	(6) medical cannabis flower as defined in section 342.01, subdivision 54, or medical 
14.2 	cannabinoid products as defined in section 342.01, subdivision 52.
14.3 	(c) If a single-source drug used by at least two percent of the fee-for-service medical 
14.4 	assistance recipients is removed from the formulary due to the failure of the manufacturer 
14.5 	to sign a rebate agreement with the Department of Health and Human Services, the 
14.6 	commissioner shall notify prescribing practitioners within 30 days of receiving notification 
14.7 	from the Centers for Medicare and Medicaid Services (CMS) that a rebate agreement was 
14.8 	not signed.

14.9 	EFFECTIVE DATE. This section is effective the day following final enactment.

14.10 	Sec. 10. Minnesota Statutes 2023 Supplement, section 290.0132, subdivision 29, is amended 
14.11 	to read:
14.12 		Subd. 29.Disallowed section 280E expenses; cannabis licensees. The amount of 
14.13 	expenses of a medical cannabis business license holder, as defined under section 342.01, 
14.14 	subdivision 53 48, related to the business of medical cannabis under sections 342.47 to 
14.15 	342.59, or a license holder under chapter 342, related to the business of nonmedical cannabis 
14.16 	under that chapter,cannabis or hemp and not allowed for federal income tax purposes under 
14.17 	section 280E of the Internal Revenue Code is a subtraction.

14.18 	Sec. 11. Minnesota Statutes 2023 Supplement, section 290.0134, subdivision 19, is amended 
14.19 	to read:
14.20 		Subd. 19.Disallowed section 280E expenses; cannabis licensees. The amount of 
14.21 	expenses of a medical cannabis business license holder, as defined under section 342.01, 
14.22 	subdivision 53 48, related to the business of medical cannabis under sections 342.47 to 
14.23 	342.59, or a license holder under chapter 342, related to the business of nonmedical cannabis 
14.24 	under that chapter,cannabis or hemp and not allowed for federal income tax purposes under 
14.25 	section 280E of the Internal Revenue Code is a subtraction.

14.26 	Sec. 12. Minnesota Statutes 2023 Supplement, section 295.81, subdivision 1, is amended 
14.27 	to read:
14.28 		Subdivision 1.Definitions. (a) For purposes of this section, the following terms have 
14.29 	the meanings given.
14.30 	(b) "Bundled transaction" means the retail sale of two or more products when the products 
14.31 	are otherwise distinct and identifiable and the products are sold for one nonitemized price.
15.1 	(c) "Cannabis flower" has the meaning given in section 342.01, subdivision 16.
15.2 	(d) "Cannabis product" has the meaning given in section 342.01, subdivision 20.
15.3 	(e) "Cannabis solution product" means any cartridge, bottle, or other package that contains 
15.4 	a taxable cannabis product in a solution that is consumed or meant to be consumed through 
15.5 	the use of a heating element, power source, electronic circuit, or other electronic, chemical, 
15.6 	or mechanical means that produces vapor or aerosol. A cannabis solution product includes 
15.7 	any electronic delivery system, electronic vaping device, electronic vape pen, electronic 
15.8 	oral device, electronic delivery device, or similar product or device, and any batteries, 
15.9 	heating elements, or other components, parts, or accessories sold with and meant to be used 
15.10 	in the consumption of a solution containing a taxable cannabis product.
15.11 	(f) "Cannabis mezzobusiness" means a cannabis business licensed under section 342.29.
15.12 	(g) "Cannabis microbusiness" means a cannabis business licensed under section 342.28.
15.13 	(h) "Cannabis retailer" means a cannabis business licensed under section 342.32.
15.14 	(i) "Commissioner" means the commissioner of revenue.
15.15 	(j) "Gross receipts" means the total amount received in money or by barter or exchange 
15.16 	for all taxable cannabis product sales at retail as measured by the sales price. Gross receipts 
15.17 	include but are not limited to delivery charges and packaging costs. Gross receipts do not 
15.18 	include:
15.19 	(1) any taxes imposed directly on the customer that are separately stated on the invoice, 
15.20 	bill of sale, or similar document given to the purchaser; and
15.21 	(2) discounts, including cash, terms, or coupons, that are not reimbursed by a third party 
15.22 	and that are allowed by the seller and taken by a purchaser on a sale.
15.23 	(k) "Hemp-derived consumer product" has the meaning given in section 342.01, 
15.24 	subdivision 37.
15.25 	(l) "Lower-potency hemp edible" has the meaning given in section 342.01, subdivision 
15.26 	50.
15.27 	(m) "Lower-potency hemp edible retailer" means a cannabis business licensed under 
15.28 	section 342.43, subdivision 1, clause (2).
15.29 	(n) "Medical cannabis flower" has the meaning given in section 342.01, subdivision 54.
15.30 	(o) "Medical cannabinoid product" has the meaning given in section 342.01, subdivision 
15.31 	52.
16.1 	(p) "Medical cannabis paraphernalia" has the meaning given in section 342.01, 
16.2 	subdivision 55.
16.3 	(q) (n) "Retail sale" has the meaning given in section 297A.61, subdivision 4.
16.4 	(r) (o) "Taxable cannabis product" means cannabis flower, cannabis product, cannabis 
16.5 	solution product, hemp-derived consumer product, lower-potency hemp edible, and any 
16.6 	substantially similar item, and does not include items exempt from tax under subdivision 
16.7 	4, paragraph (b).
16.8 	(s) (p) "Taxable cannabis product retailer" means a retailer that sells any taxable cannabis 
16.9 	product, and includes a cannabis retailer, cannabis microbusiness, cannabis mezzobusiness, 
16.10 	medical cannabis combination business, and lower-potency hemp edible retailer. Taxable 
16.11 	cannabis product retailer includes but is not limited to a:
16.12 	(1) retailer maintaining a place of business in this state;
16.13 	(2) marketplace provider maintaining a place of business in this state, as defined in 
16.14 	section 297A.66, subdivision 1, paragraph (a);
16.15 	(3) retailer not maintaining a place of business in this state; and
16.16 	(4) marketplace provider not maintaining a place of business in this state, as defined in 
16.17 	section 297A.66, subdivision 1, paragraph (b).

16.18 	Sec. 13. Minnesota Statutes 2023 Supplement, section 295.81, subdivision 4, is amended 
16.19 	to read:
16.20 		Subd. 4.Exemptions. (a) The use tax imposed under subdivision 3, paragraph (a), does 
16.21 	not apply to the possession, use, or storage of taxable cannabis products if (1) the taxable 
16.22 	cannabis products have an aggregate cost in any calendar month to the customer of $100 
16.23 	or less, and (2) the taxable cannabis products were carried into this state by the customer.
16.24 	(b) The tax imposed under this section does not apply to sales by a cannabis business 
16.25 	with a medical cannabis retail endorsement or by a medical cannabis combination business 
16.26 	of medical the following items purchased by or for a patient: cannabis flower, cannabinoid 
16.27 	products, or cannabis paraphernalia. Items sold under this paragraph must be sold to a person
16.28 	enrolled in the registry program, including medical cannabis flower, medical cannabinoid 
16.29 	products, or medical cannabis paraphernalia.
16.30 	(c) Unless otherwise specified in this section, the exemptions applicable to taxes imposed 
16.31 	under chapter 297A are not applicable to the taxes imposed under this section.
16.32 	(d) The tax imposed under this section does not apply to:
17.1 	(1) sales made in Indian country as defined in United States Code, title 18, section 1151, 
17.2 	by a cannabis business licensed by a Minnesota Tribal government, as defined in section 
17.3 	3.9228, subdivision 1, paragraph (f); or
17.4 	(2) use tax owed on taxable cannabis products purchased on Tribally regulated land as 
17.5 	defined in section 3.9228, subdivision 1, from a cannabis business licensed by a Minnesota 
17.6 	Tribal government as defined in section 3.9228, subdivision 1, paragraph (f).

17.7 	Sec. 14. Minnesota Statutes 2023 Supplement, section 297A.70, subdivision 2, is amended 
17.8 	to read:
17.9 		Subd. 2.Sales to government. (a) All sales, except those listed in paragraph (b), to the 
17.10 	following governments and political subdivisions, or to the listed agencies or instrumentalities 
17.11 	of governments and political subdivisions, are exempt:
17.12 	(1) the United States and its agencies and instrumentalities;
17.13 	(2) school districts, local governments, the University of Minnesota, state universities, 
17.14 	community colleges, technical colleges, state academies, the Perpich Minnesota Center for 
17.15 	Arts Education, and an instrumentality of a political subdivision that is accredited as an 
17.16 	optional/special function school by the North Central Association of Colleges and Schools;
17.17 	(3) hospitals and nursing homes owned and operated by political subdivisions of the 
17.18 	state of tangible personal property and taxable services used at or by hospitals and nursing 
17.19 	homes;
17.20 	(4) other states or political subdivisions of other states, if the sale would be exempt from 
17.21 	taxation if it occurred in that state; and
17.22 	(5) public libraries, public library systems, multicounty, multitype library systems as 
17.23 	defined in section 134.001, county law libraries under chapter 134A, state agency libraries, 
17.24 	the state library under section 480.09, and the Legislative Reference Library.
17.25 	(b) This exemption does not apply to the sales of the following products and services:
17.26 	(1) building, construction, or reconstruction materials purchased by a contractor or a 
17.27 	subcontractor as a part of a lump-sum contract or similar type of contract with a guaranteed 
17.28 	maximum price covering both labor and materials for use in the construction, alteration, or 
17.29 	repair of a building or facility;
17.30 	(2) construction materials purchased by tax exempt entities or their contractors to be 
17.31 	used in constructing buildings or facilities which will not be used principally by the tax 
17.32 	exempt entities;
18.1 	(3) the leasing of a motor vehicle as defined in section 297B.01, subdivision 11, except 
18.2 	for leases entered into by the United States or its agencies or instrumentalities;
18.3 	(4) lodging as defined under section 297A.61, subdivision 3, paragraph (g), clause (2), 
18.4 	prepared food, candy, soft drinks, alcoholic beverages as defined in section 297A.67, 
18.5 	subdivision 2, and taxable cannabis products as defined under section 295.81, subdivision 
18.6 	1, paragraph (r), except for lodging, prepared food, candy, soft drinks, alcoholic beverages, 
18.7 	and taxable cannabis products purchased directly by the United States or its agencies or 
18.8 	instrumentalities; or
18.9 	(5) goods or services purchased by a local government as inputs to a liquor store, taxable 
18.10 	cannabis product retailer as defined under section 295.81, subdivision 1, paragraph (s), gas 
18.11 	or electric utility, solid waste hauling service, solid waste recycling service, landfill, golf 
18.12 	course, marina, campground, cafe, or laundromat.
18.13 	(c) As used in this subdivision, "school districts" means public school entities and districts 
18.14 	of every kind and nature organized under the laws of the state of Minnesota, and any 
18.15 	instrumentality of a school district, as defined in section 471.59.
18.16 	(d) For purposes of the exemption granted under this subdivision, "local governments" 
18.17 	has the following meaning:
18.18 	(1) for the period prior to January 1, 2017, local governments means statutory or home 
18.19 	rule charter cities, counties, and townships; and
18.20 	(2) beginning January 1, 2017, local governments means statutory or home rule charter 
18.21 	cities, counties, and townships; special districts as defined under section 6.465; any 
18.22 	instrumentality of a statutory or home rule charter city, county, or township as defined in 
18.23 	section 471.59; and any joint powers board or organization created under section 471.59.

18.24 	Sec. 15. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 3, is amended 
18.25 	to read:
18.26 		Subd. 3.Adult-use cannabis flower. "Adult-use cannabis flower" means cannabis 
18.27 	flower that is approved for sale by the office or is substantially similar to a product approved 
18.28 	by the office. Adult-use cannabis flower does not include medical cannabis flower, hemp 
18.29 	plant parts, or hemp-derived consumer products.

18.30 	EFFECTIVE DATE. This section is effective the day following final enactment.

19.1 	Sec. 16. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 4, is amended 
19.2 	to read:
19.3 		Subd. 4.Adult-use cannabis product. "Adult-use cannabis product" means a cannabis 
19.4 	product that is approved for sale by the office or is substantially similar to a product approved 
19.5 	by the office. Adult-use cannabis product includes edible cannabis products but does not 
19.6 	include medical cannabinoid products or lower-potency hemp edibles.

19.7 	EFFECTIVE DATE. This section is effective the day following final enactment.

19.8 	Sec. 17. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 14, is amended 
19.9 	to read:
19.10 		Subd. 14.Cannabis business. "Cannabis business" means any of the following licensed 
19.11 	under this chapter:
19.12 	(1) cannabis microbusiness;
19.13 	(2) cannabis mezzobusiness;
19.14 	(3) cannabis cultivator;
19.15 	(4) cannabis manufacturer;
19.16 	(5) cannabis retailer;
19.17 	(6) cannabis wholesaler;
19.18 	(7) cannabis transporter;
19.19 	(8) cannabis testing facility;
19.20 	(9) cannabis event organizer;
19.21 	(10) cannabis delivery service; and
19.22 	(11) medical cannabis cultivator;
19.23 	(12) medical cannabis processor;
19.24 	(13) medical cannabis retailer; and
19.25 	(14) (11) medical cannabis combination business.

19.26 	EFFECTIVE DATE. This section is effective the day following final enactment.

20.1 	Sec. 18. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 16, is amended 
20.2 	to read:
20.3 		Subd. 16.Cannabis flower. "Cannabis flower" means the harvested flower, bud, leaves, 
20.4 	and or stems of a cannabis plant. Cannabis flower includes adult-use cannabis flower and 
20.5 	medical cannabis flower. Cannabis flower does not include cannabis seed, hemp plant parts, 
20.6 	or hemp-derived consumer products.

20.7 	EFFECTIVE DATE. This section is effective the day following final enactment.

20.8 	Sec. 19. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 17, is amended 
20.9 	to read:
20.10 		Subd. 17.Cannabis industry. "Cannabis industry" means every item, product, person, 
20.11 	process, action, business, or other thing related to cannabis plants, cannabis flower, and 
20.12 	cannabis products and subject to regulation under this chapter.

20.13 	EFFECTIVE DATE. This section is effective the day following final enactment.

20.14 	Sec. 20. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 19, is amended 
20.15 	to read:
20.16 		Subd. 19.Cannabis plant. "Cannabis plant" means all parts of the plant of the genus 
20.17 	Cannabis that is are growing or has have not been harvested and has a delta-9 
20.18 	tetrahydrocannabinol concentration of more than 0.3 percent on a dry weight basis, including 
20.19 	but not limited to a mother plant; a mature, flowering plant; an immature plant; or a seedling. 
20.20 	Cannabis plant does not include hemp.

20.21 	EFFECTIVE DATE. This section is effective the day following final enactment.

20.22 	Sec. 21. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 20, is amended 
20.23 	to read:
20.24 		Subd. 20.Cannabis product. (a) "Cannabis product" means any of the following:
20.25 	(1) cannabis concentrate;
20.26 	(2) a product infused with cannabinoids, including but not limited to tetrahydrocannabinol, 
20.27 	extracted or derived from cannabis plants or cannabis flower; or
20.28 	(3) any other product that contains cannabis concentrate.
20.29 	(b) Cannabis product includes adult-use cannabis products, including but not limited to 
20.30 	edible cannabis products and medical cannabinoid products. Cannabis product does not 
21.1 	include cannabis flower, artificially derived cannabinoid, lower-potency hemp edibles, 
21.2 	hemp-derived consumer products, or hemp-derived topical products.

21.3 	EFFECTIVE DATE. This section is effective the day following final enactment.

21.4 	Sec. 22. Minnesota Statutes 2023 Supplement, section 342.01, is amended by adding a 
21.5 	subdivision to read:
21.6 		Subd. 31a.Endorsement. "Endorsement" means an authorization from the Office of 
21.7 	Cannabis Management to conduct a specified operation activity.

21.8 	EFFECTIVE DATE. This section is effective the day following final enactment.

21.9 	Sec. 23. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 48, is amended 
21.10 	to read:
21.11 		Subd. 48.License holder. "License holder" means a person, cooperative, or business 
21.12 	that holds any of the following licenses:
21.13 	(1) cannabis microbusiness;
21.14 	(2) cannabis mezzobusiness;
21.15 	(3) cannabis cultivator;
21.16 	(4) cannabis manufacturer;
21.17 	(5) cannabis retailer;
21.18 	(6) cannabis wholesaler;
21.19 	(7) cannabis transporter;
21.20 	(8) cannabis testing facility;
21.21 	(9) cannabis event organizer;
21.22 	(10) cannabis delivery service;
21.23 	(11) lower-potency hemp edible manufacturer;
21.24 	(12) lower-potency hemp edible retailer; or
21.25 	(13) medical cannabis cultivator;
21.26 	(14) medical cannabis processor;
21.27 	(15) medical cannabis retailer; or
21.28 	(16) (13) medical cannabis combination business.

22.1 	EFFECTIVE DATE. This section is effective the day following final enactment.

22.2 	Sec. 24. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 64, is amended 
22.3 	to read:
22.4 		Subd. 64.Registered designated caregiver. "Registered designated caregiver" means 
22.5 	an individual who:
22.6 	(1) is at least 18 years old;
22.7 	(2) is not disqualified for a criminal offense according to rules adopted pursuant to 
22.8 	section 342.15, subdivision 2;
22.9 	(3) (2) has been approved by the Division of Medical Cannabis Office of Cannabis 
22.10 	Management to assist a patient with obtaining medical cannabis flower and medical
22.11 	cannabinoid products from a cannabis retailer or medical cannabis retailer and with 
22.12 	administering medical cannabis flower and medical cannabinoid products; and
22.13 	(4) (3) is authorized by the Division of Medical Cannabis Office of Cannabis Management
22.14 	to assist a patient with the use of medical cannabis flower and medical cannabinoid products.

22.15 	EFFECTIVE DATE. This section is effective the day following final enactment.

22.16 	Sec. 25. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 65, is amended 
22.17 	to read:
22.18 		Subd. 65.Registry or registry program. "Registry" or "registry program" means the 
22.19 	medical cannabis patient registry established under this chapter listing patients each person
22.20 	authorized to:
22.21 	(1) obtain medical cannabis flower, medical cannabinoid products, and medical cannabis 
22.22 	paraphernalia from a cannabis retailers and medical cannabis retailers business with a 
22.23 	medical cannabis retail endorsement; and
22.24 	(2) administer medical cannabis flower and medical cannabinoid products.

22.25 	EFFECTIVE DATE. This section is effective the day following final enactment.

22.26 	Sec. 26. Minnesota Statutes 2023 Supplement, section 342.01, subdivision 66, is amended 
22.27 	to read:
22.28 		Subd. 66.Registry verification. "Registry verification" means the verification provided 
22.29 	by the Division of Medical Cannabis Office of Cannabis Management that a patient is 
22.30 	enrolled in the registry program and that includes the patient's name, patient registry number, 
23.1 	and, if applicable, the name of the patient's registered designated caregiver or parent, legal 
23.2 	guardian, or spouse.

23.3 	EFFECTIVE DATE. This section is effective the day following final enactment.

23.4 	Sec. 27. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 2, is amended 
23.5 	to read:
23.6 		Subd. 2.Powers and duties. (a) The office has the following powers and duties:
23.7 	(1) to develop, maintain, and enforce an organized system of regulation for the cannabis 
23.8 	industry and hemp consumer industry;
23.9 	(2) to establish programming, services, and notification to protect, maintain, and improve 
23.10 	the health of citizens;
23.11 	(3) to prevent unauthorized access to cannabis flower, cannabis products, lower-potency 
23.12 	hemp edibles, and hemp-derived consumer products by individuals under 21 years of age;
23.13 	(4) to establish and regularly update standards for product manufacturing, testing, 
23.14 	packaging, and labeling, including requirements for an expiration, sell-by, or best-used-by 
23.15 	date;
23.16 	(5) to promote economic growth with an emphasis on growth in areas that experienced 
23.17 	a disproportionate, negative impact from cannabis prohibition;
23.18 	(6) to issue and renew licenses;
23.19 	(7) to require fingerprints from individuals determined to be subject to fingerprinting, 
23.20 	including the submission of fingerprints to the Federal Bureau of Investigation where 
23.21 	required by law and to obtain criminal conviction data for individuals seeking a license 
23.22 	from the office on the individual's behalf or as a cooperative member or director, manager, 
23.23 	or general partner of a business entity;
23.24 	(8) to receive reports required by this chapter and inspect the premises, records, books, 
23.25 	and other documents of license holders to ensure compliance with all applicable laws and 
23.26 	rules;
23.27 	(9) to authorize the use of unmarked motor vehicles to conduct seizures or investigations 
23.28 	pursuant to the office's authority;
23.29 	(10) to impose and collect civil and administrative penalties as provided in this chapter;
24.1 	(11) to publish such information as may be deemed necessary for the welfare of cannabis 
24.2 	businesses, cannabis workers, hemp businesses, and hemp workers and the health and safety 
24.3 	of citizens;
24.4 	(12) to make loans and grants in aid to the extent that appropriations are made available 
24.5 	for that purpose;
24.6 	(13) to authorize research and studies on cannabis flower, cannabis products, artificially 
24.7 	derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer products, the 
24.8 	cannabis industry, and the hemp consumer industry;
24.9 	(14) to provide reports as required by law;
24.10 	(15) to develop a warning label regarding the effects of the use of cannabis flower and 
24.11 	cannabis products by persons 25 years of age or younger;
24.12 	(16) to determine, based on a review of medical and scientific literature, whether it is 
24.13 	appropriate to require additional health and safety warnings containing information that is 
24.14 	both supported by credible science and helpful to consumers in considering potential health 
24.15 	risks from the use of cannabis flower, cannabis products, lower-potency hemp edibles, and 
24.16 	hemp-derived consumer products, including but not limited to warnings regarding any risks 
24.17 	associated with use by pregnant or breastfeeding individuals, or by individuals planning to 
24.18 	become pregnant, and the effects that use has on brain development for individuals under 
24.19 	the age of 25;
24.20 	(17) to establish limits on the potency of cannabis flower and cannabis products that can 
24.21 	be sold to customers by licensed cannabis retailers, licensed cannabis microbusinesses, and 
24.22 	licensed cannabis mezzobusinesses with an endorsement to sell cannabis flower and cannabis 
24.23 	products to customers;
24.24 	(18) to establish rules authorizing an increase in plant canopy limits and outdoor 
24.25 	cultivation limits to meet market demand and limiting cannabis manufacturing consistent 
24.26 	with the goals identified in subdivision 1; and
24.27 	(19) to order a person or business that manufactures or produces cannabis products, 
24.28 	artificially derived cannabinoids, lower-potency hemp edibles, hemp-derived consumer 
24.29 	products, or hemp-derived topical products to recall a product if the office determines that 
24.30 	the product represents a risk of causing a serious adverse incident; and
24.31 	(19) (20) to exercise other powers and authority and perform other duties required by 
24.32 	law.
25.1 	(b) In addition to the powers and duties in paragraph (a), the office has the following 
25.2 	powers and duties until January 1, 2027:
25.3 	(1) to establish limits on the potency of adult-use cannabis flower and adult-use cannabis 
25.4 	products that can be sold to customers by licensed cannabis retailers, licensed cannabis 
25.5 	microbusinesses, and licensed cannabis mezzobusinesses with an endorsement to sell 
25.6 	adult-use cannabis flower and adult-use cannabis products to customers; and
25.7 	(2) to permit, upon application to the office in the form prescribed by the director of the 
25.8 	office, a licensee under this chapter to perform any activity if such permission is substantially 
25.9 	necessary for the licensee to perform any other activity permitted by the applicant's license 
25.10 	and is not otherwise prohibited by law.

25.11 	EFFECTIVE DATE. This section is effective the day following final enactment.

25.12 	Sec. 28. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 3, is amended 
25.13 	to read:
25.14 		Subd. 3.Medical cannabis program. (a) The powers and duties of the Department of 
25.15 	Health with respect to the medical cannabis program under Minnesota Statutes 2022, sections 
25.16 	152.22 to 152.37, are transferred to the Office of Cannabis Management under section 
25.17 	15.039.
25.18 	(b) The following protections shall apply to employees who are transferred from the 
25.19 	Department of Health to the Office of Cannabis Management:
25.20 	(1) the employment status and job classification of a transferred employee shall not be 
25.21 	altered as a result of the transfer;
25.22 	(2) transferred employees who were represented by an exclusive representative prior to 
25.23 	the transfer shall continue to be represented by the same exclusive representative after the 
25.24 	transfer;
25.25 	(3) the applicable collective bargaining agreements with exclusive representatives shall 
25.26 	continue in full force and effect for such transferred employees after the transfer;
25.27 	(4) the state must meet and negotiate with the exclusive representatives of the transferred 
25.28 	employees about any proposed changes affecting or relating to the transferred employees' 
25.29 	terms and conditions of employment to the extent such changes are not addressed in the 
25.30 	applicable collective bargaining agreement; and
25.31 	(5) for an employee in a temporary unclassified position transferred to the Office of 
25.32 	Cannabis Management, the total length of time that the employee has served in the 
26.1 	appointment shall include all time served in the appointment and the transferring agency 
26.2 	and the time served in the appointment at the Office of Cannabis Management. An employee 
26.3 	in a temporary unclassified position who was hired by a transferring agency through an 
26.4 	open competitive selection process in accordance with a policy enacted by Minnesota 
26.5 	Management and Budget shall be considered to have been hired through such process after 
26.6 	the transfer.
26.7 	(c) This subdivision is effective March 1, 2025, or upon the adoption of initial rules 
26.8 	pertaining to medical cannabis under subdivision 5, whichever is later.

26.9 	EFFECTIVE DATE. This section is effective the day following final enactment.

26.10 	Sec. 29. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 5, is amended 
26.11 	to read:
26.12 		Subd. 5.Rulemaking. (a) The office may adopt rules to implement any provisions in 
26.13 	this chapter.
26.14 	(b) Rules for which a notice of intent to adopt rules is published in the State Register 
26.15 	before July 1, 2025, may be adopted using the expedited rulemaking process in section 
26.16 	14.389. The 18-month time limit imposed by section 14.125 does not apply to rules adopted 
26.17 	under this paragraph.

26.18 	EFFECTIVE DATE. This section is effective the day following final enactment.

26.19 	Sec. 30. Minnesota Statutes 2023 Supplement, section 342.02, subdivision 6, is amended 
26.20 	to read:
26.21 		Subd. 6.Director. (a) The governor shall appoint a director of the office with the advice 
26.22 	and consent of the senate. The director must be in the unclassified service and must serve 
26.23 	at the pleasure of the governor.
26.24 	(b) The salary of the director must not exceed the salary limit established under section 
26.25 	15A.0815, subdivision 3.
26.26 	(b) The director may appoint and employ no more than two deputy directors.
26.27 	(c) The director has administrative control of the office. The director has the powers 
26.28 	described in section 15.06, subdivision 6.
26.29 	(d) The director may apply for and accept on behalf of the state any grants, bequests, 
26.30 	gifts, or contributions for the purpose of carrying out the duties and responsibilities of the 
26.31 	director.
27.1 	(e) Pursuant to state law, the director may apply for and receive money made available 
27.2 	from federal sources for the purpose of carrying out the duties and responsibilities of the 
27.3 	director.
27.4 	(f) The director may make contracts with and grants to Tribal Nations, public and private 
27.5 	agencies, for-profit and nonprofit organizations, and individuals using appropriated money.

27.6 	Sec. 31. Minnesota Statutes 2023 Supplement, section 342.07, subdivision 3, is amended 
27.7 	to read:
27.8 		Subd. 3.Edible cannabinoid product handler endorsement. (a) Any person seeking 
27.9 	to manufacture, process, sell, handle, or store an edible cannabis product or lower-potency 
27.10 	hemp edible, other than an edible cannabis product or lower-potency hemp edible that has 
27.11 	been placed in its final packaging, must first obtain an edible cannabinoid product handler 
27.12 	endorsement.
27.13 	(b) In consultation with the commissioner of agriculture, the office shall establish an 
27.14 	edible cannabinoid product handler endorsement.
27.15 	(c) The office must regulate edible cannabinoid product handlers and assess penalties 
27.16 	in the same in a manner provided for consistent with Department of Agriculture regulation 
27.17 	of food handlers under chapters 28A, 31, and 34A and associated rules, with the following 
27.18 	exceptions:
27.19 	(1) the office must issue an edible cannabinoid product handler endorsement, rather than 
27.20 	a license;
27.21 	(2) eligibility for an edible cannabinoid product handler endorsement is limited to persons 
27.22 	who possess a valid license issued by the office;
27.23 	(3) the office may not charge a fee for issuing or renewing the endorsement;
27.24 	(4) the office must align the term and renewal period for edible cannabinoid product 
27.25 	handler endorsements with the term and renewal period of the license issued by the office; 
27.26 	and
27.27 	(5) an edible cannabis product or lower-potency hemp edible must not be considered 
27.28 	adulterated solely because the product or edible contains tetrahydrocannabinol, cannabis 
27.29 	concentrate, hemp concentrate, artificially derived cannabinoids, or any other material 
27.30 	extracted or derived from a cannabis plant, cannabis flower, hemp plant, or hemp plant 
27.31 	parts.
28.1 	(d) The edible cannabinoid product handler endorsement must prohibit the manufacture 
28.2 	of edible cannabis products at the same premises where food is manufactured, except for 
28.3 	the limited production of edible products produced solely for product development, sampling, 
28.4 	or testing. This limitation does not apply to the manufacture of lower-potency hemp edibles.

28.5 	Sec. 32. Minnesota Statutes 2023 Supplement, section 342.09, subdivision 1, is amended 
28.6 	to read:
28.7 		Subdivision 1.Personal adult use, possession, and transportation of cannabis flower 
28.8 	and cannabinoid products. (a) An individual 21 years of age or older may:
28.9 	(1) use, possess, or transport cannabis paraphernalia;
28.10 	(2) possess or transport two ounces or less of adult-use cannabis flower in a public place;
28.11 	(3) possess two pounds or less of adult-use cannabis flower in the individual's private 
28.12 	residence;
28.13 	(4) possess or transport eight grams or less of adult-use cannabis concentrate;
28.14 	(5) possess or transport edible cannabis products or lower-potency hemp edibles infused 
28.15 	with a combined total of 800 milligrams or less of tetrahydrocannabinol;
28.16 	(6) give for no remuneration to an individual who is at least 21 years of age:
28.17 	(i) two ounces or less of adult-use cannabis flower;
28.18 	(ii) eight grams or less of adult-use cannabis concentrate; or
28.19 	(iii) an edible cannabis product or lower-potency hemp edible infused with 800 milligrams 
28.20 	or less of tetrahydrocannabinol; and
28.21 	(7) use adult-use cannabis flower and adult-use cannabis products in the following 
28.22 	locations:
28.23 	(i) a private residence, including the individual's curtilage or yard;
28.24 	(ii) on private property, not generally accessible by the public, unless the individual is 
28.25 	explicitly prohibited from consuming cannabis flower, cannabis products, lower-potency 
28.26 	hemp edibles, or hemp-derived consumer products on the property by the owner of the 
28.27 	property; or
28.28 	(iii) on the premises of an establishment or event licensed to permit on-site consumption.
28.29 	(b) Except as provided in paragraph (c), an individual may not:
29.1 	(1) use, possess, or transport cannabis flower, cannabis products, lower-potency hemp 
29.2 	edibles, or hemp-derived consumer products if the individual is under 21 years of age;
29.3 	(2) use cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
29.4 	consumer products in a motor vehicle as defined in section 169A.03, subdivision 15;
29.5 	(3) use cannabis flower, cannabis products, or hemp-derived consumer products in a 
29.6 	manner that involves the inhalation of smoke, aerosol, or vapor at any location where 
29.7 	smoking is prohibited under section 144.414;
29.8 	(4) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or 
29.9 	hemp-derived consumer products in a public school, as defined in section 120A.05, 
29.10 	subdivisions 9, 11, and 13, or in a charter school governed by chapter 124E, including all 
29.11 	facilities, whether owned, rented, or leased, and all vehicles that a school district owns, 
29.12 	leases, rents, contracts for, or controls;
29.13 	(5) use or possess cannabis flower, cannabis products, lower-potency hemp edibles, or 
29.14 	hemp-derived consumer products in a state correctional facility;
29.15 	(6) operate a motor vehicle while under the influence of cannabis flower, cannabis 
29.16 	products, lower-potency hemp edibles, or hemp-derived consumer products;
29.17 	(7) give for no remuneration cannabis flower, cannabis products, lower-potency hemp 
29.18 	edibles, or hemp-derived consumer products to an individual under 21 years of age;
29.19 	(8) give for no remuneration cannabis flower or cannabis products as a sample or 
29.20 	promotional gift if the giver is in the business of selling goods or services; or
29.21 	(9) vaporize or smoke cannabis flower, cannabis products, artificially derived 
29.22 	cannabinoids, or hemp-derived consumer products in any location where the smoke, aerosol, 
29.23 	or vapor would be inhaled by a minor.
29.24 	(c) The prohibitions under paragraph (b), clauses (1) to (4), do not apply to use other 
29.25 	than by smoking or by a vaporized delivery method, possession, or transportation of medical
29.26 	cannabis flower or medical cannabinoid products by a patient; a registered designated 
29.27 	caregiver; or a parent, legal guardian, or spouse of a patient.
29.28 	(d) The possession limits in paragraph (a), clauses (2) to (5), do not apply to a person 
29.29 	enrolled in the medical cannabis patient registry program under section 342.52 if the person 
29.30 	possesses cannabis flower or cannabinoid products that include patient-specific labeling 
29.31 	according to sections 342.51, subdivision 2, and 342.63, subdivision 4.
30.1 	(d) (e) A proprietor of a family or group family day care program must disclose to parents 
30.2 	or guardians of children cared for on the premises of the family or group family day care 
30.3 	program, if the proprietor permits the smoking or use of cannabis flower, cannabis products, 
30.4 	lower-potency hemp edibles, or hemp-derived consumer products on the premises outside 
30.5 	of its hours of operation. Disclosure must include posting on the premises a conspicuous 
30.6 	written notice and orally informing parents or guardians. Cannabis flower or cannabis 
30.7 	products must be inaccessible to children and stored away from food products.

30.8 	EFFECTIVE DATE. This section is effective the day following final enactment.

30.9 	Sec. 33. Minnesota Statutes 2023 Supplement, section 342.09, subdivision 3, is amended 
30.10 	to read:
30.11 		Subd. 3.Home extraction of cannabis concentrate by use of volatile solvent 
30.12 	prohibited. No person may use a volatile solvent to separate or extract cannabis concentrate 
30.13 	or hemp concentrate without a cannabis microbusiness, cannabis mezzobusiness, cannabis 
30.14 	manufacturer, medical cannabis processor, or lower-potency hemp edible manufacturer 
30.15 	license issued under this chapter.

30.16 	EFFECTIVE DATE. This section is effective the day following final enactment.

30.17 	Sec. 34. Minnesota Statutes 2023 Supplement, section 342.10, is amended to read:
30.18 	342.10 LICENSES; TYPES.
30.19 	The office shall issue the following types of license:
30.20 	(1) cannabis microbusiness;
30.21 	(2) cannabis mezzobusiness;
30.22 	(3) cannabis cultivator;
30.23 	(4) cannabis manufacturer;
30.24 	(5) cannabis retailer;
30.25 	(6) cannabis wholesaler;
30.26 	(7) cannabis transporter;
30.27 	(8) cannabis testing facility;
30.28 	(9) cannabis event organizer;
30.29 	(10) cannabis delivery service;
31.1 	(11) lower-potency hemp edible manufacturer;
31.2 	(12) lower-potency hemp edible retailer; or
31.3 	(13) medical cannabis cultivator;
31.4 	(14) medical cannabis processor;
31.5 	(15) medical cannabis retailer; or
31.6 	(16) (13) medical cannabis combination business.

31.7 	EFFECTIVE DATE. This section is effective the day following final enactment.

31.8 	Sec. 35. Minnesota Statutes 2023 Supplement, section 342.11, is amended to read:
31.9 	342.11 LICENSES; FEES.
31.10 	(a) The office shall require the payment of application fees, initial licensing fees, and 
31.11 	renewal licensing fees as provided in this section. The initial license fee shall include the 
31.12 	fee for initial issuance of the license and the first annual renewal. The renewal fee shall be 
31.13 	charged at the time of the second renewal and each subsequent annual renewal thereafter. 
31.14 	Nothing in this section prohibits a local unit of government from charging the retailer 
31.15 	registration fee established in section 342.22. Application fees, initial licensing fees, and 
31.16 	renewal licensing fees are nonrefundable.
31.17 	(b) Application and licensing fees shall be as follows:
31.18 	(1) for a cannabis microbusiness:
31.19 	(i) an application fee of $500;
31.20 	(ii) an initial license fee of $0; and
31.21 	(iii) a renewal license fee of $2,000;
31.22 	(2) for a cannabis mezzobusiness:
31.23 	(i) an application fee of $5,000;
31.24 	(ii) an initial license fee of $5,000; and
31.25 	(iii) a renewal license fee of $10,000;
31.26 	(3) for a cannabis cultivator:
31.27 	(i) an application fee of $10,000;
31.28 	(ii) an initial license fee of $20,000; and
32.1 	(iii) a renewal license fee of $30,000;
32.2 	(4) for a cannabis manufacturer:
32.3 	(i) an application fee of $10,000;
32.4 	(ii) an initial license fee of $10,000; and
32.5 	(iii) a renewal license fee of $20,000;
32.6 	(5) for a cannabis retailer:
32.7 	(i) an application fee of $2,500;
32.8 	(ii) an initial license fee of $2,500; and
32.9 	(iii) a renewal license fee of $5,000;
32.10 	(6) for a cannabis wholesaler:
32.11 	(i) an application fee of $5,000;
32.12 	(ii) an initial license fee of $5,000; and
32.13 	(iii) a renewal license fee of $10,000;
32.14 	(7) for a cannabis transporter:
32.15 	(i) an application fee of $250;
32.16 	(ii) an initial license fee of $500; and
32.17 	(iii) a renewal license fee of $1,000;
32.18 	(8) for a cannabis testing facility:
32.19 	(i) an application fee of $5,000;
32.20 	(ii) an initial license fee of $5,000; and
32.21 	(iii) a renewal license fee of $10,000;
32.22 	(9) for a cannabis delivery service:
32.23 	(i) an application fee of $250;
32.24 	(ii) an initial license fee of $500; and
32.25 	(iii) a renewal license fee of $1,000;
32.26 	(10) for a cannabis event organizer:
32.27 	(i) an application fee of $750; and
33.1 	(ii) an initial license fee of $750;
33.2 	(11) for a lower-potency hemp edible manufacturer:
33.3 	(i) an application fee of $250;
33.4 	(ii) an initial license fee of $1,000; and
33.5 	(iii) a renewal license fee of $1,000;
33.6 	(12) for a lower-potency hemp edible retailer:
33.7 	(i) an application fee of $250 per retail location;
33.8 	(ii) an initial license fee of $250 per retail location; and
33.9 	(iii) a renewal license fee of $250 per retail location; and
33.10 	(13) for a medical cannabis cultivator:
33.11 	(i) an application fee of $250;
33.12 	(ii) an initial license fee of $0; and
33.13 	(iii) a renewal license fee of $0;
33.14 	(14) for a medical cannabis processor:
33.15 	(i) an application fee of $250;
33.16 	(ii) an initial license fee of $0; and
33.17 	(iii) a renewal license fee of $0;
33.18 	(15) for a medical cannabis retailer:
33.19 	(i) an application fee of $250;
33.20 	(ii) an initial license fee of $0; and
33.21 	(iii) a renewal license fee of $0; and
33.22 	(16) (13) for a medical cannabis combination business:
33.23 	(i) an application fee of $10,000;
33.24 	(ii) an initial license fee of $20,000; and
33.25 	(iii) a renewal license fee of $70,000.

34.1 	Sec. 36. Minnesota Statutes 2023 Supplement, section 342.12, is amended to read:
34.2 	342.12 LICENSES; TRANSFERS; ADJUSTMENTS.
34.3 	(a) Licenses A person holding a license issued under this chapter may be freely transferred
34.4 	transfer that license to another entity subject to the prior written approval of the office, 
34.5 	which approval may be given or withheld in the office's sole discretion, provided that a 
34.6 	social equity applicant may only transfer the applicant's license to another social equity 
34.7 	applicant unless the license is temporary or is held by a social equity applicant during the 
34.8 	first three years from the date of issuance. A new license must be obtained when:
34.9 	(1) the form of the licensee's legal business structure converts or changes to a different 
34.10 	type of legal business structure; or
34.11 	(2) the licensee dissolves; consolidates; reorganizes; undergoes bankruptcy, insolvency, 
34.12 	or receivership proceedings; merges with another legal organization; or assigns all or 
34.13 	substantially all of its assets for the benefit of creditors.
34.14 	(b) Transfers between During the first three years from the date that a social equity 
34.15 	applicant holds a license, the social equity applicants applicant may only transfer the license 
34.16 	to another social equity applicant. Three years after a license was issued, a social equity 
34.17 	applicant may transfer the license to any entity. A license transfer by a social equity applicant
34.18 	must be reviewed by the Division of Social Equity.
34.19 	(c) Licenses must be renewed annually.
34.20 	(d) License holders may petition the office to adjust the tier of a license issued within a 
34.21 	license category provided that the license holder meets all applicable requirements.
34.22 	(e) The office by rule may permit the relocation of a licensed cannabis business,; permit 
34.23 	the relocation of an approved operational location, including a grow or retail location; adopt 
34.24 	requirements for the submission of a license relocation application,; establish standards for 
34.25 	the approval of a relocation application,; and charge a fee not to exceed $250 for reviewing 
34.26 	and processing applications. Relocation of a licensed premises pursuant to this paragraph 
34.27 	does not extend or otherwise modify the license term of the license subject to relocation.

34.28 	Sec. 37. [342.125] TEMPORARY LICENSES.
34.29 		Subdivision 1.Temporary license. (a) The office may establish a temporary license 
34.30 	and application process for a limited number of licenses, but the office shall issue no more 
34.31 	than the following number of temporary licenses:
34.32 	(1) cannabis microbusiness licenses, 100;
35.1 	(2) cannabis mezzobusiness licenses, 11;
35.2 	(3) cannabis cultivator licenses, 13;
35.3 	(4) cannabis manufacturer licenses, six;
35.4 	(5) cannabis retailer licenses, 50;
35.5 	(6) cannabis wholesaler licenses, 20;
35.6 	(7) cannabis transporter licenses, 20;
35.7 	(8) cannabis testing facility licenses, 25;
35.8 	(9) cannabis event organizer licenses, ten; and
35.9 	(10) cannabis delivery service licenses, ten.
35.10 	(b) The temporary license period begins on the day that the office issues a temporary 
35.11 	license to the applicant and is effective for 18 months after the date that the temporary 
35.12 	license was issued.
35.13 		Subd. 2.Eligibility. (a) Only a social equity applicant as defined by section 342.17 is 
35.14 	eligible for a temporary license.
35.15 	(b) An applicant for a temporary license must:
35.16 	(1) complete an initial application according to section 342.14, subdivision 1, on a form 
35.17 	approved by the office; and
35.18 	(2) pay the application fee required by section 342.11, paragraph (b), to the office.
35.19 	(c) As part of the application, the office must verify the applicant's status as a social 
35.20 	equity applicant.
35.21 	(d) The office may not issue a temporary license in violation of section 342.18, 
35.22 	subdivision 2.
35.23 	(e) The office shall not require an applicant to possess or own any property on which or 
35.24 	facility in which to operate a cannabis business at the time of the initial application.
35.25 		Subd. 3.Application process. (a) The office must announce the commencement of a 
35.26 	temporary license application period at least 14 days before the date that the office begins 
35.27 	to accept applications for temporary licenses. The announcement must include:
35.28 	(1) the types of licenses that are available during the temporary license application 
35.29 	period;
35.30 	(2) the number of licenses available by license type;
36.1 	(3) the date on which the temporary license application period will begin; and
36.2 	(4) the date on which the temporary license application period will end.
36.3 	(b) The office must accept applications for temporary licenses for 30 calendar days 
36.4 	during a temporary license application period.
36.5 	(c) The office may deny an application for a temporary license that:
36.6 	(1) is incomplete;
36.7 	(2) contains a material false statement about the applicant or omits material information 
36.8 	about the applicant;
36.9 	(3) fails to meet the minimum qualifications for the license in section 342.18, subdivision 
36.10 	3; or
36.11 	(4) is not submitted by the deadline established by the office.
36.12 	(d) The office may request additional information from any applicant if the office 
36.13 	determines that the information is necessary to review or process the application. If the 
36.14 	applicant does not provide the additional requested information within 14 calendar days, 
36.15 	the office may deny the application.
36.16 		Subd. 4.Lottery. (a) If the number of available temporary licenses is less than the 
36.17 	number of applicants qualified for temporary licenses, the office must conduct a lottery. 
36.18 	The lottery must be impartial, random, and in a format determined by the office.
36.19 	(b) The office must include in the lottery any applicant that meets the requirements under 
36.20 	subdivisions 2 and 3.
36.21 	(c) The office may rescind an applicant's status as a selected lottery applicant if:
36.22 	(1) there are grounds for revocation under section 342.21;
36.23 	(2) the applicant is disqualified under section 342.15; or
36.24 	(3) the applicant is determined to be in arrears on property, business, or personal taxes.
36.25 		Subd. 5.Authority and restrictions. (a) The holder of a temporary license may take 
36.26 	the necessary steps to prepare for business operations, including:
36.27 	(1) establishing legal control of the site of the cannabis business through lease, purchase, 
36.28 	or other means;
36.29 	(2) gaining zoning or planning approval for the site of the cannabis business from a local 
36.30 	unit of government; or
37.1 	(3) raising capital for the license holder's business operations.
37.2 	(b) The holder of a temporary license shall not:
37.3 	(1) engage in purchasing, possessing, cultivating, manufacturing, or selling cannabis or 
37.4 	cannabis products;
37.5 	(2) grow, process, distribute, dispense, or otherwise handle cannabis;
37.6 	(3) make any transfer of an ownership interest that causes a change in the individual or 
37.7 	entity that holds the controlling ownership interest;
37.8 	(4) make any change or transfer of ownership or control that would require a new business 
37.9 	registration with the secretary of state; or
37.10 	(5) make any transfer of ownership interest that causes the holder of the temporary 
37.11 	license to no longer qualify as a social equity applicant as defined in section 342.17.
37.12 		Subd. 6.Revocation and other penalties. (a) The office may revoke a temporary license 
37.13 	if the holder of the temporary license or, if the license holder is a business entity, any 
37.14 	cooperative member or director, manager, or general partner of the business entity:
37.15 	(1) fraudulently or deceptively obtained the temporary license;
37.16 	(2) fails to reveal any material fact pertaining to the licensee's qualification for a license;
37.17 	(3) fails to convert a temporary license into a license that is not temporary within 18 
37.18 	months of the date that the temporary license was issued;
37.19 	(4) violates this chapter;
37.20 	(5) is not registered or in good standing with the Office of the Secretary of State; or
37.21 	(6) is in arrears on property, business, or personal taxes.
37.22 		Subd. 7.Conversion of temporary license. (a) The office must convert a temporary 
37.23 	license into a license that is not temporary after the office:
37.24 	(1) adopts initial rules pursuant to section 342.02, subdivision 5; and
37.25 	(2) finds that the license holder or, if the license holder is a business entity, every 
37.26 	cooperative member or director, manager, or general partner of the business entity, has not 
37.27 	violated this chapter.
37.28 	(b) The office must not convert a temporary license into a license that is not temporary 
37.29 	if the ownership of the temporary license holder's business has changed since being granted 
37.30 	a temporary license and the temporary license holder has not filed an updated ownership 
38.1 	disclosure with information consistent with the original application and section 342.14, 
38.2 	subdivision 1, paragraph (b).
38.3 	(c) The office must not convert a temporary license into a license that is not temporary 
38.4 	if the cannabis business for which the license is held does not meet local zoning and land 
38.5 	use laws.
38.6 	(d) A license that is converted from a temporary license according to this subdivision 
38.7 	expires 18 months after the date of the conversion.
38.8 		Subd. 8.Applicants; right to a reconsideration. (a) An applicant that is not issued a 
38.9 	temporary license or an applicant that the office has not entered into the lottery may request 
38.10 	a records review of the submitted application within seven calendar days of receiving 
38.11 	notification that the application does not meet the minimum qualifications for a license 
38.12 	under section 342.18, subdivision 3.
38.13 	(b) Upon an applicant's request, the office must allow the applicant to examine the 
38.14 	applicant's records received by the office.
38.15 	(c) If the office determines that an applicant is ineligible for a temporary license, the 
38.16 	office must inform the applicant of any reasons that form the basis of the office's 
38.17 	determination.
38.18 	(d) Data submitted by applicants must be classified as protected consistent with chapter 
38.19 	13.
38.20 	(e) The following applicants may request reconsideration by the director:
38.21 	(1) an applicant selected in a lottery whose license is later revoked by the office; or
38.22 	(2) an applicant who previously held a temporary license until the temporary license 
38.23 	was revoked by the office.
38.24 	(f) An applicant who does not meet the minimum qualifications for a license under 
38.25 	section 342.18, subdivision 3, and is not selected in the lottery may not appeal or request a 
38.26 	hearing.
38.27 		Subd. 9.Multiple lotteries; application retention. (a) Upon receiving notification that 
38.28 	an applicant was not selected in the lottery, the applicant may request that the office retain 
38.29 	the applicant's application for subsequent lotteries.
38.30 	(b) The office must retain any application requested for retention under paragraph (a) 
38.31 	for one year after the date of the request.
39.1 	(c) The office may contact an applicant with a retained application for any additional 
39.2 	information required for a subsequent lottery.
39.3 	(d) Any application retained by the office that meets the specifications and requirements 
39.4 	of a subsequent lottery within the one-year retention period, may be entered into the lottery 
39.5 	if the applicant:
39.6 	(1) pays the relevant application fee;
39.7 	(2) amends the application upon the request of the office; and
39.8 	(3) provides the office with any additional information requested by the office.
39.9 	(e) The office must not enter a retained application into a subsequent lottery if the 
39.10 	applicant or, if the applicant is a business entity, any cooperative member or director, 
39.11 	manager, or general partner of the business entity has violated this chapter.

39.12 	EFFECTIVE DATE. This section is effective the day following final enactment.

39.13 	Sec. 38. Minnesota Statutes 2023 Supplement, section 342.13, is amended to read:
39.14 	342.13 LOCAL CONTROL.
39.15 	(a) A local unit of government may not prohibit the possession, transportation, or use 
39.16 	of cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived 
39.17 	consumer products authorized under this chapter.
39.18 	(b) Except as provided in section 342.22, a local unit of government may not prohibit 
39.19 	the establishment or operation of a cannabis business licensed under this chapter.
39.20 	(c) A local unit of government may adopt reasonable restrictions on the time, place, and 
39.21 	manner of the operation of a cannabis business provided that such restrictions do not prohibit 
39.22 	the establishment or operation of cannabis businesses. A local unit of government may 
39.23 	prohibit the operation of a cannabis business within 1,000 feet of a school, or 500 feet of a 
39.24 	day care, residential treatment facility, or an attraction within a public park that is regularly 
39.25 	used by minors, including a playground or athletic field.
39.26 	(d) The office shall work with local units of government to:
39.27 	(1) develop model ordinances for reasonable restrictions on the time, place, and manner 
39.28 	of the operation of a cannabis business;
39.29 	(2) develop standardized forms and procedures for the issuance of a retail registration 
39.30 	pursuant to section 342.22; and
40.1 	(3) develop model policies and procedures for the performance of compliance checks 
40.2 	required under section 342.22.
40.3 	(e) If a local unit of government is conducting studies or has authorized a study to be 
40.4 	conducted or has held or has scheduled a hearing for the purpose of considering adoption 
40.5 	or amendment of reasonable restrictions on the time, place, and manner of the operation of 
40.6 	a cannabis business, the governing body of the local unit of government may adopt an 
40.7 	interim ordinance applicable to all or part of its jurisdiction for the purpose of protecting 
40.8 	the planning process and the health, safety, and welfare of its citizens. Before adopting the 
40.9 	interim ordinance, the governing body must hold a public hearing. The interim ordinance 
40.10 	may regulate, restrict, or prohibit the operation of a cannabis business within the jurisdiction 
40.11 	or a portion thereof until January 1, 2025.
40.12 	(f) Within 30 days of receiving a copy of an application from the office, a local unit of 
40.13 	government shall certify on a form provided by the office whether a proposed cannabis 
40.14 	business complies with local zoning ordinances and, if applicable, whether the proposed 
40.15 	business complies with the state fire code and building code. The office may not issue a 
40.16 	licensean endorsement to a cannabis business if a the cannabis business does not meet local 
40.17 	zoning and land use laws.
40.18 	(g) Upon receipt of an application for a license issued under this chapter, the office shall 
40.19 	contact the local unit of government in which the business would be located and provide 
40.20 	the local unit of government with 30 days in which to provide input on the application. The 
40.21 	local unit of government may provide the office with any additional information it believes 
40.22 	is relevant to the office's decision on whether to issue a license, including but not limited 
40.23 	to identifying concerns about the proposed location of a cannabis business or sharing public 
40.24 	information about an applicant.
40.25 	(h) (g) The office by rule shall establish an expedited complaint process to receive, 
40.26 	review, and respond to complaints made by a local unit of government about a cannabis 
40.27 	business. Complaints may include alleged violations of local ordinances or other alleged 
40.28 	violations. The office may only investigate complaints that are made under this chapter. At 
40.29 	a minimum, the expedited complaint process shall require the office to provide an initial 
40.30 	response to the complaint within seven days and perform any necessary inspections within 
40.31 	30 days. Nothing in this paragraph prohibits a local unit of government from enforcing a 
40.32 	local ordinance. If a local unit of government notifies the office that a cannabis business 
40.33 	other than a cannabis retailer, cannabis microbusiness with a retail operations endorsement, 
40.34 	cannabis mezzobusiness, lower-potency hemp edible retailer, medical cannabis retailer, or 
40.35 	medical cannabis combination business poses an immediate threat to the health or safety 
41.1 	of the public, the office must respond within one business day and may take any action 
41.2 	described in section 342.19 or 342.21.
41.3 	(i) (h) A local government unit that issues cannabis retailer registration under section 
41.4 	342.22 may, by ordinance, limit the number of licensed cannabis retailers, cannabis 
41.5 	mezzobusinesses with a retail operations endorsement, and cannabis microbusinesses with 
41.6 	a retail operations endorsement to no fewer than one registration for every 12,500 residents.
41.7 	(j) (i) If a county has one active registration for every 12,500 residents, a city or town 
41.8 	within the county is not obligated to register a cannabis business.
41.9 	(k) (j) Nothing in this section shall prohibit a local government unit from allowing 
41.10 	licensed cannabis retailers in excess of the minimums set in paragraph (i) (h).
41.11 	(l) (k) Notwithstanding the foregoing provisions, the state shall not issue a license to 
41.12 	any cannabis business to operate in Indian country, as defined in United States Code, title 
41.13 	18, section 1151, of a Minnesota Tribal government without the consent of the Tribal 
41.14 	government.

41.15 	Sec. 39. Minnesota Statutes 2023 Supplement, section 342.14, is amended to read:
41.16 	342.14 CANNABIS LICENSE APPLICATION AND RENEWAL.
41.17 		Subdivision 1.Application; contents. (a) The office by rule shall establish forms and 
41.18 	procedures for the processing of cannabis licenses issued under this chapter. At a minimum, 
41.19 	any application to obtain or renew a cannabis license shall The office may direct an applicant 
41.20 	to include the following information, if applicable in an application to obtain or renew a 
41.21 	cannabis license:
41.22 	(1) the name, address, and date of birth of the applicant;
41.23 	(2) the disclosure of ownership and control required under paragraph (b);
41.24 	(3) the disclosure of whether the applicant or, if the applicant is a business, any officer, 
41.25 	director, manager, and general partner of the business has ever filed for bankruptcy;
41.26 	(4) the address and legal property description of the business, if applicable, except an 
41.27 	applicant is not required to secure a physical premises for the business at the time of 
41.28 	application;
41.29 	(5) a general description of the location or locations that the applicant plans to operate, 
41.30 	including the planned square feet of planned space for cultivation, wholesaling, and retailing, 
41.31 	as applicable;
42.1 	(6) a copy of the security plan;
42.2 	(7) proof of trade name registration;
42.3 	(8) a copy of the applicant's business plan showing the expected size of the business; 
42.4 	anticipated growth; the methods of record keeping; the knowledge and experience of the 
42.5 	applicant and any officer, director, manager, and general partner of the business; the 
42.6 	environmental plan; and other relevant financial and operational components;
42.7 	(9) an attestation signed by a bona fide labor organization stating that the applicant has 
42.8 	entered into a labor peace agreement;
42.9 	(10) certification that the applicant will comply with the requirements of this chapter 
42.10 	relating to the ownership and operation of a cannabis business;
42.11 	(11) identification of one or more controlling persons or managerial employees as agents 
42.12 	who shall be responsible for dealing with the office on all matters; and
42.13 	(12) a statement that the applicant agrees to respond to the office's supplemental requests 
42.14 	for information.
42.15 	(b) An applicant must file and update as necessary a disclosure of ownership and control. 
42.16 	The office by rule shall establish the contents and form of the disclosure. Except as provided 
42.17 	in paragraph (f), the disclosure shall, at a minimum, include the following:
42.18 	(1) the management structure, ownership, and control of the applicant or license holder, 
42.19 	including the name of each cooperative member, officer, director, manager, general partner, 
42.20 	or business entity; the office or position held by each person; each person's percentage 
42.21 	ownership interest, if any; and, if the business has a parent company, the name of each 
42.22 	owner, board member, and officer of the parent company and the owner's, board member's, 
42.23 	or officer's percentage ownership interest in the parent company and the cannabis business;
42.24 	(2) a statement from the applicant and, if the applicant is a business, from every officer, 
42.25 	director, manager, and general partner of the business, indicating whether that person has 
42.26 	previously held, or currently holds, an ownership interest in a cannabis business in Minnesota, 
42.27 	any other state or territory of the United States, or any other country;
42.28 	(3) if the applicant is a corporation, copies of the applicant's articles of incorporation 
42.29 	and bylaws and any amendments to the applicant's articles of incorporation or bylaws;
42.30 	(4) copies of any partnership agreement, operating agreement, or shareholder agreement;
42.31 	(5) copies of any promissory notes, security instruments, or other similar agreements;
42.32 	(6) an explanation detailing the funding sources used to finance the business;
43.1 	(7) a list of operating and investment accounts for the business, including any applicable 
43.2 	financial institution and account number; and
43.3 	(8) a list of each outstanding loan and financial obligation obtained for use in the business, 
43.4 	including the loan amount, loan terms, and name and address of the creditor.
43.5 	(c) An application may include:
43.6 	(1) proof that the applicant is a social equity applicant;
43.7 	(2) a description of the training and education that will be provided to any employee; 
43.8 	or
43.9 	(3) a copy of business policies governing operations to ensure compliance with this 
43.10 	chapter.
43.11 	(d) Commitments made by an applicant in its application, including but not limited to 
43.12 	the maintenance of a labor peace agreement, shall be an ongoing material condition of 
43.13 	maintaining and renewing the license.
43.14 	(e) An application on behalf of a corporation or association shall be signed by at least 
43.15 	two officers or managing agents of that entity.
43.16 	(f) The office may, by rule, establish exceptions to the disclosures required under 
43.17 	paragraph (b) for members of a cooperative who hold less than a five percent ownership 
43.18 	interest in the cooperative.
43.19 		Subd. 2.Application; process. (a) An applicant must submit all required information 
43.20 	to the office on the forms and in the manner prescribed by the office.
43.21 	(b) If the office receives an application that fails to provide the required information, 
43.22 	the office shall issue a deficiency notice to the applicant. The applicant shall have ten 
43.23 	business days from the date of the deficiency notice to submit the required information.
43.24 	(c) Failure by an applicant to submit all required information will result in the application 
43.25 	being rejected.
43.26 	(d) Upon receipt of a completed application and fee, the office shall forward a copy of 
43.27 	the application to the local unit of government in which the business operates or intends to 
43.28 	operate with a form for certification as to whether a proposed cannabis business complies 
43.29 	with local zoning ordinances and, if applicable, whether the proposed business complies 
43.30 	with the state fire code and building code.
44.1 	(e) (d) Within 90 days of receiving a completed application and the results of any required 
44.2 	criminal history check, the office shall issue the appropriate license or send the applicant a 
44.3 	notice of rejection setting forth specific reasons that the office did not approve the application.
44.4 		Subd. 3.License revocation. The office may revoke a cannabis business license if the 
44.5 	licensee has not made good faith efforts to obtain an endorsement within 18 months of the 
44.6 	date that the license was issued. The office may give a licensee a onetime extension to obtain 
44.7 	an endorsement if the licensee demonstrates that the licensee made good faith efforts to 
44.8 	obtain an endorsement within 18 months of the date that the license was issued.

44.9 	Sec. 40. Minnesota Statutes 2023 Supplement, section 342.15, subdivision 1, is amended 
44.10 	to read:
44.11 		Subdivision 1.Criminal history check. (a) Upon request by the office, every license 
44.12 	applicant, license holder, or, in the case of a business entity, every individual responsible 
44.13 	for conducting the affairs of the entity, including but not limited to every owner and every 
44.14 	cooperative member or director, manager, and general partner of the business entity, for a 
44.15 	cannabis business license, or in the case of a business entity, every cooperative member or 
44.16 	director, manager, and general partner of the business entity, and prospective cannabis 
44.17 	worker must submit a completed criminal history records check consent form, a full set of 
44.18 	classifiable fingerprints, and the required fees to the office. Upon receipt of this information, 
44.19 	the office must submit the completed criminal history records check consent form, full set 
44.20 	of classifiable fingerprints, and required fees to the Bureau of Criminal Apprehension.
44.21 	(b) After receiving this information, the bureau must conduct a Minnesota state criminal 
44.22 	history records check of the license applicant or prospective cannabis worker an individual 
44.23 	identified in paragraph (a). The bureau may exchange a license applicant's or prospective 
44.24 	cannabis worker's an individual's fingerprints with the Federal Bureau of Investigation to 
44.25 	obtain the license applicant's or prospective cannabis worker's national criminal history 
44.26 	record information of the individual. The bureau must return the results of the Minnesota
44.27 	state and federal criminal history records checks to the office to determine if the license 
44.28 	applicant or prospective cannabis worker individual is disqualified under rules adopted 
44.29 	pursuant to this section.
44.30 	(b)(c) The office may, by rule, establish exceptions to the requirement under paragraph
44.31 	paragraphs (a) and (b) for members of a cooperative who hold less than a five percent 
44.32 	ownership interest in the cooperative.

45.1 	Sec. 41. Minnesota Statutes 2023 Supplement, section 342.15, subdivision 2, is amended 
45.2 	to read:
45.3 		Subd. 2.Criminal offenses; disqualifications. The office may by rule determine whether 
45.4 	any felony convictions shall, including but not limited to convictions for noncannabis 
45.5 	controlled substance crimes in the first or second degree, human trafficking, labor trafficking, 
45.6 	fraud, or financial crimes, disqualify a person an individual from holding or receiving a 
45.7 	cannabis business license issued under this chapter or working for a cannabis business, and 
45.8 	the length of any such disqualification. In adopting rules pursuant to this subdivision, the 
45.9 	office shall not disqualify a person an individual for a violation of section 152.025.

45.10 	Sec. 42. Minnesota Statutes 2023 Supplement, section 342.15, is amended by adding a 
45.11 	subdivision to read:
45.12 		Subd. 5.Civil and regulatory offenses; disqualifications. The office may, by rule, 
45.13 	determine whether any civil or regulatory violations, as determined by another state agency, 
45.14 	local unit of government, or any other jurisdiction, disqualify an individual from holding 
45.15 	or receiving a cannabis business license issued under this chapter or disqualify an individual 
45.16 	from working for a cannabis business, and the length of the disqualification. The office 
45.17 	must have access to all investigative or regulatory data, regardless of its data classification 
45.18 	under chapter 13, relating to an individual who applies for a cannabis license or applies to 
45.19 	work for a cannabis business, when the data is held by any other state agency that has 
45.20 	regulatory authority over the individual.

45.21 	Sec. 43. [342.151] EMPLOYEES OF LICENSE HOLDERS.
45.22 		Subdivision 1.Definitions. For purposes of this section, a "license holder" includes a 
45.23 	cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis manufacturer, 
45.24 	cannabis retailer, cannabis wholesaler, cannabis transporter, cannabis testing facility, cannabis 
45.25 	event organizer, cannabis delivery service, lower-potency hemp edible manufacturer, 
45.26 	lower-potency hemp edible retailer, or medical cannabis combination business.
45.27 		Subd. 2.Criminal history check. A license holder may employ or contract with as 
45.28 	many unlicensed individuals as may be necessary, provided that the license holder is at all 
45.29 	times accountable for the good conduct of every individual employed by or contracted with 
45.30 	the license holder. Before hiring an individual as a cannabis worker, the license holder must 
45.31 	submit to the Bureau of Criminal Apprehension the individual's full set of fingerprints and 
45.32 	written consent for the bureau to conduct a state and national criminal history check. The 
45.33 	bureau may exchange an individual's fingerprints with the Federal Bureau of Investigation. 
46.1 	The Bureau of Criminal Apprehension must determine whether the individual is qualified 
46.2 	to be employed as a cannabis worker and must notify the license holder of the bureau's 
46.3 	determination. The license holder must not employ an individual who is disqualified from 
46.4 	being employed as a cannabis worker.
46.5 		Subd. 3.Disqualification. (a) A license holder must not employ an individual as a 
46.6 	cannabis worker if the individual has been convicted of any of the following crimes that 
46.7 	would constitute a felony:
46.8 	(1) human trafficking;
46.9 	(2) noncannabis controlled substance crimes in the first or second degree;
46.10 	(3) labor trafficking;
46.11 	(4) fraud;
46.12 	(5) embezzlement;
46.13 	(6) extortion;
46.14 	(7) money laundering; or
46.15 	(8) insider trading;
46.16 	if committed in this state or any other jurisdiction for which a full pardon or similar relief 
46.17 	has not been granted.
46.18 	(b) A license holder must not employ an individual as a cannabis worker if the individual 
46.19 	made any false statement in an application for employment.

46.20 	Sec. 44. Minnesota Statutes 2023 Supplement, section 342.17, is amended to read:
46.21 	342.17 SOCIAL EQUITY APPLICANTS.
46.22 	(a) An applicant qualifies as a social equity applicant if the applicant:
46.23 	(1) was convicted of an offense involving the possession or sale of cannabis or marijuana 
46.24 	prior to May 1, 2023;
46.25 	(2) had a parent, guardian, child, spouse, or dependent who was convicted of an offense 
46.26 	involving the possession or sale of cannabis or marijuana prior to May 1, 2023;
46.27 	(3) was a dependent of an individual who was convicted of an offense involving the 
46.28 	possession or sale of cannabis or marijuana prior to May 1, 2023;
46.29 	(4) is a military veteran, including status as a service-disabled veteran, current or former 
46.30 	member of the national guard, or any military veteran or current or former member of the 
47.1 	national guard who lost honorable status due to an offense involving the possession or sale 
47.2 	of cannabis or marijuana;
47.3 	(5) has been a resident for the last five years of one or more subareas, such as census 
47.4 	tracts or neighborhoods, that experienced a disproportionately large amount of cannabis 
47.5 	enforcement as determined by the study conducted by the office pursuant to section 342.04, 
47.6 	paragraph (b), and reported in the preliminary report, final report, or both;
47.7 	(6) is an emerging farmer as defined in section 17.055, subdivision 1; or
47.8 	(6) is currently a farmer or an aspiring cannabis farmer who faces barriers to education 
47.9 	or employment; or
47.10 	(7) has been a resident for the last five years of one or more census tracts where, as 
47.11 	reported in the most recently completed decennial census published by the United States 
47.12 	Bureau of the Census, either:
47.13 	(i) the poverty rate was 20 percent or more; or
47.14 	(ii) the median family income did not exceed 80 percent of statewide median family 
47.15 	income or, if in a metropolitan area, did not exceed the greater of 80 percent of the statewide 
47.16 	median family income or 80 percent of the median family income for that metropolitan 
47.17 	area.
47.18 	(b) The qualifications described in paragraph (a) apply to each individual applicant or, 
47.19 	in the case of a business entity, every cooperative member or director, manager, and general 
47.20 	partner apply to at least 65 percent of the controlling ownership of the business entity.

47.21 	Sec. 45. [342.175] SOCIAL EQUITY LICENSE CLASSIFICATION.
47.22 		Subdivision 1.Social equity license classification. (a) The office must make a social 
47.23 	equity classification available to a social equity applicant under section 342.17.
47.24 	(b) The office must classify any type of license under section 342.10 as a social equity 
47.25 	license if the license is held by a social equity applicant.
47.26 		Subd. 2.Social equity applicants; temporary licenses. After accepting and reviewing 
47.27 	an application for a license from a social equity applicant, the office may issue a temporary 
47.28 	license according to section 342.125 to the social equity applicant.

48.1 	Sec. 46. Minnesota Statutes 2023 Supplement, section 342.18, subdivision 3, is amended 
48.2 	to read:
48.3 		Subd. 3.Application score; license priority review. (a) The office shall award points 
48.4 	to review each completed application for a license to operate a cannabis business in the 
48.5 	following categories:
48.6 	(1) status as a social equity applicant or as an applicant who is substantially similar to 
48.7 	a social equity applicant as described in paragraph (c);
48.8 	(2) status as a veteran or retired national guard applicant who does not meet the definition 
48.9 	of social equity applicant;
48.10 	(3) (1) security and record keeping;
48.11 	(4) (2) employee training plan;
48.12 	(5) (3) business plan and financial situation;
48.13 	(6) (4) labor and employment practices;
48.14 	(7) (5) knowledge and experience; and
48.15 	(8) (6) environmental plan.
48.16 	(b) The office may award additional points to an application if the license holder would 
48.17 	expand service to an underrepresented market, including but not limited to participation in 
48.18 	the medical cannabis program.
48.19 	(c) The office shall establish application materials permitting individual applicants to 
48.20 	demonstrate the impact that cannabis prohibition has had on that applicant, including but 
48.21 	not limited to the arrest or imprisonment of the applicant or a member of the applicant's 
48.22 	immediate family, and the office may award points to such applicants in the same manner 
48.23 	as points are awarded to social equity applicants.
48.24 	(d) (b) The office shall by rule establish policies and guidelines, which the office must 
48.25 	be made make available to the public, regarding the number of points available minimum 
48.26 	qualifications in each category and the basis for awarding those points. Status as a social 
48.27 	equity applicant must account for at least 20 percent of the total available points. In 
48.28 	determining the number of points to award to a cooperative or business applying as a social 
48.29 	equity applicant, the office shall consider the number or ownership percentage of cooperative 
48.30 	members, officers, directors, managers, and general partners who qualify as social equity 
48.31 	applicants criteria that the office uses to determine whether an applicant meets the minimum 
48.32 	qualifications in each category.
49.1 	(e) Consistent with the goals identified in subdivision 1, the office shall issue licenses 
49.2 	in each license category, giving priority to applicants who receive the highest score under 
49.3 	paragraphs (a) and (b). If there are insufficient licenses available for entities that receive 
49.4 	identical scores, the office shall utilize a lottery to randomly select license recipients from 
49.5 	among those entities.

49.6 	Sec. 47. Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a 
49.7 	subdivision to read:
49.8 		Subd. 4.Maximum number of licenses. (a) Through as many licensing periods as the 
49.9 	office deems necessary, the office shall issue no more than the maximum number of licenses 
49.10 	in each license category listed in paragraphs (e) and (f) to applicants that meet the minimum 
49.11 	qualifications in subdivision 3. After 24 months from the beginning of the license application 
49.12 	process, the office may adjust the maximum number of licenses of any type listed in this 
49.13 	subdivision based on market demand, consistent with the objectives in section 342.02, 
49.14 	subdivision 1, and the annual report required under section 342.04, paragraph (f).
49.15 	(b) If there are insufficient licenses available for all applicants that meet the minimum 
49.16 	qualifications in subdivision 3, the office shall hold a lottery to randomly select license 
49.17 	recipients from among the applicants. The office may issue as many licenses as the office 
49.18 	deems necessary of a license type that is not listed in this subdivision. The office is not 
49.19 	required to issue a license for a license type that is not listed in this subdivision.
49.20 	(c) Cannabis microbusiness and cannabis mezzobusiness license holders must earn no 
49.21 	less than two distinctly different endorsements for authorized actions under the license 
49.22 	category within 18 months of license issuance or the office may revoke the license holder's 
49.23 	license or take appropriate enforcement action.
49.24 	(d) The office is not required to issue licenses to meet the maximum number of licenses 
49.25 	that may be issued under paragraphs (e) and (f).
49.26 	(e) For licenses that are available to social equity applicants, the maximum number of 
49.27 	licenses that the office may issue are:
49.28 	(1) cultivator licenses, 25;
49.29 	(2) product manufacturer licenses, 12;
49.30 	(3) retailer licenses, 100; and
49.31 	(4) cannabis mezzobusiness licenses, 22.
50.1 	(f) For licenses that are available to all applicants, the maximum number of licenses that 
50.2 	the office may issue are:
50.3 	(1) cultivator licenses, 25;
50.4 	(2) product manufacturer licenses, 12;
50.5 	(3) retailer licenses, 100; and
50.6 	(4) cannabis mezzobusiness licenses, 22.

50.7 	Sec. 48. Minnesota Statutes 2023 Supplement, section 342.18, is amended by adding a 
50.8 	subdivision to read:
50.9 		Subd. 5.Conversion to cannabis business license. (a) After the office adopts initial 
50.10 	rules pertaining to cannabis, the office may permit a holder of a hemp-derived cannabinoid 
50.11 	business registration pursuant to section 151.72 to convert the holder's registration to a 
50.12 	comparable lower-potency hemp edible business license if:
50.13 	(1) the registration was active before the office adopted initial rules pertaining to cannabis;
50.14 	(2) the registrant submits documentation to the office sufficient to meet the minimum 
50.15 	requirements in section 342.44;
50.16 	(3) the registrant pays an application and licensing fee as required by section 342.11; 
50.17 	and
50.18 	(4) the registrant is in good standing with the state.
50.19 	(b) A registrant with an active hemp-derived cannabinoid business registration pursuant 
50.20 	to section 151.72 may continue operations under an active registration for no more than 30 
50.21 	days after the office begins accepting applications for a lower-potency hemp edible business 
50.22 	license.
50.23 	(c) Upon the submission of an application for a lower-potency hemp edible business 
50.24 	license to the office, a registrant's hemp-derived cannabinoid business registration shall 
50.25 	remain active until the office makes a determination regarding the registrant's application, 
50.26 	as long as the registrant remains in good standing with the state.

51.1 	Sec. 49. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 1, is amended 
51.2 	to read:
51.3 		Subdivision 1.Authority to inspect. (a) In order to carry out the purposes of this chapter, 
51.4 	the office, upon presenting appropriate credentials to the owner, operator, or agent in charge, 
51.5 	is authorized to:
51.6 	(1) enter any cannabis business or hemp business the place of business of any entity 
51.7 	participating in the cannabis industry or hemp consumer industry without delay and at 
51.8 	reasonable times;
51.9 	(2) inspect and investigate during regular working hours and at other reasonable times, 
51.10 	within reasonable limits and in a reasonable manner, any cannabis business or hemp business
51.11 	the place of business of any entity participating in the cannabis industry or hemp consumer 
51.12 	industry and all relevant conditions, equipment, records, and materials therein; and
51.13 	(3) question privately any employer, owner, operator, agent, or employee of a cannabis 
51.14 	business or hemp business any business participating in the cannabis industry or hemp 
51.15 	consumer industry.
51.16 	(b) An employer, owner, operator, agent, or employee must not refuse the office entry 
51.17 	or otherwise deter or prohibit the office from taking action under paragraph (a).

51.18 	Sec. 50. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 3, is amended 
51.19 	to read:
51.20 		Subd. 3.Aiding of inspection. Subject to rules issued by the office, a representative of 
51.21 	a cannabis business or hemp business shall business participating in the cannabis industry 
51.22 	or hemp consumer industry must be given an opportunity to accompany the office during 
51.23 	the physical inspection of any cannabis business or hemp the business for the purpose of 
51.24 	aiding such inspection.

51.25 	Sec. 51. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 4, is amended 
51.26 	to read:
51.27 		Subd. 4.Complaints and reports; priority of inspection. (a) The office may conduct 
51.28 	inspections of any licensed cannabis business or hemp business place of business of any 
51.29 	person or business participating in the cannabis industry or hemp consumer industry at any 
51.30 	time to ensure compliance with the ownership and operation requirements of this chapter.
51.31 	(b) Any person may report a suspected violation of a safety or health standard. If upon 
51.32 	receipt of such notification the office determines that there are reasonable grounds to believe 
52.1 	that such violation or danger exists, the office shall make a special inspection as soon as 
52.2 	practicable to determine if such danger or violation exists.
52.3 	(c) The office shall prioritize inspections of cannabis businesses and hemp businesses
52.4 	where there are reasonable grounds to believe that a violation by a person or business poses 
52.5 	imminent danger to the public or customers. Inspections must take place within one business 
52.6 	day of the receipt of a credible report.
52.7 	(d) The office shall promptly inspect cannabis businesses and hemp businesses the place 
52.8 	of business of any person or business participating in the cannabis industry or hemp consumer 
52.9 	industry that are is the subject of complaint by a local unit of government.

52.10 	Sec. 52. Minnesota Statutes 2023 Supplement, section 342.19, subdivision 5, is amended 
52.11 	to read:
52.12 		Subd. 5.Violations; administrative orders and penalties. (a) The office may issue an 
52.13 	administrative order to any licensed cannabis business or hemp business person or business 
52.14 	participating in the cannabis industry or hemp consumer industry that the office determines 
52.15 	has committed a violation of this chapter or rules adopted pursuant to this chapter. The 
52.16 	administrative order may require the business to correct the violation or to cease and desist 
52.17 	from committing the violation. The order must state the deficiencies that constitute the 
52.18 	violation and the time by which the violation must be corrected. If the business believes 
52.19 	that the information in the administrative order is in error, the business may ask the office 
52.20 	to consider the parts of the order that are alleged to be in error. The request must be in 
52.21 	writing, delivered to the office by certified mail within seven days after receipt of the order, 
52.22 	and provide documentation to support the allegation of error. The office must respond to a 
52.23 	request for reconsideration within 15 days after receiving the request. A request for 
52.24 	reconsideration does not stay the correction order unless the office issues a supplemental 
52.25 	order granting additional time. The office's disposition of a request for reconsideration is 
52.26 	final.
52.27 	(b) For each violation of this chapter or rules adopted pursuant to this chapter, the office 
52.28 	may issue to each cannabis business or hemp individual or business a monetary penalty of 
52.29 	up to $10,000, an amount that deprives the individual or business of any economic advantage 
52.30 	gained by the violation, or both.
52.31 	(c) An administrative penalty may be recovered in a civil action in the name of the state 
52.32 	brought in the district court of the county where the violation is alleged to have occurred 
52.33 	or the district court where the office is housed.
53.1 	(d) In addition to penalties listed in this subdivision, a person or business who violates 
53.2 	the provisions of this chapter is subject to any applicable criminal penalty.

53.3 	Sec. 53. Minnesota Statutes 2023 Supplement, section 342.22, is amended to read:
53.4 	342.22 RETAILERS; LOCAL REGISTRATION AND ENFORCEMENT.
53.5 		Subdivision 1.Registration required. Before receiving a retail operations endorsement 
53.6 	and making retail sales to customers or patients, a cannabis microbusiness with a retail 
53.7 	operations endorsement, cannabis mezzobusiness with a retail operations endorsement, 
53.8 	cannabis retailer, medical cannabis retailer, medical cannabis combination business, or 
53.9 	lower-potency hemp edible retailer must register with the city, town, or county in which 
53.10 	the retail establishment is located. A county may issue a registration in cases where a city 
53.11 	or town has provided consent for the county to issue the registration for the jurisdiction.
53.12 		Subd. 2.Registration fee. (a) A local unit of government may impose an initial retail 
53.13 	registration fee of $500 or up to half the amount of the applicable initial license fee under 
53.14 	section 342.11, whichever is less. The local unit of government may also impose a renewal 
53.15 	retail registration fee of $1,000 or up to half the amount of the applicable renewal license 
53.16 	fee under section 342.11, whichever is less. The initial registration fee shall include the fee 
53.17 	for initial registration and the first annual renewal. Any renewal fee imposed by the local 
53.18 	unit of government shall be charged at the time of the second renewal and each subsequent 
53.19 	annual renewal thereafter.
53.20 	(b) The local unit of government may not charge an application fee.
53.21 	(c) A cannabis business with a cannabis retailer license and a medical cannabis retailer 
53.22 	license for the same location may only be charged a single registration fee.
53.23 	(d) (c) Registration fees are nonrefundable.
53.24 		Subd. 3.Issuance of registration. (a) A local unit of government shall issue a retail 
53.25 	registration to a cannabis microbusiness with a retail operations endorsement, cannabis 
53.26 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
53.27 	retailer, or lower-potency hemp edible retailer that:
53.28 	(1) has a valid license issued an application that has been approved by the office;
53.29 	(2) has paid the registration fee or renewal fee pursuant to subdivision 2;
53.30 	(3) is found to be in compliance with the requirements of this chapter at any preliminary 
53.31 	compliance check that the local unit of government performs; and
54.1 	(4) if applicable, is current on all property taxes and assessments at the location where 
54.2 	the retail establishment is located.
54.3 	(b) Before issuing a retail registration, the local unit of government may conduct a 
54.4 	preliminary compliance check to ensure that the cannabis business or hemp business is in 
54.5 	compliance with the any applicable operation requirements and the limits on the types of 
54.6 	cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
54.7 	products that may be sold local ordinance established pursuant to section 342.13.
54.8 	(c) A local unit of government shall renew the retail registration of a cannabis business 
54.9 	or hemp business when the office renews the license of the cannabis business or hemp 
54.10 	business.
54.11 	(d) A retail registration issued under this section may not be transferred.
54.12 		Subd. 4.Compliance checks. (a) A local unit of government shall conduct compliance 
54.13 	checks of every cannabis business and hemp business with a retail registration issued by 
54.14 	the local unit of government. The checks During a compliance check, a local unit of 
54.15 	government shall assess a business's compliance with age verification requirements, the
54.16 	and compliance with any applicable operation requirements, and the applicable limits on 
54.17 	the types of cannabis flower, cannabis products, lower-potency hemp edibles, and 
54.18 	hemp-derived consumer products being sold local ordinance established pursuant to section 
54.19 	342.13.
54.20 	(b) The A local unit of government must conduct unannounced age verification 
54.21 	compliance checks of every cannabis business and hemp business at least once each calendar 
54.22 	year. Age verification compliance checks must involve persons at least 17 years of age but 
54.23 	under the age of 21 who, with the prior written consent of a parent or guardian if the person 
54.24 	is under the age of 18, attempt to purchase adult-use cannabis flower, adult-use cannabis 
54.25 	products, lower-potency hemp edibles, or hemp-derived consumer products under the direct 
54.26 	supervision of a law enforcement officer or an employee of the local unit of government.
54.27 	(c) Checks to ensure compliance with the applicable operation requirements and the 
54.28 	limits on the types of cannabis flower, cannabis products, lower-potency hemp edibles, and 
54.29 	hemp-derived consumer products that may be sold must be performed at least once each 
54.30 	calendar year and may be performed by a law enforcement officer or an employee of the 
54.31 	local unit of government.
54.32 		Subd. 5.Registration suspension and cancellation; notice to office; penalties. (a) If 
54.33 	a local unit of government determines that a cannabis business or hemp business with a 
54.34 	retail registration issued by the local unit of government is not operating in compliance with 
55.1 	the requirements of this chapter a local ordinance authorized under section 342.13 or that 
55.2 	the operation of the business poses an immediate threat to the health or safety of the public, 
55.3 	the local unit of government may suspend the retail registration of the cannabis business or 
55.4 	hemp business. The local unit of government must immediately notify the office of the 
55.5 	suspension and shall include a description of the grounds for the suspension.
55.6 	(b) The office shall review the retail registration suspension and may order reinstatement 
55.7 	of the retail registration or take any action described in section 342.19 or 342.21.
55.8 	(c) The retail registration suspension must be for up to 30 days unless the office suspends 
55.9 	the license and operating privilege of the cannabis business or hemp business for a longer 
55.10 	period or revokes the license.
55.11 	(d) The local unit of government may reinstate the retail registration if the local unit of 
55.12 	government determines that any violation has been cured. The local unit of government 
55.13 	must reinstate the retail registration if the office orders reinstatement.
55.14 	(e) No cannabis microbusiness with a retail operations endorsement, cannabis 
55.15 	mezzobusiness with a retail operations endorsement, cannabis retailer, medical cannabis 
55.16 	retailer, medical cannabis combination business, or lower-potency hemp edible retailer may 
55.17 	make any sale to a customer or patient without a valid retail registration with a local unit 
55.18 	of government and a valid endorsement from the office. A local unit of government may 
55.19 	impose a civil penalty of up to $2,000 for each violation of this paragraph.

55.20 	Sec. 54. Minnesota Statutes 2023 Supplement, section 342.24, subdivision 1, is amended 
55.21 	to read:
55.22 		Subdivision 1.Individuals under 21 years of age. (a) A cannabis business may not 
55.23 	employ an individual under 21 years of age and may not contract with an individual under 
55.24 	21 years of age if the individual's scope of work involves the handling of cannabis plants, 
55.25 	cannabis flower, artificially derived cannabinoids, or cannabinoid products.
55.26 	(b) A cannabis business may not permit an individual under 21 years of age to enter the 
55.27 	business premises other than entry by a patient person enrolled in the registry program.
55.28 	(c) A cannabis business may not sell or give cannabis flower, cannabis products, 
55.29 	lower-potency hemp edibles, or hemp-derived consumer products to an individual under 
55.30 	21 years of age unless the individual is a patient; registered designated caregiver; or a parent, 
55.31 	legal guardian, or spouse of a patient who is authorized to use, possess, or transport medical 
55.32 	cannabis flower or medical cannabinoid products enrolled in the patient registry program 
55.33 	and the cannabis business holds a medical cannabis retail endorsement.

56.1 	Sec. 55. Minnesota Statutes 2023 Supplement, section 342.24, subdivision 2, is amended 
56.2 	to read:
56.3 		Subd. 2.Use of cannabis flower and products within a licensed cannabis business. (a) 
56.4 	A cannabis business may not permit an individual who is not an employee to consume 
56.5 	cannabis flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
56.6 	products within its licensed premises unless the business is licensed to permit on-site 
56.7 	consumption.
56.8 	(b) Except as otherwise provided in this subdivision, a cannabis business may not permit 
56.9 	an employee to consume cannabis flower, cannabis products, lower-potency hemp edibles, 
56.10 	or hemp-derived consumer products within its licensed premises or while the employee is 
56.11 	otherwise engaged in activities within the course and scope of employment.
56.12 	(c) A cannabis business may permit an employee to use medical cannabis flower and 
56.13 	medical cannabinoid products if that individual is a patient enrolled in the registry program.
56.14 	(d) For quality control, employees of a licensed cannabis business may sample cannabis 
56.15 	flower, cannabis products, lower-potency hemp edibles, or hemp-derived consumer products. 
56.16 	Employees may not interact directly with customers for at least three hours after sampling 
56.17 	a product. Employees may not consume more than three samples in a single 24-hour period. 
56.18 	All samples must be recorded in the statewide monitoring system.

56.19 	Sec. 56. Minnesota Statutes 2023 Supplement, section 342.28, is amended by adding a 
56.20 	subdivision to read:
56.21 		Subd. 1a.Cannabis research. A cannabis researcher may apply for a cannabis 
56.22 	microbusiness license to conduct cannabis crop research. A cannabis researcher with a 
56.23 	cannabis microbusiness license may perform activities identified in subdivision 1, clauses 
56.24 	(1) to (9) and (13). Cannabis grown for research purposes must not be offered for sale or 
56.25 	otherwise enter the stream of commerce.

56.26 	Sec. 57. Minnesota Statutes 2023 Supplement, section 342.28, subdivision 2, is amended 
56.27 	to read:
56.28 		Subd. 2.Size limitations. (a) A cannabis microbusiness that cultivates cannabis at an 
56.29 	indoor facility may cultivate up to 5,000 square feet of plant canopy. The office may adjust 
56.30 	plant canopy limits upward or downward but not below 5,000 square feet to meet market 
56.31 	demand consistent with the goals identified in section 342.02, subdivision 1.
57.1 	(b) A cannabis microbusiness that cultivates cannabis at an outdoor location may cultivate 
57.2 	up to one-half acre of mature, flowering plants unless the office increases that limit. The 
57.3 	office may increase the limit to no more than one acre if the office determines that expansion 
57.4 	is plant canopy. The office may adjust plant canopy limits upward or downward but not 
57.5 	below one-half acre to meet market demand consistent with the goals identified in section 
57.6 	342.02, subdivision 1.
57.7 	(c) The office shall establish a limit on the manufacturing of cannabis products, 
57.8 	lower-potency hemp edibles, or hemp-derived consumer products a cannabis microbusiness 
57.9 	that manufactures such products may perform. The limit must be equivalent to the amount 
57.10 	of cannabis flower that can be harvested from a facility with a plant canopy of 5,000 square 
57.11 	feet in a year, but may be increased if the office expands the allowable area of cultivation 
57.12 	under paragraph (a).
57.13 	(d) A cannabis microbusiness with the appropriate endorsement may operate one retail 
57.14 	location.

57.15 	Sec. 58. Minnesota Statutes 2023 Supplement, section 342.29, subdivision 1, is amended 
57.16 	to read:
57.17 		Subdivision 1.Authorized actions. A cannabis mezzobusiness license, consistent with 
57.18 	the specific license endorsement or endorsements, entitles the license holder to perform any 
57.19 	or all of the following within the limits established by this section:
57.20 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
57.21 	cannabis flower from a mature plant for use as adult-use cannabis flower or for use in 
57.22 	adult-use cannabis products;
57.23 	(2) grow cannabis plants from seed or immature plant to mature plant and harvest 
57.24 	cannabis flower from a mature plant for use as medical cannabis flower or for use in medical 
57.25 	cannabinoid products;
57.26 	(3) (2) make cannabis concentrate;
57.27 	(4) (3) make hemp concentrate, including hemp concentrate with a delta-9 
57.28 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
57.29 	(5) (4) manufacture artificially derived cannabinoids;
57.30 	(6) (5) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
57.31 	hemp-derived consumer products for public consumption;
57.32 	(7) (6) manufacture and process medical cannabinoid products;
58.1 	(8) (7) purchase immature cannabis plants and seedlings and cannabis flower from a 
58.2 	cannabis microbusiness, another cannabis mezzobusiness, a cannabis manufacturer, or a 
58.3 	cannabis wholesaler;
58.4 	(9) (8) purchase cannabis concentrate, hemp concentrate, and synthetically derived 
58.5 	cannabinoids from a cannabis microbusiness, another cannabis mezzobusiness, a cannabis 
58.6 	manufacturer, or a cannabis wholesaler for use in manufacturing adult-use cannabis products, 
58.7 	lower-potency hemp edibles, or hemp-derived consumer products;
58.8 	(10) (9) purchase hemp plant parts and propagules from a licensed hemp grower licensed 
58.9 	under chapter 18K;
58.10 	(11) (10) purchase hemp concentrate from an industrial hemp processor licensed under 
58.11 	chapter 18K;
58.12 	(12) (11) package and label adult-use cannabis flower, adult-use cannabis products, 
58.13 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
58.14 	(13) (12) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
58.15 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
58.16 	other products authorized by law to other cannabis businesses and to customers; and
58.17 	(14) (13) perform other actions approved by the office.

58.18 	Sec. 59. Minnesota Statutes 2023 Supplement, section 342.29, subdivision 4, is amended 
58.19 	to read:
58.20 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
58.21 	cannabis mezzobusiness license may also hold a cannabis event organizer license and a 
58.22 	medical cannabis retailer license.
58.23 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
58.24 	cannabis mezzobusiness license may own or operate any other cannabis business or hemp 
58.25 	business or hold more than one cannabis mezzobusiness license.
58.26 	(c) For purposes of this subdivision, a restriction on the number or type of license that 
58.27 	a business may hold applies to every cooperative member or every director, manager, and 
58.28 	general partner of a cannabis business.

59.1 	Sec. 60. Minnesota Statutes 2023 Supplement, section 342.30, subdivision 4, is amended 
59.2 	to read:
59.3 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
59.4 	cannabis cultivator license may also hold a cannabis manufacturing license, medical cannabis 
59.5 	cultivator license, medical cannabis producer license, license to grow industrial hemp, and 
59.6 	cannabis event organizer license.
59.7 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
59.8 	cannabis cultivator license may own or operate any other cannabis business or hemp business. 
59.9 	This prohibition does not prevent the transportation of cannabis flower from a cannabis 
59.10 	cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business 
59.11 	and located on the same premises.
59.12 	(c) The office by rule may limit the number of cannabis cultivator licenses a person, 
59.13 	cooperative, or business may hold.
59.14 	(d) For purposes of this subdivision, a restriction on the number or type of license a 
59.15 	business may hold applies to every cooperative member or every director, manager, and 
59.16 	general partner of a cannabis business.

59.17 	Sec. 61. Minnesota Statutes 2023 Supplement, section 342.31, subdivision 4, is amended 
59.18 	to read:
59.19 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
59.20 	cannabis manufacturer license may also hold a cannabis cultivator license, a medical cannabis 
59.21 	cultivator license, a medical cannabis processor license, and a cannabis event organizer 
59.22 	license.
59.23 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
59.24 	cannabis manufacturer license may own or operate any other cannabis business or hemp 
59.25 	business. This prohibition does not prevent transportation of cannabis flower from a cannabis 
59.26 	cultivator to a cannabis manufacturer licensed to the same person, cooperative, or business 
59.27 	and located on the same premises.
59.28 	(c) The office by rule may limit the number of cannabis manufacturer licenses that a 
59.29 	person or business may hold.
59.30 	(d) For purposes of this subdivision, a restriction on the number or type of license that 
59.31 	a business may hold applies to every cooperative member or every director, manager, and 
59.32 	general partner of a cannabis business.

60.1 	Sec. 62. Minnesota Statutes 2023 Supplement, section 342.32, subdivision 4, is amended 
60.2 	to read:
60.3 		Subd. 4.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
60.4 	cannabis retailer license may also hold a cannabis delivery service license, a medical cannabis 
60.5 	retailer license, and a cannabis event organizer license.
60.6 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
60.7 	cannabis retailer license may own or operate any other cannabis business or hemp business.
60.8 	(c) No person, cooperative, or business may hold a license to own or operate more than 
60.9 	one cannabis retail business in one city and three retail businesses in one county.
60.10 	(d) The office by rule may limit the number of cannabis retailer licenses a person, 
60.11 	cooperative, or business may hold.
60.12 	(e) For purposes of this subdivision, a restriction on the number or type of license a 
60.13 	business may hold applies to every cooperative member or every director, manager, and 
60.14 	general partner of a cannabis business.

60.15 	Sec. 63. Minnesota Statutes 2023 Supplement, section 342.35, subdivision 1, is amended 
60.16 	to read:
60.17 		Subdivision 1.Authorized actions. A cannabis transporter license entitles the license 
60.18 	holder to transport immature cannabis plants and seedlings, cannabis flower, cannabis 
60.19 	products, artificially derived cannabinoids, hemp plant parts, hemp concentrate, 
60.20 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
60.21 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
60.22 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis retailers, 
60.23 	medical cannabis processors, and industrial hemp growers to cannabis microbusinesses, 
60.24 	cannabis mezzobusinesses, cannabis manufacturers, cannabis testing facilities, cannabis 
60.25 	wholesalers, cannabis retailers, lower-potency hemp edible retailers, medical cannabis 
60.26 	processors, medical cannabis retailers, and medical cannabis combination businesses and 
60.27 	perform other actions approved by the office.

60.28 	Sec. 64. Minnesota Statutes 2023 Supplement, section 342.35, is amended by adding a 
60.29 	subdivision to read:
60.30 		Subd. 4.License to transport not required; other transportation requirements. (a) 
60.31 	A person, cooperative, or business holding a cannabis microbusiness, cannabis 
60.32 	mezzobusiness, or medical combination cannabis business license is not required to have 
61.1 	a license under this chapter to transport immature cannabis plants and seedlings, cannabis 
61.2 	flower, cannabis products, artificially derived cannabinoids, hemp plant parts, hemp 
61.3 	concentrate, lower-potency hemp edibles, and hemp-derived consumer products between 
61.4 	facilities operated by the person, cooperative, or business.
61.5 	(b) A person, cooperative, or business holding a cannabis microbusiness, mezzobusiness, 
61.6 	or medical combination cannabis business license transporting immature cannabis plants 
61.7 	and seedlings, cannabis flower, cannabis products, artificially derived cannabinoids, hemp 
61.8 	plant parts, hemp concentrate, lower-potency hemp edibles, and hemp-derived consumer 
61.9 	products under paragraph (a) must comply with subdivision 2.

61.10 	Sec. 65. Minnesota Statutes 2023 Supplement, section 342.37, subdivision 1, is amended 
61.11 	to read:
61.12 		Subdivision 1.Authorized actions. A cannabis testing facility license entitles the license 
61.13 	holder to obtain and test immature cannabis plants and seedlings, cannabis flower, cannabis 
61.14 	products, hemp plant parts, hemp concentrate, artificially derived cannabinoids, 
61.15 	lower-potency hemp edibles, and hemp-derived consumer products from cannabis 
61.16 	microbusinesses, cannabis mezzobusinesses, cannabis cultivators, cannabis manufacturers, 
61.17 	cannabis wholesalers, lower-potency hemp edible manufacturers, medical cannabis 
61.18 	cultivators, medical cannabis processors, medical cannabis combination businesses, and 
61.19 	industrial hemp growers.

61.20 	Sec. 66. Minnesota Statutes 2023 Supplement, section 342.40, subdivision 7, is amended 
61.21 	to read:
61.22 		Subd. 7.Cannabis event sales. (a) Cannabis microbusinesses with a retail endorsement, 
61.23 	cannabis mezzobusinesses with a retail endorsement, cannabis retailers, and lower-potency 
61.24 	hemp edible retailers, including the cannabis event organizer, may be authorized to sell 
61.25 	cannabis plants, adult-use cannabis flower, adult-use cannabis products, lower-potency 
61.26 	hemp edibles, and hemp-derived consumer products to customers at a cannabis event.
61.27 	(b) All sales of cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
61.28 	lower-potency hemp edibles, and hemp-derived consumer products at a cannabis event must 
61.29 	take place in a retail area as designated in the premises diagram.
61.30 	(c) Authorized retailers may only conduct sales within their specifically assigned area.
61.31 	(d) Authorized retailers must verify the age of all customers pursuant to section 342.27, 
61.32 	subdivision 4, before completing a sale and may not sell cannabis plants, adult-use cannabis 
62.1 	flower, adult-use cannabis products, lower-potency hemp edibles, or hemp-derived consumer 
62.2 	products to an individual under 21 years of age.
62.3 	(e) Authorized retailers may display one sample of each type of cannabis plant, adult-use 
62.4 	cannabis flower, adult-use cannabis product, lower-potency hemp edible, and hemp-derived 
62.5 	consumer product available for sale. Samples of adult-use cannabis and adult-use cannabis 
62.6 	products must be stored in a sample jar or display case and be accompanied by a label or 
62.7 	notice containing the information required to be affixed to the packaging or container 
62.8 	containing adult-use cannabis flower and adult-use cannabis products sold to customers. A 
62.9 	sample may not consist of more than eight grams of adult-use cannabis flower or adult-use 
62.10 	cannabis concentrate, or an edible cannabis product infused with more than 100 milligrams 
62.11 	of tetrahydrocannabinol. A cannabis retailer may allow customers to smell the adult-use 
62.12 	cannabis flower or adult-use cannabis product before purchase.
62.13 	(f) The notice requirements under section 342.27, subdivision 6, apply to authorized 
62.14 	retailers offering cannabis plants, adult-use cannabis flower, adult-use cannabinoid products, 
62.15 	and hemp-derived consumer products for sale at a cannabis event.
62.16 	(g) Authorized retailers may not:
62.17 	(1) sell adult-use cannabis flower, adult-use cannabis products, lower-potency hemp 
62.18 	edibles, or hemp-derived consumer products to a person who is visibly intoxicated;
62.19 	(2) knowingly sell more cannabis plants, adult-use cannabis flower, adult-use cannabis 
62.20 	products, lower-potency hemp edibles, or hemp-derived consumer products than a customer 
62.21 	is legally permitted to possess;
62.22 	(3) sell medical cannabis flower or medical cannabinoid products;
62.23 	(4) give away cannabis plants, cannabis flower, cannabis products, lower-potency hemp 
62.24 	edibles, or hemp-derived consumer products; or
62.25 	(5) allow for the dispensing of cannabis plants, cannabis flower, cannabis products, 
62.26 	lower-potency hemp edibles, or hemp-derived consumer products in vending machines.
62.27 	(h) Except for samples of a cannabis plant, adult-use cannabis flower, adult-use cannabis 
62.28 	product, lower-potency hemp edible, and hemp-derived consumer product, all cannabis 
62.29 	plants, adult-use cannabis flower, adult-use cannabis products, lower-potency hemp edibles, 
62.30 	and hemp-derived consumer products for sale at a cannabis event must be stored in a secure, 
62.31 	locked container that is not accessible to the public. Such items being stored at a cannabis 
62.32 	event shall not be left unattended.
63.1 	(i) All cannabis plants, adult-use cannabis flower, adult-use cannabis products, 
63.2 	lower-potency hemp edibles, and hemp-derived consumer products for sale at a cannabis 
63.3 	event must comply with this chapter and rules adopted pursuant to this chapter regarding 
63.4 	the testing, packaging, and labeling of those items.
63.5 	(j) All cannabis plants, adult-use cannabis flower, and adult-use cannabis products sold, 
63.6 	damaged, or destroyed at a cannabis event must be recorded in the statewide monitoring 
63.7 	system.

63.8 	Sec. 67. Minnesota Statutes 2023 Supplement, section 342.41, subdivision 1, is amended 
63.9 	to read:
63.10 		Subdivision 1.Authorized actions. A cannabis delivery service license entitles the 
63.11 	license holder to purchase cannabis flower, cannabis products, lower-potency hemp edibles, 
63.12 	and hemp-derived consumer products from licensed cannabis microbusinesses with a retail 
63.13 	endorsement, cannabis mezzobusinesses with a retail endorsement, cannabis retailers, 
63.14 	medical cannabis retailers, and medical cannabis combination businesses; transport and 
63.15 	deliver cannabis flower, cannabis products, lower-potency hemp edibles, and hemp-derived 
63.16 	consumable products to customers; and perform other actions approved by the office.

63.17 	Sec. 68. Minnesota Statutes 2023 Supplement, section 342.41, subdivision 3, is amended 
63.18 	to read:
63.19 		Subd. 3.Multiple licenses; limits. (a) A person, cooperative, or business holding a 
63.20 	cannabis delivery service license may also hold a cannabis retailer license, a cannabis 
63.21 	wholesaler license, a cannabis transporter license, and a cannabis event organizer license, 
63.22 	and a medical cannabis retailer license subject to the ownership limitations that apply to 
63.23 	those licenses.
63.24 	(b) Except as provided in paragraph (a), no person, cooperative, or business holding a 
63.25 	cannabis delivery service license may own or operate any other cannabis business or hemp 
63.26 	business.
63.27 	(c) The office by rule may limit the number of cannabis delivery service licenses that a 
63.28 	person or business may hold.
63.29 	(d) For purposes of this subdivision, a restriction on the number or type of license that 
63.30 	a business may hold applies to every cooperative member or every director, manager, and 
63.31 	general partner of a cannabis business.

64.1 	Sec. 69. Minnesota Statutes 2023 Supplement, section 342.44, subdivision 1, is amended 
64.2 	to read:
64.3 		Subdivision 1.Application; contents. (a) Except as otherwise provided in this 
64.4 	subdivision, the provisions of this chapter relating to license applications, license selection 
64.5 	criteria, general ownership disqualifications and requirements, and general operational 
64.6 	requirements do not apply to hemp businesses.
64.7 	(b) The office, by rule, shall establish forms and procedures for the processing of hemp 
64.8 	licenses issued under this chapter. At a minimum, any application to obtain or renew a hemp 
64.9 	license shall must include the following information, if applicable:
64.10 	(1) the name, address, and date of birth of the applicant;
64.11 	(2) the address and legal property description of the business;
64.12 	(3) proof of trade name registration;
64.13 	(4) certification that the applicant will comply with the requirements of this chapter 
64.14 	relating to the ownership and operation of a hemp business;
64.15 	(5) identification of one or more controlling persons or managerial employees as agents 
64.16 	who shall be responsible for dealing with the office on all matters; and
64.17 	(6) a statement that the applicant agrees to respond to the office's supplemental requests 
64.18 	for information.
64.19 	(c) An applicant for a lower-potency hemp edible manufacturer license must submit an 
64.20 	attestation signed by a bona fide labor organization stating that the applicant has entered 
64.21 	into a labor peace agreement.
64.22 	(d) An application on behalf of a corporation or association shall must be signed by at 
64.23 	least two officers or managing agents of that entity.

64.24 	Sec. 70. Minnesota Statutes 2023 Supplement, section 342.51, is amended to read:
64.25 	342.51 MEDICAL CANNABIS RETAILERS RETAIL ENDORSEMENT.
64.26 		Subdivision 1.Authorized actions. (a) The office must issue a medical cannabis retail 
64.27 	endorsement to a cannabis business, if the business:
64.28 	(1) submits a medical cannabis retail endorsement application to the office;
64.29 	(2) has at least one employee who earned a medical cannabis consultant certificate issued 
64.30 	by the office and has completed the required training or has at least one employee who is 
64.31 	a licensed pharmacist under chapter 151; and
65.1 	(3) otherwise meets all applicable requirements established by the office.
65.2 	(b) A medical cannabis retailer license retail endorsement entitles the license holder to 
65.3 	purchase medical cannabis flower and medical cannabinoid products from medical cannabis 
65.4 	cultivators and medical cannabis processors and sell or distribute medical cannabis flower 
65.5 	and medical cannabinoid products to any person authorized to receive medical cannabis 
65.6 	flower or medical cannabinoid products. sell or distribute the following products to any 
65.7 	person enrolled in the medical cannabis patient registry under section 342.52:
65.8 	(1) cannabis plants, cannabis flower, cannabis products, artificially derived cannabinoids, 
65.9 	lower-potency hemp edibles, and hemp-derived consumer products that are a product 
65.10 	category approved by the office and that comply with this chapter and rules adopted pursuant 
65.11 	to this chapter regarding the testing, packaging, and labeling of cannabis plants, cannabis 
65.12 	flower, cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, 
65.13 	and hemp-derived consumer products; and
65.14 	(2) associated paraphernalia.
65.15 	(b) (c) A medical cannabis retailer license retail endorsement holder must verify that all 
65.16 	medical cannabis flower and medical cannabinoid products under paragraph (b), clause (1), 
65.17 	have passed safety, potency, and consistency testing at a cannabis testing facility approved 
65.18 	by the office for the testing of medical cannabis flower and medical cannabinoid products 
65.19 	under paragraph (b), clause (1), before the medical cannabis retailer business may distribute 
65.20 	the medical cannabis flower or medical cannabinoid product products to any person 
65.21 	authorized to receive medical cannabis flower or medical cannabinoid products enrolled in 
65.22 	the medical cannabis patient registry program under section 342.52.
65.23 		Subd. 2.Distribution requirements. (a) Prior to distribution of medical cannabis flower 
65.24 	or medical cannabinoid products, a medical cannabis retailer licensee products listed in 
65.25 	subdivision 1, paragraph (b), to a person enrolled in the patient registry program, an employee 
65.26 	with a valid medical cannabis consultant certificate issued by the office or a licensed 
65.27 	pharmacist under chapter 151 must:
65.28 	(1) review and confirm the patient's enrollment in the registry verification program;
65.29 	(2) verify that the person requesting the distribution of medical cannabis flower or 
65.30 	medical cannabinoid products listed under subdivision 1, paragraph (b), is the patient, the 
65.31 	patient's registered designated caregiver, or the patient's parent, legal guardian, or spouse 
65.32 	using the procedures specified in section 152.11, subdivision 2d established by the office;
66.1 	(3) ensure that a pharmacist employee of the medical cannabis retailer has consulted 
66.2 	with the patient if required according to subdivision 3; and
66.3 	(3) provide consultation to the patient to determine the proper type of product, dosage, 
66.4 	and paraphernalia for the patient if required under subdivision 3;
66.5 	(4) apply a patient-specific label on the medical cannabis flower or medical cannabinoid
66.6 	product that includes recommended dosage requirements and other information as required 
66.7 	by rules adopted by the office.; and
66.8 	(5) provide the patient with any other information required by the office.
66.9 	(b) A medical cannabis retailer retail endorsement holder may not deliver medical 
66.10 	cannabis flower or medical cannabinoid products listed in subdivision 1, paragraph (b), to 
66.11 	a person enrolled in the patient registry program unless the medical cannabis retailer retail 
66.12 	endorsement holder also holds a cannabis delivery service license. The delivery of medical 
66.13 	cannabis flower and medical cannabinoid products are a product listed in subdivision 1, 
66.14 	paragraph (b), is subject to the provisions of section 342.42.
66.15 		Subd. 3.Final approval for distribution of medical cannabis flower and medical 
66.16 	cannabinoid products. (a) A cannabis worker who is employed by a medical cannabis 
66.17 	retailer and retail endorsement holder who is licensed as a pharmacist pursuant to chapter 
66.18 	151shall be or certified as a medical cannabis consultant by the office is the only person 
66.19 	who may give final approval for the distribution of medical cannabis flower and medical 
66.20 	cannabinoid products listed in subdivision 1, paragraph (b). Prior to the distribution of 
66.21 	medical cannabis flower or medical cannabinoid products listed in subdivision 1, paragraph 
66.22 	(b), a pharmacist or certified medical cannabis consultant employed by the a business with 
66.23 	a medical cannabis retailer retail endorsement must consult with the patient to determine 
66.24 	the proper type of medical cannabis flower, medical cannabinoid product, or medical cannabis
66.25 	proper type of paraphernalia, and proper dosage for the patient after reviewing the range of 
66.26 	chemical compositions of medical cannabis flower or medical cannabinoid the product.
66.27 	intended for distribution:
66.28 	(1) if the patient is purchasing the product for the first time;
66.29 	(2) if the patient purchases a product that the patient must administer using a different 
66.30 	method than the patient's previous method of administration;
66.31 	(3) if the patient purchases a product with a cannabinoid concentration of at least double 
66.32 	the patient's prior dosage; or
66.33 	(4) upon the request of the patient.
67.1 	(b) For purposes of this subdivision, a consultation may be conducted remotely by secure 
67.2 	videoconference, telephone, or other remote means, as long as:
67.3 	(1) the pharmacist or consultant engaging in the consultation is able to confirm the 
67.4 	identity of the patient; and
67.5 	(2) the consultation adheres to patient privacy requirements that apply to health care 
67.6 	services delivered through telemedicine.
67.7 	(b) Notwithstanding paragraph (a), a pharmacist consultation is not required prior to the 
67.8 	distribution of medical cannabis flower or medical cannabinoid products when a medical 
67.9 	cannabis retailer is distributing medical cannabis flower or medical cannabinoid products 
67.10 	to a patient according to a patient-specific dosage plan established with that medical cannabis 
67.11 	retailer and is not modifying the dosage or product being distributed under that plan. Medical 
67.12 	cannabis flower or medical cannabinoid products distributed under this paragraph must be 
67.13 	distributed by a pharmacy technician employed by the medical cannabis retailer.
67.14 		Subd. 4.90-day supply. A medical cannabis retailer shall not distribute more than a 
67.15 	90-day supply of medical cannabis flower or medical cannabinoid products to a patient, 
67.16 	registered designated caregiver, or parent, legal guardian, or spouse of a patient according 
67.17 	to the dosages established for the individual patient.
67.18 		Subd. 5.Distribution to recipient in a motor vehicle. A medical cannabis retailer retail 
67.19 	endorsement holder may distribute medical cannabis flower and medical cannabinoid 
67.20 	products a product listed in subdivision 1, paragraph (b), to a patient, registered designated 
67.21 	caregiver, or parent, legal guardian, or spouse of a patient person enrolled in the patient 
67.22 	registry program who is at a dispensary location but remains in a motor vehicle, provided 
67.23 	that:
67.24 	(1) staff receive payment and distribute medical cannabis flower and medical cannabinoid 
67.25 	products a product listed in subdivision 1, paragraph (b), in a designated zone that is as 
67.26 	close as feasible to the front door of the facility;
67.27 	(2) the medical cannabis retailer retail endorsement holder ensures that the receipt of 
67.28 	payment and distribution of medical cannabis flower and medical cannabinoid products a 
67.29 	product listed in subdivision 1, paragraph (b), are visually recorded by a closed-circuit 
67.30 	television surveillance camera and provides any other necessary security safeguards;
67.31 	(3) the medical cannabis retailer retail endorsement holder does not store medical cannabis 
67.32 	flower or medical cannabinoid products a product listed in subdivision 1, paragraph (b),
67.33 	outside a restricted access area and staff transport medical cannabis flower and medical 
68.1 	cannabinoid products the product from a restricted access area to the designated zone for 
68.2 	distribution only after confirming that the patient, designated caregiver, or parent, guardian, 
68.3 	or spouse person enrolled in the patient registry program has arrived in the designated zone;
68.4 	(4) the payment for and distribution of medical cannabis flower and medical cannabinoid 
68.5 	products a product listed in subdivision 1, paragraph (b), take place only after a pharmacist 
68.6 	consultation takes place, if required under subdivision 3 meeting the requirements in 
68.7 	subdivision 2;
68.8 	(5) immediately following the distribution of medical cannabis flower or medical 
68.9 	cannabinoid products a product listed in subdivision 1, paragraph (b), staff enter record the 
68.10 	transaction in the statewide monitoring system; and
68.11 	(6) immediately following the distribution of medical cannabis flower and medical 
68.12 	cannabinoid products a product listed in subdivision 1, paragraph (b), staff take the payment 
68.13 	received into the facility.

68.14 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
68.15 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
68.16 	is later.

68.17 	Sec. 71. Minnesota Statutes 2023 Supplement, section 342.515, is amended to read:
68.18 	342.515 MEDICAL CANNABIS COMBINATION BUSINESSES.
68.19 		Subdivision 1.Authorized actions. (a) A person, cooperative, or business holding a 
68.20 	medical cannabis combination business license is prohibited from owning or operating any 
68.21 	other cannabis business or hemp business.
68.22 	(b) A person or business may hold only one medical cannabis combination business 
68.23 	license.
68.24 	(c) A medical cannabis combination business license entitles the license holder to perform 
68.25 	any or all of the following within the limits established by this section:
68.26 	(1) grow cannabis plants from seed or immature plant to mature plant and harvest 
68.27 	adult-use cannabis flower and medical cannabis flower from a mature plant;
68.28 	(2) make cannabis concentrate;
68.29 	(3) make hemp concentrate, including hemp concentrate with a delta-9 
68.30 	tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight;
68.31 	(4) manufacture artificially derived cannabinoids;
69.1 	(5) manufacture medical cannabinoid products;
69.2 	(6) manufacture adult-use cannabis products, lower-potency hemp edibles, and 
69.3 	hemp-derived consumer products for public consumption;
69.4 	(7) purchase immature cannabis plants and seedlings and cannabis flower from a cannabis 
69.5 	microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a cannabis wholesaler, 
69.6 	a medical cannabis cultivator, or another medical cannabis combination business;
69.7 	(8) purchase hemp plant parts and propagules from an industrial hemp grower licensed 
69.8 	under chapter 18K;
69.9 	(9) purchase cannabis concentrate, hemp concentrate, and artificially derived cannabinoids 
69.10 	from a cannabis microbusiness, a cannabis mezzobusiness, a cannabis manufacturer, a 
69.11 	cannabis wholesaler, a medical cannabis processor, or another medical cannabis combination 
69.12 	business;
69.13 	(10) purchase hemp concentrate from an industrial hemp processor licensed under chapter 
69.14 	18K;
69.15 	(11) package and label medical cannabis flower and medical cannabinoid products for 
69.16 	sale to medical cannabis processors, medical cannabis retailers, other medical cannabis 
69.17 	combination businesses, and patients enrolled in the registry program, registered designated 
69.18 	caregivers, and parents, legal guardians, and spouses of an enrolled patient;
69.19 	(12) package and label adult-use cannabis flower, adult-use cannabis products, 
69.20 	lower-potency hemp edibles, and hemp-derived consumer products for sale to customers;
69.21 	(13) sell medical cannabis flower and medical cannabinoid products to patients enrolled 
69.22 	in the registry program, registered designated caregivers, and parents, legal guardians, and 
69.23 	spouses of an enrolled patient;
69.24 	(14) sell immature cannabis plants and seedlings, adult-use cannabis flower, adult-use 
69.25 	cannabis products, lower-potency hemp edibles, hemp-derived consumer products, and 
69.26 	other products authorized by law to other cannabis businesses and to customers; and
69.27 	(15) perform other actions approved by the office.
69.28 		Subd. 2.Cultivation; size limitations. (a) A medical cannabis combination business 
69.29 	may cultivate cannabis to be sold as medical cannabis flower or used in medical cannabinoid 
69.30 	products in an area of up to 60,000 square feet of plant canopy subject to the limits on 
69.31 	adult-use cannabis cultivation in subdivision 1, paragraph (c).
70.1 	(b) A medical cannabis combination business may cultivate cannabis to be sold as 
70.2 	adult-use cannabis flower or used in adult-use cannabis products in an area authorized by 
70.3 	the office as described in paragraph (c).
70.4 	(c) The office shall authorize a medical cannabis combination business to cultivate 
70.5 	cannabis for sale in the adult-use market in an area of plant canopy that is equal to one-half 
70.6 	of the area the business used to cultivate cannabis sold in the medical market in the preceding 
70.7 	year. The office shall establish an annual verification and authorization procedure. The 
70.8 	office may increase the area of plant canopy in which a medical cannabis combination 
70.9 	business is authorized to cultivate cannabis for sale in the adult-use market between 
70.10 	authorization periods if the business demonstrates a significant increase in the sale of medical 
70.11 	cannabis and medical cannabis products.
70.12 		Subd. 3.Manufacturing; size limitations. The office may establish limits on cannabis 
70.13 	manufacturing that are consistent with the area of plant canopy a business is authorized to 
70.14 	cultivate.
70.15 		Subd. 4.Retail locations. A medical cannabis combination business may operate up to 
70.16 	one retail location in each congressional district. A medical cannabis combination business 
70.17 	must offer medical cannabis flower, medical cannabinoid products, or both at every retail 
70.18 	location. Each retail location of a medical cannabis combination business must continuously 
70.19 	make cannabis flower or cannabinoid products available to patients enrolled in the registry 
70.20 	program, registered designated caregivers, and parents, legal guardians, and spouses of an 
70.21 	enrolled patient.
70.22 		Subd. 5.Failure to participate; suspension or revocation of license. The office may 
70.23 	suspend or revoke a medical cannabis combination business license if the office determines 
70.24 	that the business is no longer actively participating in the medical cannabis market. The 
70.25 	office may, by rule, establish minimum requirements related to cannabis cultivation, 
70.26 	manufacturing of medical cannabinoid products, retail sales of medical cannabis flower and 
70.27 	medical cannabinoid products, and other relevant criteria to demonstrate active participation 
70.28 	in the medical cannabis market.
70.29 		Subd. 6.Operations. A medical cannabis combination business must comply with the 
70.30 	relevant requirements of sections 342.25, 342.26, 342.27, and 342.51, subdivisions 2 to 5.

70.31 	EFFECTIVE DATE. This section is effective the day following final enactment.

71.1 	Sec. 72. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 1, is amended 
71.2 	to read:
71.3 		Subdivision 1.Administration. The Division of Medical Cannabis office must administer 
71.4 	the medical cannabis patient registry program.

71.5 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
71.6 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
71.7 	is later.

71.8 	Sec. 73. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 2, is amended 
71.9 	to read:
71.10 		Subd. 2.Application procedure for patients. (a) A patient seeking to enroll in the 
71.11 	registry program must submit to the Division of Medical Cannabis office an application 
71.12 	established by the Division of Medical Cannabis office and a copy of the certification 
71.13 	specified in paragraph (b) or, if the patient is a veteran who receives care from the United 
71.14 	States Department of Veterans Affairs, the information required pursuant to subdivision 3. 
71.15 	The patient must provide at least the following information in the application:
71.16 	(1) the patient's name, mailing address, and date of birth;
71.17 	(2) the name, mailing address, and telephone number of the patient's health care 
71.18 	practitioner;
71.19 	(3) the name, mailing address, and date of birth of the patient's registered designated 
71.20 	caregiver, if any, or the patient's parent, legal guardian, or spouse if the parent, legal guardian, 
71.21 	or spouse will be acting as the patient's caregiver;
71.22 	(4) a disclosure signed by the patient that includes:
71.23 	(i) a statement that, notwithstanding any law to the contrary, the office of Cannabis 
71.24 	Management, the Division of Medical Cannabis, or an employee of the office of Cannabis 
71.25 	Management or Division of Medical Cannabis may not be held civilly or criminally liable 
71.26 	for any injury, loss of property, personal injury, or death caused by an act or omission while 
71.27 	acting within the employee's scope of office or employment under this section; and
71.28 	(ii) the patient's acknowledgment that enrollment in the registry program is conditional 
71.29 	on the patient's agreement to meet all other requirements of this section; and
71.30 	(5) all other information required by the Division of Medical Cannabis office.
71.31 	(b) As part of the application under this subdivision, a patient must submit a copy of a 
71.32 	certification from the patient's health care practitioner that is dated within 90 days prior to 
72.1 	the submission of the application and that certifies that the patient has been diagnosed with 
72.2 	a qualifying medical condition.
72.3 	(c) A patient's health care practitioner may submit a statement to the Division of Medical 
72.4 	Cannabis office declaring that the patient is no longer diagnosed with a qualifying medical 
72.5 	condition. Within 30 days after receipt of a statement from a patient's health care practitioner, 
72.6 	the Division of Medical Cannabis office must provide written notice to a patient stating that 
72.7 	the patient's enrollment in the registry program will be revoked in 30 days unless the patient 
72.8 	submits a certification from a health care practitioner that the patient is currently diagnosed 
72.9 	with a qualifying medical condition or, if the patient is a veteran, the patient submits 
72.10 	confirmation that the patient is currently diagnosed with a qualifying medical condition in 
72.11 	a form and manner consistent with the information required for an application made pursuant 
72.12 	to subdivision 3. If the Division of Medical Cannabis office revokes a patient's enrollment 
72.13 	in the registry program pursuant to this paragraph, the division must provide notice to the 
72.14 	patient and to the patient's health care practitioner.

72.15 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
72.16 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
72.17 	is later.

72.18 	Sec. 74. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 3, is amended 
72.19 	to read:
72.20 		Subd. 3.Application procedure for veterans. (a) The Division of Medical Cannabis
72.21 	office shall establish an alternative certification procedure for veterans who receive care 
72.22 	from the United States Department of Veterans Affairs to confirm that the veteran has been 
72.23 	diagnosed with a qualifying medical condition.
72.24 	(b) A patient who is also a veteran and is seeking to enroll in the registry program must 
72.25 	submit to the Division of Medical Cannabis office an application established by the Division 
72.26 	of Medical Cannabis office that includes the information identified in subdivision 2, 
72.27 	paragraph (a), and the additional information required by the Division of Medical Cannabis
72.28 	office to certify that the patient has been diagnosed with a qualifying medical condition.

72.29 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
72.30 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
72.31 	is later.

73.1 	Sec. 75. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 4, is amended 
73.2 	to read:
73.3 		Subd. 4.Enrollment; denial of enrollment; revocation. (a) Within 30 days after the 
73.4 	receipt of an application and certification or other documentation of a diagnosis with a 
73.5 	qualifying medical condition, the Division of Medical Cannabis office must approve or 
73.6 	deny a patient's enrollment in the registry program. If the Division of Medical Cannabis
73.7 	office approves a patient's enrollment in the registry program, the office must provide notice 
73.8 	to the patient and to the patient's health care practitioner.
73.9 	(b) The office may deny a patient's enrollment in the registry program must only be 
73.10 	denied only if the patient:
73.11 	(1) does not submit a certification from a health care practitioner or, if the patient is a 
73.12 	veteran, the documentation required under subdivision 3 that the patient has been diagnosed 
73.13 	with a qualifying medical condition;
73.14 	(2) has not signed the disclosure required in subdivision 2;
73.15 	(3) does not provide the information required by the Division of Medical Cannabis
73.16 	office;
73.17 	(4) provided false information on the application; or
73.18 	(5) at the time of application, is also enrolled in a federally approved clinical trial for 
73.19 	the treatment of a qualifying medical condition with medical cannabis.
73.20 	(c) If the Division of Medical Cannabis office denies a patient's enrollment in the registry 
73.21 	program, the Division of Medical Cannabis office must provide written notice to a patient 
73.22 	of all reasons for denying enrollment. Denial of enrollment in the registry program is 
73.23 	considered a final decision of the office and is subject to judicial review under chapter 14.
73.24 	(d) The office may revoke a patient's enrollment in the registry program may be revoked
73.25 	only:
73.26 	(1) pursuant to subdivision 2, paragraph (c);
73.27 	(2) upon the death of the patient;
73.28 	(3) if the patient's certifying health care practitioner has filed a declaration under 
73.29 	subdivision 2, paragraph (c), that the patient's qualifying diagnosis no longer exists and the 
73.30 	patient does not submit another certification within 30 days;
73.31 	(4) if the patient does not comply with subdivision 6; or
74.1 	(5) if the patient intentionally sells or diverts medical cannabis flower or medical
74.2 	cannabinoid products in violation of this chapter.
74.3 	(e) If the office has revoked a patient's enrollment in the registry program has been 
74.4 	revoked due to a violation of subdivision 6, the patient may apply for enrollment 12 months 
74.5 	after the date on which the patient's enrollment was revoked. The office must process such 
74.6 	an application in accordance with this subdivision.

74.7 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
74.8 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
74.9 	is later.

74.10 	Sec. 76. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 5, is amended 
74.11 	to read:
74.12 		Subd. 5.Registry verification. When a patient is enrolled in the registry program, the 
74.13 	Division of Medical Cannabis office must assign the patient a patient registry number and 
74.14 	must issue the patient and the patient's registered designated caregiver, parent, legal guardian, 
74.15 	or spouse, if applicable, a registry verification. The Division of Medical Cannabis office
74.16 	must also make the registry verification available to medical cannabis retailers businesses 
74.17 	with a medical cannabis retail endorsement. The registry verification must include:
74.18 	(1) the patient's name and date of birth;
74.19 	(2) the patient registry number assigned to the patient; and
74.20 	(3) the name and date of birth of the patient's registered designated caregiver, if any, or 
74.21 	the name of the patient's parent, legal guardian, or spouse if the parent, legal guardian, or 
74.22 	spouse will act as a caregiver.

74.23 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
74.24 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
74.25 	is later.

74.26 	Sec. 77. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 9, is amended 
74.27 	to read:
74.28 		Subd. 9.Registered designated caregiver. (a) The Division of Medical Cannabis office
74.29 	must register a designated caregiver for a patient if the patient requires assistance in 
74.30 	administering medical cannabis flower or medical cannabinoid products or in obtaining 
74.31 	medical cannabis flower, medical cannabinoid products, or medical cannabis paraphernalia 
75.1 	from a medical cannabis retailer business with a medical cannabis retail endorsement under 
75.2 	section 342.51.
75.3 	(b) In order to serve as a designated caregiver, a person must:
75.4 	(1) be at least 18 years of age;
75.5 	(2) agree to only possess the patient's medical cannabis flower and medical cannabinoid
75.6 	products purchased under section 342.51 for purposes of assisting the patient; and
75.7 	(3) agree that if the application is approved, the person will not serve as a registered 
75.8 	designated caregiver for more than six registered patients at one time. Patients who reside 
75.9 	in the same residence count as one patient.
75.10 	(c) The office shall conduct a criminal background check on the designated caregiver 
75.11 	prior to registration to ensure that the person does not have a conviction for a disqualifying 
75.12 	felony offense. Any cost of the background check shall be paid by the person seeking 
75.13 	registration as a designated caregiver. A designated caregiver must have the criminal 
75.14 	background check renewed every two years.
75.15 	(d) (c) Nothing in this section shall be construed to prevent a registered designated 
75.16 	caregiver from being enrolled in the registry program as a patient and possessing and 
75.17 	administering medical cannabis flower or medical cannabinoid products as a patient.

75.18 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
75.19 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
75.20 	is later.

75.21 	Sec. 78. Minnesota Statutes 2023 Supplement, section 342.52, subdivision 11, is amended 
75.22 	to read:
75.23 		Subd. 11.Notice of change of name or address. Patients and registered designated 
75.24 	caregivers must notify the Division of Medical Cannabis office of any address or name 
75.25 	change within 30 days of the change having occurred. A patient or registered designated 
75.26 	caregiver is subject to a $100 fine for failure to notify the office of the change.

75.27 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
75.28 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
75.29 	is later.

76.1 	Sec. 79. Minnesota Statutes 2023 Supplement, section 342.53, is amended to read:
76.2 	342.53 DUTIES OF OFFICE OF CANNABIS MANAGEMENT; REGISTRY 
76.3 	PROGRAM ADDING OR MODIFYING QUALIFYING MEDICAL CONDITIONS.
76.4 	The office may add an allowable form of medical cannabinoid product, and may add or 
76.5 	modify a qualifying medical condition upon its the office's own initiative, upon a petition 
76.6 	from a member of the public or from the Cannabis Advisory Council, or as directed by law. 
76.7 	The office must evaluate all petitions and must make the addition or modification if the 
76.8 	office determines that the addition or modification is warranted by the best available evidence 
76.9 	and research. If the office wishes to add an allowable form or add or modify a qualifying 
76.10 	medical condition, the office must notify the chairs and ranking minority members of the 
76.11 	legislative committees and divisions with jurisdiction over health finance and policy by 
76.12 	January 15 of the year in which the change becomes effective. In this notification, the office 
76.13 	must specify the proposed addition or modification, the reasons for the addition or 
76.14 	modification, any written comments received by the office from the public about the addition 
76.15 	or modification, and any guidance received from the Cannabis Advisory Council. An addition 
76.16 	or modification by the office under this subdivision becomes effective on August 1 of that 
76.17 	year unless the legislature by law provides otherwise.

76.18 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
76.19 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
76.20 	is later.

76.21 	Sec. 80. Minnesota Statutes 2023 Supplement, section 342.54, is amended to read:
76.22 	342.54 DUTIES OF DIVISION OF MEDICAL CANNABIS OFFICE OF 
76.23 	CANNABIS MANAGEMENT; MEDICAL CANNABIS PATIENT REGISTRY 
76.24 	PROGRAM.
76.25 		Subdivision 1.Duties related to health care practitioners. The Division of Medical 
76.26 	Cannabis office must:
76.27 	(1) provide notice of the registry program to health care practitioners in the state;
76.28 	(2) allow health care practitioners to participate in the registry program if they request 
76.29 	to participate and meet the program's requirements;
76.30 	(3) provide explanatory information and assistance to health care practitioners to 
76.31 	understand the nature of the therapeutic use of medical cannabis flower and medical
76.32 	cannabinoid products within program requirements;
77.1 	(4) make available to participating health care practitioners a certification form in which 
77.2 	a health care practitioner certifies that a patient has a qualifying medical condition; and
77.3 	(5) supervise the participation of health care practitioners in the registry reporting system 
77.4 	in which health care practitioners report patient treatment and health records information 
77.5 	to the office in a manner that ensures stringent security and record keeping requirements 
77.6 	and that prevents the unauthorized release of private data on individuals as defined in section 
77.7 	13.02.
77.8 		Subd. 2.Duties related to the medical registry program. The Division of Medical 
77.9 	Cannabis office must:
77.10 	(1) administer the registry program according to section 342.52;
77.11 	(2) provide information to patients enrolled in the registry program on the existence of 
77.12 	federally approved clinical trials for the treatment of the patient's qualifying medical condition 
77.13 	with medical cannabis flower or medical cannabinoid products as an alternative to enrollment 
77.14 	in the registry program;
77.15 	(3) maintain safety criteria with which patients must comply as a condition of participation 
77.16 	in the registry program to prevent patients from undertaking any task under the influence 
77.17 	of medical cannabis flower or medical cannabinoid products that would constitute negligence 
77.18 	or professional malpractice;
77.19 	(4) review and publicly report on existing medical and scientific literature regarding the 
77.20 	range of recommended dosages for each qualifying medical condition, the range of chemical 
77.21 	compositions of medical cannabis flower and medical cannabinoid products that will likely 
77.22 	be medically beneficial for each qualifying medical condition, and any risks of noncannabis 
77.23 	drug interactions. This information must be updated by December 1 of each year. The office 
77.24 	may consult with an independent laboratory under contract with the office or other experts 
77.25 	in reporting and updating this information; and
77.26 	(5) annually consult with cannabis businesses about medical cannabis that the businesses 
77.27 	cultivate, manufacture, and offer for sale and post on the Division of Medical Cannabis
77.28 	office website a list of the medical cannabis flower and medical cannabinoid products offered 
77.29 	for sale by each medical cannabis retailer.
77.30 		Subd. 3.Research. (a) The Division of Medical Cannabis office must conduct or contract 
77.31 	with a third party to conduct research and studies using data from health records submitted 
77.32 	to the registry program under section 342.55, subdivision 2, and data submitted to the registry 
77.33 	program under section 342.52, subdivisions 2 and 3. If the division office contracts with a 
78.1 	third party for research and studies, the third party must provide the division office with 
78.2 	access to all research and study results. The division office must submit reports on 
78.3 	intermediate or final research results to the legislature and major scientific journals. All 
78.4 	data used by the division office or a third party under this subdivision must be used or 
78.5 	reported in an aggregated nonidentifiable form as part of a scientific peer-reviewed 
78.6 	publication of research or in the creation of summary data, as defined in section 13.02, 
78.7 	subdivision 19.
78.8 	(b) The Division of Medical Cannabis office may submit medical research based on the 
78.9 	data collected under sections 342.55, subdivision 2, and data collected through the statewide 
78.10 	monitoring system to any federal agency with regulatory or enforcement authority over 
78.11 	medical cannabis flower and medical cannabinoid products to demonstrate the effectiveness 
78.12 	of medical cannabis flower or medical cannabinoid products for treating or alleviating the 
78.13 	symptoms of a qualifying medical condition.

78.14 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
78.15 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
78.16 	is later.

78.17 	Sec. 81. Minnesota Statutes 2023 Supplement, section 342.55, subdivision 1, is amended 
78.18 	to read:
78.19 		Subdivision 1.Health care practitioner duties before patient enrollment. Before a 
78.20 	patient's enrollment in the registry program, a health care practitioner must:
78.21 	(1) determine, in the health care practitioner's medical judgment, whether a patient has 
78.22 	a qualifying medical condition and, if so determined, provide the patient with a certification 
78.23 	of that diagnosis;
78.24 	(2) advise patients, registered designated caregivers, and parents, legal guardians, and 
78.25 	spouses acting as caregivers of any nonprofit patient support groups or organizations;
78.26 	(3) provide to patients explanatory information from the Division of Medical Cannabis
78.27 	office, including information about the experimental nature of the therapeutic use of medical
78.28 	cannabis flower and medical cannabinoid products; the possible risks, benefits, and side 
78.29 	effects of the proposed treatment; and the application and other materials from the office;
78.30 	(4) provide to patients a Tennessen warning as required under section 13.04, subdivision 
78.31 	2; and
78.32 	(5) agree to continue treatment of the patient's qualifying medical condition and to report 
78.33 	findings to the Division of Medical Cannabis office.

79.1 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
79.2 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
79.3 	is later.

79.4 	Sec. 82. Minnesota Statutes 2023 Supplement, section 342.55, subdivision 2, is amended 
79.5 	to read:
79.6 		Subd. 2.Duties upon patient's enrollment in registry program. Upon receiving 
79.7 	notification from the Division of Medical Cannabis office of the patient's enrollment in the 
79.8 	registry program, a health care practitioner must:
79.9 	(1) participate in the patient registry reporting system under the guidance and supervision 
79.10 	of the Division of Medical Cannabis office;
79.11 	(2) report to the Division of Medical Cannabis office patient health records throughout 
79.12 	the patient's ongoing treatment in a manner determined by the office and in accordance with 
79.13 	subdivision 4;
79.14 	(3) determine on a yearly basis if the patient continues to have a qualifying medical 
79.15 	condition and, if so, issue the patient a new certification of that diagnosis. The patient 
79.16 	assessment conducted under this clause may be conducted via telehealth, as defined in 
79.17 	section 62A.673, subdivision 2; and
79.18 	(4) otherwise comply with requirements established by the office of Cannabis 
79.19 	Management and the Division of Medical Cannabis.

79.20 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
79.21 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
79.22 	is later.

79.23 	Sec. 83. Minnesota Statutes 2023 Supplement, section 342.56, subdivision 1, is amended 
79.24 	to read:
79.25 		Subdivision 1.Limitations on consumption; locations of consumption. (a) Nothing 
79.26 	in sections 342.47 342.51 to 342.60 permits any person to engage in, and does not prevent 
79.27 	the imposition of any civil, criminal, or other penalties for:
79.28 	(1) undertaking a task under the influence of medical cannabis flower or medical
79.29 	cannabinoid products that would constitute negligence or professional malpractice;
79.30 	(2) possessing or consuming medical cannabis flower or medical cannabinoid products:
79.31 	(i) on a school bus or van;
80.1 	(ii) in a correctional facility;
80.2 	(iii) in a state-operated treatment program, including the Minnesota sex offender program; 
80.3 	or
80.4 	(iv) on the grounds of a child care facility or family or group family day care program;
80.5 	(3) vaporizing or smoking medical cannabis:
80.6 	(i) on any form of public transportation;
80.7 	(ii) where the vapor would be inhaled by a nonpatient minor or where the smoke would 
80.8 	be inhaled by a minor; or
80.9 	(iii) in any public place, including any indoor or outdoor area used by or open to the 
80.10 	general public or a place of employment, as defined in section 144.413, subdivision 1b; and
80.11 	(4) operating, navigating, or being in actual physical control of a motor vehicle, aircraft, 
80.12 	train, or motorboat or working on transportation property, equipment, or facilities while 
80.13 	under the influence of medical cannabis flower or a medical cannabinoid product.
80.14 	(b) Except for the use of medical cannabis flower or medical cannabinoid products by 
80.15 	a patient enrolled in the patient registry program under section 342.52, the vaporizing or 
80.16 	smoking of cannabis flower, cannabis products, artificially derived cannabinoids, or 
80.17 	hemp-derived consumer products is prohibited in a multifamily housing building, including 
80.18 	balconies and patios appurtenant thereto. A violation of this paragraph is punishable through 
80.19 	a civil administrative fine in an amount of $250.

80.20 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
80.21 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
80.22 	is later.

80.23 	Sec. 84. Minnesota Statutes 2023 Supplement, section 342.56, subdivision 2, is amended 
80.24 	to read:
80.25 		Subd. 2.Health care facilities. (a) Health care facilities licensed under chapter 144A; 
80.26 	hospice providers licensed under chapter 144A; boarding care homes or supervised living 
80.27 	facilities licensed under section 144.50; assisted living facilities under chapter 144G; facilities 
80.28 	owned, controlled, managed, or under common control with hospitals licensed under chapter 
80.29 	144; and other health care facilities licensed by the commissioner of health or the 
80.30 	commissioner of human services may adopt reasonable restrictions on the use of medical
80.31 	cannabis flower or medical cannabinoid products by a patient enrolled in the registry program 
80.32 	who resides at or is actively receiving treatment or care at the facility. The restrictions may 
81.1 	include a provision that the facility must not store or maintain a patient's supply of medical
81.2 	cannabis flower or medical cannabinoid products on behalf of the patient; that a patient 
81.3 	store the patient's supply of medical cannabis flower or medicinal cannabinoid products in 
81.4 	a locked container accessible only to the patient, the patient's designated caregiver, or the 
81.5 	patient's parent, legal guardian, or spouse; that the facility is not responsible for providing 
81.6 	medical cannabis for patients; and that medical cannabis flower or medical cannabinoid 
81.7 	products are used only in a location specified by the facility or provider. Nothing in this 
81.8 	subdivision requires facilities and providers listed in this subdivision to adopt such 
81.9 	restrictions.
81.10 	(b) No facility or provider listed in this subdivision may unreasonably limit a patient's 
81.11 	access to or use of medical cannabis flower or medical cannabinoid products to the extent 
81.12 	that such use is authorized under sections 342.47 342.51 to 342.59. No facility or provider 
81.13 	listed in this subdivision may prohibit a patient access to or use of medical cannabis flower 
81.14 	or medical cannabinoid products due solely to the fact that cannabis is a Schedule I drug 
81.15 	pursuant to the federal Uniform Controlled Substances Act. If a federal regulatory agency, 
81.16 	the United States Department of Justice, or the federal Centers for Medicare and Medicaid 
81.17 	Services takes one of the following actions, a facility or provider may suspend compliance 
81.18 	with this paragraph until the regulatory agency, the United States Department of Justice, or 
81.19 	the federal Centers for Medicare and Medicaid Services notifies the facility or provider that 
81.20 	it may resume permitting the use of medical cannabis flower or medical cannabinoid products 
81.21 	within the facility or in the provider's service setting:
81.22 	(1) a federal regulatory agency or the United States Department of Justice initiates 
81.23 	enforcement action against a facility or provider related to the facility's compliance with 
81.24 	the medical cannabis program; or
81.25 	(2) a federal regulatory agency, the United States Department of Justice, or the federal 
81.26 	Centers for Medicare and Medicaid Services issues a rule or otherwise provides notification 
81.27 	to the facility or provider that expressly prohibits the use of medical cannabis in health care 
81.28 	facilities or otherwise prohibits compliance with the medical cannabis program.
81.29 	(c) An employee or agent of a facility or provider listed in this subdivision or a person 
81.30 	licensed under chapter 144E is not violating this chapter or chapter 152 for the possession 
81.31 	of medical cannabis flower or medical cannabinoid products while carrying out employment 
81.32 	duties, including providing or supervising care to a patient enrolled in the registry program, 
81.33 	or distribution of medical cannabis flower or medical cannabinoid products to a patient 
81.34 	enrolled in the registry program who resides at or is actively receiving treatment or care at 
81.35 	the facility or from the provider with which the employee or agent is affiliated.

82.1 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
82.2 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
82.3 	is later.

82.4 	Sec. 85. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 1, is amended 
82.5 	to read:
82.6 		Subdivision 1.Presumption. There is a presumption that a patient or other person 
82.7 	enrolled in the registry program is engaged in the authorized use or possession of medical
82.8 	cannabis flower and medical cannabinoid products. This presumption may be rebutted by 
82.9 	evidence that the patient's use of medical cannabis flower or medical cannabinoid products
82.10 	use or possession of cannabis flower or cannabinoid products by a patient or other person 
82.11 	enrolled in the registry program was not for the purpose of assisting with, treating, or 
82.12 	alleviating the patient's or other person's qualifying medical condition or symptoms associated 
82.13 	with the patient's or other person's qualifying medical condition.

82.14 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
82.15 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
82.16 	is later.

82.17 	Sec. 86. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 2, is amended 
82.18 	to read:
82.19 		Subd. 2.Criminal and civil protections. (a) Subject to section 342.56, the use or 
82.20 	possession of cannabis flower, cannabinoid products, or cannabis paraphernalia by the 
82.21 	following are persons is not violations a violation of this chapter or chapter 152:
82.22 	(1) use or possession of medical cannabis flower, medical cannabinoid products, or 
82.23 	medical cannabis paraphernalia by a patient or person enrolled in the registry program or 
82.24 	by a visiting patient to whom medical cannabis flower or medical cannabinoid products are 
82.25 	distributed under section 342.51, subdivision 5;
82.26 	(2) possession of medical cannabis flower, medical cannabinoid products, or medical 
82.27 	cannabis paraphernalia by a registered designated caregiver or a parent, legal guardian, or 
82.28 	spouse of a patient or person enrolled in the registry program; or
82.29 	(3) possession of medical cannabis flower, medical cannabinoid products, or medical 
82.30 	cannabis paraphernalia by any person while that person is carrying out duties required under 
82.31 	sections 342.47 342.51 to 342.60.
83.1 	(b) The office of Cannabis Management, members of the Cannabis Advisory Council, 
83.2 	office of Cannabis Management employees, agents or contractors of the office of Cannabis 
83.3 	Management, and health care practitioners participating in the registry program are not 
83.4 	subject to any civil penalties or disciplinary action by the Board of Medical Practice, the 
83.5 	Board of Nursing, or any business, occupational, or professional licensing board or entity 
83.6 	solely for participating in the registry program either in a professional capacity or as a 
83.7 	patient. A pharmacist licensed under chapter 151 is not subject to any civil penalties or 
83.8 	disciplinary action by the Board of Pharmacy when acting in accordance with sections 
83.9 	342.47 to 342.60 either in a professional capacity or as a patient. Nothing in this section 
83.10 	prohibits a professional licensing board from taking action in response to a violation of law.
83.11 	(c) Notwithstanding any law to the contrary, a Cannabis Advisory Council member, the 
83.12 	governor, or an employee of a state agency must not be held civilly or criminally liable for 
83.13 	any injury, loss of property, personal injury, or death caused by any act or omission while 
83.14 	acting within the scope of office or employment under sections 342.47 342.51 to 342.60.
83.15 	(d) Federal, state, and local law enforcement authorities are prohibited from accessing 
83.16 	the registry except when acting pursuant to a valid search warrant. Notwithstanding section 
83.17 	13.09, a violation of this paragraph is a gross misdemeanor.
83.18 	(e) Notwithstanding any law to the contrary, the office and employees of the office must 
83.19 	not release data or information about an individual contained in any report or document or 
83.20 	in the registry and must not release data or information obtained about a patient enrolled in 
83.21 	the registry program, except as provided in sections 342.47 342.51 to 342.60. 
83.22 	Notwithstanding section 13.09, a violation of this paragraph is a gross misdemeanor.
83.23 	(f) No information contained in a report or document, contained in the registry, or 
83.24 	obtained from a patient under sections 342.47 342.51 to 342.60 may be admitted as evidence 
83.25 	in a criminal proceeding, unless:
83.26 	(1) the information is independently obtained; or
83.27 	(2) admission of the information is sought in a criminal proceeding involving a criminal 
83.28 	violation of sections 342.47 342.51 to 342.60.
83.29 	(g) Possession of a registry verification or an application for enrollment in the registry 
83.30 	program:
83.31 	(1) does not constitute probable cause or reasonable suspicion;
83.32 	(2) must not be used to support a search of the person or property of the person with a 
83.33 	registry verification or application to enroll in the registry program; and
84.1 	(3) must not subject the person or the property of the person to inspection by any 
84.2 	government agency.

84.3 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
84.4 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
84.5 	is later.

84.6 	Sec. 87. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 3, is amended 
84.7 	to read:
84.8 		Subd. 3.School enrollment; rental property. (a) No school may refuse to enroll or 
84.9 	otherwise penalize a patient or person enrolled in the registry program as a pupil or otherwise 
84.10 	penalize a patient solely because the patient or person is enrolled in the registry program, 
84.11 	unless failing to do so would violate federal law or regulations or cause the school to lose 
84.12 	a monetary or licensing-related benefit under federal law or regulations.
84.13 	(b) No landlord may refuse to lease to a patient or person enrolled in the registry program 
84.14 	or otherwise penalize a patient or person enrolled in the registry program solely because 
84.15 	the patient or person is enrolled in the registry program, unless failing to do so would violate 
84.16 	federal law or regulations or cause the landlord to lose a monetary or licensing-related 
84.17 	benefit under federal law or regulations.

84.18 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
84.19 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
84.20 	is later.

84.21 	Sec. 88. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 4, is amended 
84.22 	to read:
84.23 		Subd. 4.Medical care. For purposes of medical care, including organ transplants, a 
84.24 	patient's use of medical cannabis flower or medical cannabinoid products according to 
84.25 	sections 342.47 342.51 to 342.60 is considered the equivalent of the authorized use of a 
84.26 	medication used at the discretion of a health care practitioner and does not disqualify a 
84.27 	patient from needed medical care.

84.28 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
84.29 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
84.30 	is later.

85.1 	Sec. 89. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 5, is amended 
85.2 	to read:
85.3 		Subd. 5.Employment. (a) Unless a failure to do so would violate federal or state law 
85.4 	or regulations or cause an employer to lose a monetary or licensing-related benefit under 
85.5 	federal law or regulations, an employer may not discriminate against a person in hiring, 
85.6 	termination, or any term or condition of employment, or otherwise penalize a person, if the 
85.7 	discrimination is based on:
85.8 	(1) the person's status as a patient or person enrolled in the registry program; or
85.9 	(2) a patient's positive drug test for cannabis components or metabolites, unless the 
85.10 	patient used, possessed, sold, transported, or was impaired by medical cannabis flower or 
85.11 	a medical cannabinoid product on work premises, during working hours, or while operating 
85.12 	an employer's machinery, vehicle, or equipment.
85.13 	(b) An employee who is a patient and whose employer requires the employee to undergo 
85.14 	drug testing according to section 181.953 may present the employee's registry verification 
85.15 	as part of the employee's explanation under section 181.953, subdivision 6.

85.16 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
85.17 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
85.18 	is later.

85.19 	Sec. 90. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 6, is amended 
85.20 	to read:
85.21 		Subd. 6.Custody; visitation; parenting time. A person must not be denied custody of 
85.22 	a minor child or visitation rights or parenting time with a minor child based solely on the 
85.23 	person's status as a patient or person enrolled in the registry program. There must be no 
85.24 	presumption of neglect or child endangerment for conduct allowed under sections 342.47
85.25 	342.51 to 342.60, unless the person's behavior creates an unreasonable danger to the safety 
85.26 	of the minor as established by clear and convincing evidence.

85.27 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
85.28 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
85.29 	is later.

86.1 	Sec. 91. Minnesota Statutes 2023 Supplement, section 342.57, subdivision 7, is amended 
86.2 	to read:
86.3 		Subd. 7.Action for damages. In addition to any other remedy provided by law, a patient 
86.4 	or person enrolled in the registry program may bring an action for damages against any 
86.5 	person who violates subdivision 3, 4, or 5. A person who violates subdivision 3, 4, or 5 is 
86.6 	liable to a patient or person enrolled in the registry program injured by the violation for the 
86.7 	greater of the person's actual damages or a civil penalty of $100 and reasonable attorney 
86.8 	fees.

86.9 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
86.10 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
86.11 	is later.

86.12 	Sec. 92. Minnesota Statutes 2023 Supplement, section 342.58, is amended to read:
86.13 	342.58 VIOLATION BY HEALTH CARE PRACTITIONER; CRIMINAL 
86.14 	PENALTY.
86.15 	A health care practitioner who knowingly refers patients to a medical cannabis business 
86.16 	or to a designated caregiver, who advertises as a retailer or producer of medical cannabis 
86.17 	flower or medical cannabinoid products, or who issues certifications while holding a financial 
86.18 	interest in a cannabis retailer or medical cannabis business is guilty of a misdemeanor and 
86.19 	may be sentenced to imprisonment for not more than 90 days or to payment of not more 
86.20 	than $1,000, or both.

86.21 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
86.22 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
86.23 	is later.

86.24 	Sec. 93. Minnesota Statutes 2023 Supplement, section 342.60, is amended to read:
86.25 	342.60 APPLIED RESEARCH.
86.26 	The Division of Medical Cannabis office may conduct, or award grants to health care 
86.27 	providers or research organizations to conduct, applied research on the safety and efficacy 
86.28 	of using medical cannabis flower or medical cannabinoid products to treat a specific health 
86.29 	condition. A health care provider or research organization receiving a grant under this section 
86.30 	must provide the office with access to all data collected in applied research funded under 
86.31 	this section. The office may use data from applied research conducted or funded under this 
87.1 	section as evidence to approve additional qualifying medical conditions or additional 
87.2 	allowable forms of medical cannabis.

87.3 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
87.4 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
87.5 	is later.

87.6 	Sec. 94. Minnesota Statutes 2023 Supplement, section 342.61, subdivision 4, is amended 
87.7 	to read:
87.8 		Subd. 4.Testing of samples; disclosures. (a) On a schedule determined by the office, 
87.9 	every cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
87.10 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
87.11 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
87.12 	medical cannabis combination business shall make each batch of cannabis flower, cannabis 
87.13 	products, artificially derived cannabinoids, lower-potency hemp edibles, or hemp-derived 
87.14 	consumer products grown, manufactured, or imported by the cannabis business or hemp 
87.15 	business available to a cannabis testing facility.
87.16 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
87.17 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
87.18 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
87.19 	medical cannabis combination business must disclose all known information regarding 
87.20 	pesticides, fertilizers, solvents, or other foreign materials, including but not limited to 
87.21 	catalysts used in creating artificially derived cannabinoids, applied or added to the batch of 
87.22 	cannabis flower, cannabis products, artificially derived cannabinoids, lower-potency hemp 
87.23 	edibles, or hemp-derived consumer products subject to testing. Disclosure must be made 
87.24 	to the cannabis testing facility and must include information about all applications by any 
87.25 	person, whether intentional or accidental.
87.26 	(c) The cannabis testing facility shall select one or more representative samples from 
87.27 	each batch, test the samples for the presence of contaminants, and test the samples for 
87.28 	potency and homogeneity and to allow the cannabis flower, cannabis product, artificially 
87.29 	derived cannabinoid, lower-potency hemp edible, or hemp-derived consumer product to be 
87.30 	accurately labeled with its cannabinoid profile. Testing for contaminants must include testing 
87.31 	for residual solvents, foreign material, microbiological contaminants, heavy metals, pesticide 
87.32 	residue, mycotoxins, and any items identified pursuant to paragraph (b), and may include 
87.33 	testing for other contaminants. A cannabis testing facility must destroy or return to the 
87.34 	cannabis business or hemp business any part of the sample that remains after testing.

88.1 	EFFECTIVE DATE. This section is effective the day following final enactment.

88.2 	Sec. 95. Minnesota Statutes 2023 Supplement, section 342.61, subdivision 5, is amended 
88.3 	to read:
88.4 		Subd. 5.Test results. (a) If a sample meets the applicable testing standards, a cannabis 
88.5 	testing facility shall issue a certification to a cannabis microbusiness, cannabis 
88.6 	mezzobusiness, cannabis cultivator, cannabis manufacturer, cannabis wholesaler with an 
88.7 	endorsement to import products, lower-potency hemp edible manufacturer, medical cannabis 
88.8 	cultivator, medical cannabis processor, or medical cannabis combination business and the 
88.9 	cannabis business or hemp business may then sell or transfer the batch of cannabis flower, 
88.10 	cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or 
88.11 	hemp-derived consumer products from which the sample was taken to another cannabis 
88.12 	business or hemp business, or offer the cannabis flower, cannabis products, lower-potency 
88.13 	hemp edibles, or hemp-derived consumer products for sale to customers or patients. If a 
88.14 	sample does not meet the applicable testing standards or if the testing facility is unable to 
88.15 	test for a substance identified pursuant to subdivision 4, paragraph (b), the batch from which 
88.16 	the sample was taken shall be subject to procedures established by the office for such batches, 
88.17 	including destruction, remediation, or retesting.
88.18 	(b) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
88.19 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
88.20 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
88.21 	medical cannabis combination business must maintain the test results for cannabis flower, 
88.22 	cannabis products, artificially derived cannabinoids, lower-potency hemp edibles, or 
88.23 	hemp-derived consumer products grown, manufactured, or imported by that cannabis 
88.24 	business or hemp business for at least five years after the date of testing.
88.25 	(c) A cannabis microbusiness, cannabis mezzobusiness, cannabis cultivator, cannabis 
88.26 	manufacturer, cannabis wholesaler with an endorsement to import products, lower-potency 
88.27 	hemp edible manufacturer, medical cannabis cultivator, medical cannabis processor, or 
88.28 	medical cannabis combination business shall make test results maintained by that cannabis 
88.29 	business or hemp business available for review by any member of the public, upon request. 
88.30 	Test results made available to the public must be in plain language.

88.31 	EFFECTIVE DATE. This section is effective the day following final enactment.

89.1 	Sec. 96. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 2, is amended 
89.2 	to read:
89.3 		Subd. 2.Content of label; cannabis. All cannabis flower and hemp-derived consumer 
89.4 	products that consist of hemp plant parts sold to customers or patients must have affixed 
89.5 	on the packaging or container of the cannabis flower or hemp-derived consumer product a 
89.6 	label that contains at least the following information:
89.7 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
89.8 	cannabis cultivator, medical cannabis cultivator, or industrial hemp grower where the 
89.9 	cannabis flower or hemp plant part was cultivated;
89.10 	(2) the net weight or volume of cannabis flower or hemp plant parts in the package or 
89.11 	container;
89.12 	(3) the batch number;
89.13 	(4) the cannabinoid profile;
89.14 	(5) a universal symbol established by the office indicating that the package or container 
89.15 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
89.16 	hemp-derived consumer product;
89.17 	(6) verification that the cannabis flower or hemp plant part was tested according to 
89.18 	section 342.61 and that the cannabis flower or hemp plant part complies with the applicable 
89.19 	standards;
89.20 	(7) the maximum dose, quantity, or consumption that may be considered medically safe 
89.21 	within a 24-hour period;
89.22 	(7) information on the usage of the cannabis flower or hemp-derived consumer product;
89.23 	(8) the following statement: "Keep this product out of reach of children."; and
89.24 	(9) any other statements or information required by the office.

89.25 	EFFECTIVE DATE. This section is effective the day following final enactment.

89.26 	Sec. 97. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 3, is amended 
89.27 	to read:
89.28 		Subd. 3.Content of label; cannabinoid products. (a) All cannabis products, 
89.29 	lower-potency hemp edibles, hemp-derived consumer products other than products subject 
89.30 	to the requirements under subdivision 2, medical cannabinoid products, and hemp-derived 
90.1 	topical products sold to customers or patients must have affixed to the packaging or container 
90.2 	of the cannabis product a label that contains at least the following information:
90.3 	(1) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
90.4 	cannabis cultivator, medical cannabis cultivator, or industrial hemp grower that cultivated 
90.5 	the cannabis flower or hemp plant parts used in the cannabis product, lower-potency hemp 
90.6 	edible, hemp-derived consumer product, or medical cannabinoid product;
90.7 	(2) the name and license number of the cannabis microbusiness, cannabis mezzobusiness, 
90.8 	cannabis manufacturer, lower-potency hemp edible manufacturer, medical cannabis 
90.9 	processor, or industrial hemp grower that manufactured the cannabis concentrate, hemp 
90.10 	concentrate, or artificially derived cannabinoid and, if different, the name and license number 
90.11 	of the cannabis microbusiness, cannabis mezzobusiness, cannabis manufacturer, or 
90.12 	lower-potency hemp edible manufacturer, or medical cannabis processor that manufactured 
90.13 	the product;
90.14 	(3) the net weight or volume of the cannabis product, lower-potency hemp edible, or 
90.15 	hemp-derived consumer product in the package or container;
90.16 	(4) the type of cannabis product, lower-potency hemp edible, or hemp-derived consumer 
90.17 	product;
90.18 	(5) the batch number;
90.19 	(6) the serving size;
90.20 	(7) the cannabinoid profile per serving and in total;
90.21 	(8) a list of ingredients;
90.22 	(9) a universal symbol established by the office indicating that the package or container 
90.23 	contains cannabis flower, a cannabis product, a lower-potency hemp edible, or a 
90.24 	hemp-derived consumer product;
90.25 	(10) a warning symbol developed by the office in consultation with the commissioner 
90.26 	of health and the Minnesota Poison Control System that:
90.27 	(i) is at least three-quarters of an inch tall and six-tenths of an inch wide;
90.28 	(ii) is in a highly visible color;
90.29 	(iii) includes a visual element that is commonly understood to mean a person should 
90.30 	stop;
90.31 	(iv) indicates that the product is not for children; and
91.1 	(v) includes the phone number of the Minnesota Poison Control System;
91.2 	(11) verification that the cannabis product, lower-potency hemp edible, hemp-derived 
91.3 	consumer product, or medical cannabinoid product was tested according to section 342.61 
91.4 	and that the cannabis product, lower-potency hemp edible, hemp-derived consumer product, 
91.5 	or medical cannabinoid product complies with the applicable standards;
91.6 	(12) the maximum dose, quantity, or consumption that may be considered medically 
91.7 	safe within a 24-hour period;
91.8 	(12) information on the usage of the product;
91.9 	(13) the following statement: "Keep this product out of reach of children."; and
91.10 	(14) any other statements or information required by the office.
91.11 	(b) The office may by rule establish alternative labeling requirements for lower-potency 
91.12 	hemp edibles that are imported into the state provided that those requirements provide 
91.13 	consumers with information that is substantially similar to the information described in 
91.14 	paragraph (a).

91.15 	EFFECTIVE DATE. This section is effective the day following final enactment.

91.16 	Sec. 98. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 4, is amended 
91.17 	to read:
91.18 		Subd. 4.Additional content of label; medical cannabis flower and medical
91.19 	cannabinoid products. In addition to the applicable requirements for labeling under 
91.20 	subdivision 2 or 3, all medical cannabis flower sold to patients and medical cannabinoid 
91.21 	products sold to patients must include at least the following information on the label affixed 
91.22 	to the packaging or container of the medical cannabis flower or medical cannabinoid product:
91.23 	(1) the patient's name and date of birth;
91.24 	(2) the name and date of birth of the patient's registered designated caregiver or, if listed 
91.25 	on the registry verification, the name of the patient's parent, legal guardian, or spouse, if 
91.26 	applicable; and
91.27 	(3) the patient's registry identification number.

91.28 	EFFECTIVE DATE. This section is effective the day following final enactment.

92.1 	Sec. 99. Minnesota Statutes 2023 Supplement, section 342.63, subdivision 6, is amended 
92.2 	to read:
92.3 		Subd. 6.Additional information. (a) A cannabis microbusiness, cannabis mezzobusiness, 
92.4 	cannabis retailer, medical cannabis retailer, or medical cannabis combination business must 
92.5 	provide customers and patients with the following information:
92.6 	(1) factual information about impairment effects and the expected timing of impairment 
92.7 	effects, side effects, adverse effects, and health risks of cannabis flower, cannabis products, 
92.8 	lower-potency hemp edibles, and hemp-derived consumer products;
92.9 	(2) a statement that customers and patients must not operate a motor vehicle or heavy 
92.10 	machinery while under the influence of cannabis flower, cannabis products, lower-potency 
92.11 	hemp edibles, and hemp-derived consumer products;
92.12 	(3) resources customers and patients may consult to answer questions about cannabis 
92.13 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
92.14 	products, and any side effects and adverse effects;
92.15 	(4) contact information for the poison control center and a safety hotline or website for 
92.16 	customers to report and obtain advice about side effects and adverse effects of cannabis 
92.17 	flower, cannabis products, lower-potency hemp edibles, and hemp-derived consumer 
92.18 	products;
92.19 	(5) substance use disorder treatment options; and
92.20 	(6) any other information specified by the office.
92.21 	(b) A cannabis microbusiness, cannabis mezzobusiness, or cannabis retailer, or medical 
92.22 	cannabis retailer may include the information described in paragraph (a) on the label affixed 
92.23 	to the packaging or container of cannabis flower, cannabis products, lower-potency hemp 
92.24 	edibles, and hemp-derived consumer products by:
92.25 	(1) posting the information in the premises of the cannabis microbusiness, cannabis 
92.26 	mezzobusiness, cannabis retailer, medical cannabis retailer, or medical cannabis combination 
92.27 	business; or
92.28 	(2) providing the information on a separate document or pamphlet provided to customers 
92.29 	or patients when the customer purchases cannabis flower, a cannabis product, a lower-potency 
92.30 	hemp edible, or a hemp-derived consumer product.

92.31 	EFFECTIVE DATE. This section is effective the day following final enactment.

93.1 	Sec. 100. Laws 2023, chapter 63, article 1, section 2, the effective date, is amended to 
93.2 	read:

93.3 	EFFECTIVE DATE. This section is effective July 1, 2023, except for subdivision 3, 
93.4 	which is effective March 1, 2025.

93.5 	Sec. 101. Laws 2023, chapter 63, article 1, section 51, the effective date, is amended to 
93.6 	read:

93.7 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
93.8 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
93.9 	is later.

93.10 	Sec. 102. Laws 2023, chapter 63, article 1, section 52, the effective date, is amended to 
93.11 	read:

93.12 	EFFECTIVE DATE. This section is effective March 1, 2025 the day following final 
93.13 	enactment.

93.14 	Sec. 103. Laws 2023, chapter 63, article 1, section 53, the effective date, is amended to 
93.15 	read:

93.16 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
93.17 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
93.18 	is later.

93.19 	Sec. 104. Laws 2023, chapter 63, article 1, section 54, the effective date, is amended to 
93.20 	read:

93.21 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
93.22 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
93.23 	is later.

93.24 	Sec. 105. Laws 2023, chapter 63, article 1, section 55, the effective date, is amended to 
93.25 	read:

93.26 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
93.27 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
93.28 	is later.

94.1 	Sec. 106. Laws 2023, chapter 63, article 1, section 56, the effective date, is amended to 
94.2 	read:

94.3 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
94.4 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
94.5 	is later.

94.6 	Sec. 107. Laws 2023, chapter 63, article 1, section 57, the effective date, is amended to 
94.7 	read:

94.8 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
94.9 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
94.10 	is later.

94.11 	Sec. 108. Laws 2023, chapter 63, article 1, section 58, the effective date, is amended to 
94.12 	read:

94.13 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
94.14 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
94.15 	is later.

94.16 	Sec. 109. Laws 2023, chapter 63, article 1, section 59, the effective date, is amended to 
94.17 	read:

94.18 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
94.19 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
94.20 	is later.

94.21 	Sec. 110. Laws 2023, chapter 63, article 1, section 61, the effective date, is amended to 
94.22 	read:

94.23 	EFFECTIVE DATE. This section is effective March 1, 2025, or upon the adoption of 
94.24 	initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
94.25 	is later.

94.26 	Sec. 111. Laws 2023, chapter 63, article 6, section 73, the effective date, is amended to 
94.27 	read:

94.28 	EFFECTIVE DATE. Paragraph (a) is effective March 1, 2025, or upon the adoption 
94.29 	of initial rules pertaining to medical cannabis under section 342.02, subdivision 5, whichever 
94.30 	is later. Paragraph (b) is effective August 1, 2023. Paragraph (c) is effective July 1, 2023.

95.1 	Sec. 112. EMPLOYEE TRANSFER.
 95.2 	(a) The powers and duties of the Department of Health with respect to the sale of certain 
95.3 	cannabinoid products under Minnesota Statutes, section 151.72, are transferred to the Office 
95.4 	of Cannabis Management under Minnesota Statutes, section 15.039.
95.5 	(b) The following protections shall apply to employees who are transferred from the 
95.6 	Department of Health to the Office of Cannabis Management:
95.7 	(1) the employment status and job classification of a transferred employee shall not be 
95.8 	altered as a result of the transfer;
95.9 	(2) transferred employees who were represented by an exclusive representative prior to 
95.10 	the transfer shall continue to be represented by the same exclusive representative after the 
95.11 	transfer;
95.12 	(3) the applicable collective bargaining agreements with exclusive representatives shall 
95.13 	continue in full force and effect for such transferred employees after the transfer;
95.14 	(4) the state must meet and negotiate with the exclusive representatives of the transferred 
95.15 	employees about any proposed changes affecting or relating to the transferred employees' 
95.16 	terms and conditions of employment to the extent such changes are not addressed in the 
95.17 	applicable collective bargaining agreement; and
95.18 	(5) for an employee in a temporary unclassified position transferred to the Office of 
95.19 	Cannabis Management, the total length of time that the employee has served in the 
95.20 	appointment shall include all time served in the appointment at the transferring agency and 
95.21 	the time served in the appointment at the Office of Cannabis Management. An employee 
95.22 	in a temporary unclassified position who was hired by a transferring agency through an 
95.23 	open competitive selection process in accordance with a policy enacted by Minnesota 
95.24 	Management and Budget shall be considered to have been hired through such process after 
95.25 	the transfer.

95.26 	Sec. 113. TRANSFER OF ACTIVE AND INACTIVE COMPLAINTS.
 95.27 	The Department of Health shall transfer all data, including not public data as defined in 
95.28 	Minnesota Statutes, section 13.02, subdivision 8a, on active complaints and inactive 
95.29 	complaints involving alleged violations of Minnesota Statutes 2022, section 151.72, as well 
95.30 	as registration data collected under Minnesota Statutes 2022, section 151.72, subdivision 
95.31 	5b, to the Office of Cannabis Management. The Department of Health and the Office of 
95.32 	Cannabis Management shall ensure that the transfer takes place in a manner and on a schedule 
95.33 	that prioritizes public health.

96.1 	Sec. 114. REPEALER.
 96.2 	(a) Minnesota Statutes 2023 Supplement, sections 342.01, subdivisions 28, 52, 53, 54, 
96.3 	and 55; 342.18, subdivision 1; 342.27, subdivision 13; and 342.29, subdivision 9, are 
96.4 	repealed.
96.5 	(b) Minnesota Statutes 2023 Supplement, sections 342.47; 342.48; 342.49; 342.50; and 
96.6 	342.52, subdivision 8, are repealed.
96.7 	(c) Laws 2023, chapter 63, article 7, sections 4; and 6, are repealed.

96.8 	EFFECTIVE DATE. Paragraphs (a) and (c) are effective the day following final 
96.9 	enactment. Paragraph (b) is effective March 1, 2025, or upon the adoption of initial rules 
96.10 	pertaining to medical cannabis under section 342.02, subdivision 5, whichever is later.

APPENDIX 

Repealed Minnesota Statutes: 24-05391 

342.01 DEFINITIONS.Subd. 28.Division of Medical Cannabis. 
"Division of Medical Cannabis" means a division housed in the Office of Cannabis Management that operates the medical cannabis program. 

Subd. 52.Medical cannabinoid product. 
(a) "Medical cannabinoid product" means a product that: 

(1) consists of or contains cannabis concentrate or hemp concentrate or is infused with cannabinoids, including but not limited to artificially derived cannabinoids; and 

(2) is provided to a patient enrolled in the registry program; a registered designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient, by a cannabis retailer or medical cannabis retailer to treat or alleviate the symptoms of a qualifying medical condition. 

(b) A medical cannabinoid product must be in the form of: 

(1) liquid, including but not limited to oil; 

(2) pill; 

(3) liquid or oil for use with a vaporized delivery method; 

(4) water-soluble cannabinoid multiparticulate, including granules, powder, and sprinkles; 

(5) orally dissolvable product, including lozenges, gum, mints, buccal tablets, and sublingual tablets; 

(6) edible products in the form of gummies and chews; 

(7) topical formulation; or 

(8) any allowable form or delivery method approved by the office. 

(c) Medical cannabinoid product does not include adult-use cannabis products or hemp-derived consumer products. 

Subd. 53.Medical cannabis business. 
"Medical cannabis business" means an entity licensed under this chapter to engage in one or more of the following: 

(1) the cultivation of cannabis plants for medical cannabis flower; 

(2) the manufacture of medical cannabinoid products; and 

(3) the retail sale of medical cannabis flower and medical cannabinoid products. 

Subd. 54.Medical cannabis flower. 
"Medical cannabis flower" means cannabis flower provided to a patient enrolled in the registry program; a registered designated caregiver; or a parent, legal guardian, or spouse of an enrolled patient by a cannabis retailer or medical cannabis business to treat or alleviate the symptoms of a qualifying medical condition. Medical cannabis flower does not include adult-use cannabis flower. 

Subd. 55.Medical cannabis paraphernalia. 
"Medical cannabis paraphernalia" means a delivery device, related supply, or educational material used by a patient enrolled in the registry program to administer medical cannabis and medical cannabinoid products. 

342.18 LICENSE SELECTION CRITERIA.Subdivision 1.Market stability. 
The office shall issue the necessary number of licenses in order to ensure the sufficient supply of cannabis flower and cannabis products to meet demand, provide market stability, ensure a competitive market, and limit the sale of unregulated cannabis flower and cannabis products. 

342.27 RETAIL SALE OF CANNABIS FLOWER AND PRODUCTS; GENERAL REQUIREMENTS.Subd. 13.Adult-use and medical cannabis; colocation. 
(a) A cannabis business with a license or endorsement authorizing the retail sale of adult-use cannabis flower or adult-use cannabis products that is also a licensed medical cannabis retailer may sell medical cannabis flower and medical cannabinoid products on a portion of the business's premises. 

(b) The premises must provide an appropriate space for a pharmacist employee of the medical cannabis retailer to consult with a patient to determine the proper type of medical cannabis flower and medical cannabinoid products and proper dosage for the patient. 

342.29 CANNABIS MEZZOBUSINESS LICENSING AND OPERATIONS.Subd. 9.Medical cannabis endorsement. 
A cannabis mezzobusiness that cultivates cannabis plants for use as medical cannabis flower or for use in medical cannabinoid products, processes medical cannabinoid products, or both, must comply with sections 342.49, paragraph (d); 342.50, paragraph (c), and any additional requirements established by the office. 

342.47 MEDICAL CANNABIS BUSINESS LICENSES.Subdivision 1.License types. 
(a) The office shall issue the following types of medical cannabis business licenses: 

(1) medical cannabis cultivator; 

(2) medical cannabis processor; 

(3) medical cannabis retailer; and 

(4) medical cannabis combination business license. 

(b) The Division of Medical Cannabis may oversee the licensing and regulation of medical cannabis businesses. 

Subd. 2.Multiple licenses; limits. 
(a) Except as provided in subdivision 3, a person, cooperative, or business holding: 

(1) a medical cannabis cultivator license may also hold a medical cannabis processor license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses; 

(2) a medical cannabis processor license may also hold a medical cannabis cultivator license, a cannabis cultivator license, a cannabis manufacturer license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses; or 

(3) a medical cannabis retailer license may also hold a cannabis mezzobusiness license, a cannabis retailer license, a cannabis delivery service license, and a cannabis event organizer license subject to the ownership limitations that apply to those licenses. 

(b) Except as provided in paragraph (a), no person, cooperative, or business holding a medical cannabis license may own or operate any other cannabis business or hemp business. 

(c) The office by rule may limit the number of medical cannabis business licenses that a person or business may hold. 

(d) For purposes of this subdivision, a restriction on the number of licenses or type of license that a business may hold applies to every cooperative member or every director, manager, and general partner of a medical cannabis business. 

Subd. 3.Medical cannabis combination business license. 
(a) A person, cooperative, or business holding a medical cannabis combination license is prohibited from owning or operating any other cannabis business or hemp business. 

(b) A person or business may only hold one medical cannabis combination license. 

342.48 MEDICAL CANNABIS BUSINESS APPLICATIONS.
In addition to the information required to be submitted under section 342.14, subdivision 1, and rules adopted pursuant to that section, a person, cooperative, or business seeking a medical cannabis business license must submit the following information in a form approved by the office: 

(1) for medical cannabis cultivator license applicants: 

(i) an operating plan demonstrating the proposed size and layout of the cultivation facility; plans for wastewater and waste disposal for the cultivation facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the cultivation facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements; 

(ii) a cultivation plan demonstrating the proposed size and layout of the cultivation facility that will be used exclusively for cultivation for medical cannabis, including the total amount of plant canopy; and 

(iii) evidence that the business will comply with the applicable operation requirements for the license being sought; 

(2) for medical cannabis processor license applicants: 

(i) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems; plans for wastewater and waste disposal for the manufacturing facility; plans for providing electricity, water, and other utilities necessary for the normal operation of the manufacturing facility; and plans for compliance with applicable building code and federal and state environmental and workplace safety requirements; 

(ii) all methods of extraction and concentration that the applicant intends to use and the volatile chemicals, if any, that are involved in extraction or concentration; 

(iii) if the applicant is seeking an endorsement to manufacture products infused with cannabinoids for consumption by patients enrolled in the registry program, proof of an edible cannabinoid product handler endorsement from the office; and 

(iv) evidence that the applicant will comply with the applicable operation requirements for the license being sought; 

(3) for medical cannabis retailer license applicants: 

(i) a list of every retail license held by the applicant and, if the applicant is a business, every retail license held, either as an individual or as part of another business, by each officer, director, manager, and general partner of the cannabis business; 

(ii) an operating plan demonstrating the proposed layout of the facility, including a diagram of ventilation and filtration systems, policies to avoid sales to individuals who are not authorized to receive the distribution of medical cannabis flower or medical cannabinoid products, identification of a restricted area for storage, and plans to prevent the visibility of cannabis flower and cannabinoid products; and 

(iii) evidence that the applicant will comply with the applicable operation requirements for the license being sought; or 

(4) for medical cannabis combination license applicants: 

(i) the information required under clauses (1) to (3); and 

(ii) any additional information required under sections 342.30, subdivision 3; 342.31, subdivision 3; and 342.32, subdivision 3. 

342.49 MEDICAL CANNABIS CULTIVATORS.
(a) A medical cannabis cultivator license entitles the license holder to grow cannabis plants within the approved amount of space up to 60,000 square feet of plant canopy from seed or immature plant to mature plant, harvest cannabis flower from a mature plant, package and label cannabis flower as medical cannabis flower, sell medical cannabis flower to medical cannabis processors and medical cannabis retailers, transport medical cannabis flower to a medical cannabis processor located on the same premises, and perform other actions approved by the office. 

(b) A medical cannabis cultivator license holder must comply with all requirements of section 342.25. 

(c) A medical cannabis cultivator license holder must verify that every batch of medical cannabis flower has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabis flower before the medical cannabis cultivator may package, label, or sell the medical cannabis flower to any other entity. 

(d) A medical cannabis cultivator may exceed the limit of 60,000 square feet of plant canopy if it was legally cultivating medical cannabis with a greater plant canopy as of April 1, 2023. 

342.50 MEDICAL CANNABIS PROCESSORS.
(a) A medical cannabis processor license, consistent with the specific license endorsement or endorsements, entitles the license holder to: 

(1) purchase medical cannabis flower, medical cannabinoid products, hemp plant parts, and hemp concentrate from medical cannabis cultivators and other medical cannabis processors; 

(2) purchase hemp plant parts from industrial hemp growers; 

(3) make cannabis concentrate from medical cannabis flower; 

(4) make hemp concentrate, including hemp concentrate with a delta-9 tetrahydrocannabinol concentration of more than 0.3 percent as measured by weight; 

(5) manufacture medical cannabinoid products; 

(6) package and label medical cannabinoid products for sale to other medical cannabis processors and to medical cannabis retailers; and 

(7) perform other actions approved by the office. 

(b) A medical cannabis processor license holder must comply with all requirements of section 342.26, including requirements to obtain specific license endorsements. 

(c) A medical cannabis processor license holder must verify that every batch of medical cannabinoid product has passed safety, potency, and consistency testing at a cannabis testing facility approved by the office for the testing of medical cannabinoid products before the medical cannabis processor may package, label, or sell the medical cannabinoid product to any other entity. 

342.52 PATIENT REGISTRY PROGRAM.Subd. 8.Allowable delivery methods. 
A patient in the registry program may receive medical cannabis flower and medical cannabinoid products. The office may approve additional delivery methods to expand the types of products that qualify as medical cannabinoid products. 

Repealed Minnesota Session Laws: 24-05391 

Laws 2023, chapter 63, article 7, section 4
Sec. 4. EDIBLE CANNABINOID PRODUCTS; ENFORCEMENT. 
(a) The Department of Health shall enforce the provisions of Minnesota Statutes, section 151.72, and all rules, orders, stipulation agreements, settlements, compliance agreements, and registrations related to that section adopted or issued by the Office of Medical Cannabis or the Department of Health pursuant to the Health Enforcement Consolidation Act of 1993 contained in Minnesota Statutes, sections 144.989 to 144.993, and the authority to embargo products described in paragraph (b). The commissioner of health may assign enforcement responsibilities to the Office of Medical Cannabis. 

(b) Whenever a duly authorized agent of the Department of Health finds or has probable cause to believe that any product is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the agent shall affix thereto an appropriate marking, giving notice that the article is, or is suspected of being in violation of Minnesota Statutes, section 151.72, has been embargoed, and warning that it is unlawful for any person to remove or dispose of the embargoed article by sale or otherwise without permission from the agent or the court. When an agent of the Department of Health has embargoed an article, the Department of Health shall, within 30 days, petition the district court in whose jurisdiction the article is embargoed for an order of condemnation. When an embargoed article is not so found by the agent, the agent shall remove the marking. If the court finds that an embargoed article is being sold in violation of the provisions of Minnesota Statutes, section 151.72, the article shall be destroyed at the expense of the claimant thereof, who shall also pay all court costs and fees, storage, and other proper expenses. If the violation can be corrected by proper labeling or processing of the article, or by filing the proper documents with the court, the court, after the costs, fees, and expenses have been paid and a sufficient bond has been executed, may order that the article be delivered to the claimant for labeling, processing, or filing under supervision of an agent of the board. The expense of the supervision shall be paid by the claimant. The bond shall be returned to the claimant on the representation to the court by the board that the article is no longer in violation of this chapter and that the expenses of supervision have been paid. 

(c) The enforcement authority under paragraphs (a) and (b) shall transfer to the Office of Cannabis Management at any such time that the powers and duties of the Department of Health with respect to the medical cannabis program under Minnesota Statutes, sections 152.22 to 152.37, are transferred to the Office of Cannabis Management. The director of the Office of Cannabis Management may assign enforcement responsibilities to the Division of Medical Cannabis. 

(d) This section shall expire on March 1, 2025. 

EFFECTIVE DATE. 
This section is effective the day following final enactment. 

Laws 2023, chapter 63, article 7, section 6
Sec. 6. REPEALER. Minnesota Statutes 2022, section 151.72, is repealed.
EFFECTIVE DATE. 
This section is effective March 1, 2025.